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Summary
Development and evaluation o f  quantitative methods o f  analysing 
single photon emission com puted tomography blood flo w  images 
o f  the brain .
This thesis presents the investigations carried out on a particular method of functional human 
brain mapping (FHBM) analysis (SPM)1 as to its applicability to a routine nuclear medicine 
neuroimaging department. Principally designed for the investigation into positron emission 
tomography (PET) radiolabelled water studies of normal brain function during 
neuroactivation experiments the technique is still relatively novel for the purposes of 
interpreting single photon emission computed tomography (SPECT) images of brain 
function.
This thesis investigates whether the functional brain mapping technique (SPM) can be 
extended to embrace the widely available imaging technique of SPECT and to determine 
whether this combination can contribute to routine diagnosis of abnormalities in brain 
function and to research investgiations involving functional neuroactivation.
Validation of the image standardisation facility of SPM96 applied to oblique 
or incomplete image data sets.
The image standardisation component of SPM96 was validated by subjecting it to a series of 
challenge conditions created from simulated data. The challenge conditions were chosen to 
reflect those that occur in clinical scans, for example, extreme misalignments to a standard 
reference orientation resulting in axial truncation of the image volume. The results of the 
software performance under these challenges showed that the image standardisation 
component of this software had particular problems correcting for large (15°) rotations in the 
sagittal and coronal planes coupled with severe axial truncation. Modifications to the image
Statistical Parametric Mapping, Prof KJ. Friston. Wellcome department of Cognitive Neurology, Institute 
of Neurology, London, U.K.
xix
standardisation procedure were made based on these results. This involved the inclusion of a 
rigid body registration step prior to image standardisation and the editing of spurious voxel 
values, created by erroneous interpolation of edge information after re-orientation. The extra 
image registration step required the creation of an ideal CBF SPECT scan (whole brain 
coverage and orientation to a standard reference space) to which all the scans containing the 
challenge conditions were registered. Having established a set of working criteria for use 
with routine " mTc-HMPAO SPECT scans, SPM96 was then applied to images of 
individual patients presenting with symptoms of dementia. The aims were:- a) To 
determine whether SPM maps could be produced which were consistent with the original 
scans, b) To ascertain whether they could assist in the reading of scans by reducing inter- 
rater variability.
Investigation of SPM96 as an aid to the differential diagnosis of dementia 
using 99mTc HMPAO SPECT images of rCBF.
To investigate the usefulness of SPM96 analysis as an aid to the visual reporting of CBF 
SPECT scans it was used to assist in the differential diagnosis of dementia. Usefulness was 
assessed by comparing inter observer reliability for diagnosis of dementia based on 
information from the CBF scans alone compared to diagnosis based on the scans plus 
information from the SPM analysis. The hypothesis was that inter observer reliability 
would be improved with the addition of an objective measure of CBF pattern provided by 
SPM96 analysis. The results obtained from this investigation failed to show any benefit to 
using the additional data provided by SPM96 analysis, however, it may play a role in 
monitoring progression of disease or the therapeutic effects of treatment
xx
Modification of 99m xc HMPAO SPECT acquisition protocol for SPM type 
analysis of neuroactivation studies: Image quality versus statistical power
To investigate the possibility of using a similar approach to PET i.e. increase the number of 
scans per task and accept poorer individual scan quality for SPECT studies of 
neuroactivation different study paradigms (replication and non-replication) were constructed. 
The different paradigms were created by variation of the image scanning parameters a) 
administered radiation activity per scan (within allowable limits) b) number of scans per task 
and c) scan acquisition time. Simulated neuroactivation experiments were created by the 
addition of pseudo activations to the images acquired under the different scanning 
parameters. Duplicate copies of real scans were made for the purposes of this study, in 
order to have a data set (activated and non-activated) that did not include noise due to natural 
variability of CBF or anatomy between subjects. This imposed condition of no anatomical 
variation makes the distinction between the paradigms clearer by removing noise due to inter 
and intra-subject variability without introducing bias in favour of any particular paradigm. 
The statistical benefits of a replication paradigms versus a non-replication paradigm were 
established by analysing the data sets with the SPM96 analysis. The simulation was able to 
show that when an SPM investigation is used for data analysis, study replication is more 
important than the individual image quality typically available from a high performance 
SPECT system.
Applications of the optimised SPECT acquisition parameters to 
neuroactivation studies.
To confirm the hypothesis that the addition of two further scans, allowing for each condition 
to be replicated (i.e. ABAB), would greatly increase confidence in the results and their 
interpretation, the 4 scan paradigm was used to investigate the stimulation of the vagus nerve 
for the treatment of epilepsy. A four scan design is also advantageous to SPECT studies of 
neuroactivation. The application of two additional scans, could greatly enhance the power 
of investigation of neuroactivation studies involving groups of normal healthy subjects, by 
the addition of one, or perhaps two, additional cognitive conditions (i.e., ABAC or ABCD 
respectively). This would enable more subtle differences in cognitive processing to be
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investigated. To confirm that the addition of a further task can contribute to the teasing out 
of cognitive processes used in memory, a SPECT neuroactivation experiment was designed 
with the 4 scan paradigm to investigate the role of the medial temporal lobe in the processing 
of familiar and novel material.
In conclusion the first part of this investigation established that a voxel-wise analysis does 
not provide any benefit as an aid to differential diagnosis by visual reporting of CBF SPECT 
scans. However, it may provide a possible means for objectively monitoring progression of 
disease or treatment The second part of this investigation was able to demonstrate that SPM 
can be used with SPECT to investigate functional activation studies which have, up to now, 
been considered to be limited to the domain of PET and fMRI. This opens up this type of 
study to a wider research community and establishes a role for SPECT in neuroactivation 
studies for experiments or subjects unsuited to the PET or fMRI environment.
Just as importantly these investigations indicate that this type of statistical mapping is 
applicable to the lower resolution data provided by SPECT and could therefore be applied to 
images of neuroreceptor function, for which radioligands are increasingly becoming 
available, and which can only be obtained with emission tomography.
Preface and Declaration.
This thesis comprises of my own original work carried out during the period of October 
1995 and October 1998 and has not been presented previously as a thesis in any form.
The thesis presents the investigations carried out on the applicability of a particular method 
of functional human brain mapping (FHBM) analysis (Statistical Parametric Mapping 
(SPM96) - K.J Friston, Wellcome Department of Cognitive Neurology, University College 
London, UK) in a routine nuclear medicine neuroimaging department. The results are 
presented from investigations into two broadly defined areas
•  The performance of the SPM method when used with non-optimal CBF 
SPECT images and its use as an aid in the visual reporting of these scans for 
the differential diagnosis of dementia.
•  The optimisation of the cerebral blood flow (CBF) SPECT imaging 
protocol for neuroactivation experiments and its application to two different 
experiments.
Chapter 1 reviews the literature in the field of human brain mapping (FHBM). The first 
section outlines the development of functional human brain mapping in both normal and 
abnormal subjects and includes a short description of normal human brain function with 
regard to autoregulation of blood flow and its coupling with cognitive function. The second 
section provides a more detailed explanation of the various components of a typical FHBM 
analysis including image registration, image standardisation methods and statistical analysis. 
The advantages and disadvantages of the components are also described in order to 
appreciate fully the context in which the subsequent investigations were done.
Chapter 2 lists the various steps involved in using SPECT with SPM and describes the 
image acquisition and processing of images used in the experiments. Chapters 3 - 6  
describe four different experiments linked by the overall theme of validating and optimising 
the methods used when analysing SPECT CBF images with SPM.
Chapter 3 outlines the methods used to create the challenge conditions devised to validate the 
image registration software. The results of these validations are presented and discussed in 
terms of providing the best methods of image standardisation for non-optimal image data 
sets.
Chapter 4 uses the optimal image standardisation method determined in chapter 3 to 
investigate the application of a SPM analysis to images of individual patients presenting with 
symptoms of dementia. The results are presented and the routine use of SPM in a nuclear
medicine department is discussed. The visual reporting of CBF SPECT scans was carried 
out by Prof. D. J. Wyper and Dr J Patterson.
Chapter 5 outlines the methods and challenge conditions used to modify the acquisition 
protocol of CBF SPECT images for analysis by SPM methods, in particular whether 
SPECT studies of neuroactivation might benefit from a similar approach used in PET, i.e. 
increase the number of scans per task and accept poorer individual scan quality. The results 
are presented and discussed in terms of their suitability for use in neuroactivation studies 
using SPECT.
Chapter 6 uses the optimal study design determined in chapter 5 to investigate vagal nerve 
stimulation as a treatment for epilepsy. Patients were recruited for this study by Dr R 
Duncan.
Chapter 7 uses the same design to study the role of the medial temporal lobes in novelty 
detection by contrasting it with their role in the encoding and/or consolidation into long-term 
memory of associative information. Dr D. M. Montaldi recruited the volunteers and 
designed the neuropsychological experiments used in this study.
Chapter 8 outlines the conclusions drawn from each of these experiments and their 
application to the future use of SPECT in functional human brain mapping.
xxiv
CHAPTER 1
Development and evaluation
methods o f analysing single photon emission 
computed tomography blood flow images o f  the 
brain.
This chapter outlines the development of functional human brain mapping in both 
patients and normal subjects and includes a short description of normal human 
brain function with regard to autoregulation of blood flow and its coupling with 
cognitive function. This is followed by a more detailed explanation of the various 
components of a typical functional human brain mapping analysis including image 
registration, image standardisation methods and statistical analysis. The 
advantages and disadvantages of each of the components are also described in 
order to appreciate fully the context in which the subsequent investigations were 
undertaken.
1990-1999; The decade o f the brain.
Presidential proclamation 1990(1)
1.1 In troduction
The function of the human brain can now be mapped in vivo by carefully manipulating 
cognitive processes while the subject is being scanned, a process referred to as 
neuroactivation experimentation. The dramatic images produced by the new functional 
human brain mapping methods of analysis might give us the impression that we are
1
'seeing the brain thinking' but the subtleties involved in the fractionation of cognitive 
processes using sophisticated experimental designs are not straightforward and the 
understanding of the underlying neuropsychology must not be underestimated. Likewise 
the fact that sophisticated statistical analysis can now be performed at the touch of a 
button must not stop the user having a fundamental grasp of those statistical theories on 
which the analysis is based. The rapid advance in technology may now have outpaced 
the understanding of many clinical scientists traditionally involved in functional human 
brain mapping principally through the investigation of lesions studies.
Inspired by these sentiments this thesis presents investigations carried out on a particular 
method of functional human brain mapping (FHBM) analysis (Statistical Parameteric 
Mapping (SPM) - Prof. K. J. Friston, Wellcome Department of Cognitive Neurology, 
Institute of Neurology, London, UK) with particular emphasis on its applicability to the 
work of a routine nuclear medicine neuroimaging department. Principally designed for 
the analysis of positron emission tomography (PET) radiolabelled water studies of 
normal brain function during neuroactivation experiments the technique is still relatively 
novel for the purposes of interpreting single photon emission computed tomography 
(SPECT) images of brain function. This thesis evaluates and develops the use of SPM 
for use with CBF SPECT images of cerebral blood flow and focuses on two aspects. 
The first part of this thesis investigates whether or not the use of a voxelwise image 
analysis method like SPM can improve the visual reporting of SPECT scans, by 
providing objective data on deviations from a normal reference database. The second part 
of the thesis investigates the statistical analysis component of the SPM method when 
using cerebral blood flow (CBF) SPECT imaging for neuroactivation experiments, to 
determine whether brain state replication is more important than the individual image 
quality typically available from a high performance SPECT system.
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Figure 1.1 Schematic diagram of the functional anatomy of the human brain as derived from lesion 
studies and electrical stimulation of the cortex.
1.2 F unctional H um an Brain M apping
The cutting edge of functional human brain mapping is now remote from interventional 
medicine but this was not always so. The original 'hands on' in vivo neuroactivation 
studies performed by neurologists such as Foerster in the 1920's and then Penfield and 
colleagues in the '30's were very much at the 'cutting edge'. Regarding each operation as 
an opportunity to conduct physiological experiments on the exposed cortex of conscious 
patients, they stimulated areas of the brain and recorded the resulting effects in elaborate 
detail. Penfield's results of electrical stimulation of the cortex are recorded in his book 
'The cerebral cortex of man' (2) which still governs our general views of human brain 
functional anatomy (fig. 1.1).
Even earlier the methods of clinicopathological correlation were used as a method of 
functional mapping, where signs and symptoms were associated with damage or disease
located in a specific region of the brain. The names Broca's and Wernicke's areas are still 
with us today and refer to areas in the brain associated with damage in patients who 
suffered from particular language problems investigated by Paul Broca and Carl Wernicke 
in the nineteenth century. The study of clinicopathological correlation continued 
throughout the latter part of the nineteenth century and most of the twentieth century with 
interested clinicians recording the specific behaviour of patients afflicted with particular 
damage until such time as the patient's brain could be investigated pathologically. Even 
the invasive methods of twentieth century surgeons couldn't provide a complete picture of 
functional anatomy as stimulations of the exposed cortex still only provide surface 
topography: the surface of the cortex being the only part of the brain accessible to the 
scalpel or electrode.
1.3 Neuroanatomy and physiology
Neuroanatomists define the human brain in teRMS of grey matter and white matter, a 
distinction clearly discernible in the structural images provided by magnetic resonance 
scanners (fig. 1.2). The grey matter makes up the cortical layers. The white matter refers 
to the white nerve fibres connecting the two hemispheres together, passing sensory 
signals throughout the cortex.
Grey matter is one of the most metabolically active tissues in the body using almost 
exclusively oxygen and glucose for its function and consequently needing a continuous 
and plentiful supply of blood. A delicate balance of oxygen and glucose concentration is 
required for efficient functioning of the brain and this is entirely dependent on the body's 
ability to regulate the blood supply, a process referred to as autoregulation. During 
autoregulation the cerebral blood volume (CBV) can increase (by vessel dilation) to retain 
a constant rate in cerebral blood flow (CBF). Once maximum vessel dilation is reached 
and total blood volume can no longer increase CBF will fall. Normal mean CBF is kept 
constant by this autoregulation at a level of about 50-60 ml/min/lOOg of brain tissue. The 
normal flow in grey matter is slightly higher than that of the mean, at 65-85 ml/min/lOOg
4
grey
matter
white
matter
grey
matter
white
matter
Figure 1.2. Axial images showing transverse slices through the basal ganglia. The regions of white and 
grey matter are clearly discernible in the T1 MR image (from a Seimens, Magnetom 1.5T scanner). The 
SPECT " mTc HMPAO rCBF image (from a Strichman Medical Equipment SME810 scanner) shows 
how the differences in metabolic activity of in the two different brain tissues are reflected by their blood 
flow.
and is lower in white matter, at 27-33 ml/min/lOOg. Normal mean perfusion is possible 
down to 20 ml/min/lOOg CBF since the brain can compensate with a corresponding 
increase in oxygen extraction. Autoregulation begins to fail below this at approximately 
15 ml/min/lOOg, causing ischaemia (restriction of blood to the tissue) which if prolonged 
will cause irreversible damage. The disruption of autoregulation through external injury 
or disease has a profound effect on the function of brain tissue. Uncontrolled increases in 
glucose levels after head injury or decreases in blood flow from stenosis of the blood 
vessels occurring in cerebral vascular disease will cause irreparable damage and 
eventually death of the surrounding tissue.
The level of CBF and CBV is clearly related to oxygen extraction rate and consequently 
the function of the brain. More than 100 years ago scientists were able to establish that 
the level of neuronal activity dictated the level of local blood supply in the brain. Later, 
when the imaging of cerebral metabolic parameters was possible using emission 
tomography techniques scientists were able to establish that increased blood flow was 
required for the increase in glucose consumption by the neuronally active areas (3,4). 
Interestingly they also found that the corresponding increase in oxygen consumption was 
slightly smaller than the rise in blood flow (5). As a result of this mismatch between 
demand and supply the blood leaving the activated cortical region is more oxygenated
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than normal, a fact that gave rise to the now rapidly expanding field of functional 
magnetic resonance imaging (fMRI).
The study of CBF, therefore should enable us to investigate brain function in both the 
normal and diseased state. One method of doing this is to radiolabel molecules that can 
cross the fully functioning blood brain barrier (BBB) and so distribute according to blood 
flow in the brain tissue. The emission from these distributed radiolabelled molecules can 
then be picked up by an external detector. The first in vivo images of CBF using 
emission computed tomography imaging were provided by detecting the radioactive 
emissions from inhalation of radiolabelled (15C )02 (6), and intravenous injection of 
H2(150 ) (7,8) using positron emission tomography (PET). With the development of the 
ubiquitous technetium-99m (99mTc) radiochemistry, single photon emission tomography 
(SPECT), a much more widely available technique, could be used to image CBF (9-11). 
Technetium-99m hexamethylpropyleneamine oxime ( " mTc HMPAO) is now a well 
established radiopharmaceutical in nuclear medicine departments for studying CBF in 
various clinical conditions. This radiopharmaceutical has been shown to distribute in the 
brain as a function of regional CBF (iCBF) although the final distribution seems to 
underestimate CBF in regions of high flow (9-11). 99mjc HMPAO is administered 
intravenously and reaches the brain after a few seconds, 5%-6% of the total dose is 
extracted on its first pass through the brain where it becomes trapped in brain tissue due 
to a change in the lipophilicity of the molecule. This whole process takes 40-60 seconds 
allowing some of the tracer to diffuse back across the BBB in the first 2-3 mins after 
intraveneous injection (10). After this, the level of 99mxc HMPAO activity remains 
approximately constant over the next 8hrs (10) so that it is possible to image, much later, 
the actual pattern of blood flow occurring in the brain at the time of the injection. The 
time delay between injection and scanning is limited only by the decay time of the nuclide 
(T1/2 = 6hrs).
SPECT functional brain imaging using 99mjc HMPAO is a powerful clinical tool. 
Several clinical applications are now well documented (12). The study of CBF using
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Figure 1.3. A schematic diagram o f  the steps taken in a functional human brain mapping analysis o f  an 
individual subject (left side o f  diagram) and a group o f  subjects (right side o f  diagram).
ROI - region o f  interest, SD  - standard deviation
7
99mjc HMPAO has shown to be relevant to the clinical investigation of dementia, 
epilepsy, stroke and more recently the investigation of cognitive processing in both 
normal and abnormal brains (13-15), referred to as functional human brain mapping 
(FHBM).
1.4 Functional Human Brain Mapping Tools.
A functional human brain mapping investigation consists of:
•  scanning to acquire images,
•  image re-alignment to ensure common orientation,
•  a method of anatomical standardisation for between subject analysis,
•  statistical analysis, using either regions of interest or voxel-wise measurements.
The next section describes each of these components (see figure 1.3) to appreciate fully 
the context in which the subsequent investigations in chapters 3-6 were undertaken.
1.5 Imaging modalities
Advances in neuroimaging technology have meant that high resolution (temporal and 
spatial) functional and structural imaging are now routinely available. Magnetic 
resonance imaging (MRI), x-ray computed tomography (CT) and single photon emission 
computed tomography (SPECT) are now fundamental to the hospital departments of 
radiology and nuclear medicine. Positron emission tomography (PET) although usually 
in residence at centres of excellence (due to high capital and running costs) is nevertheless 
also used for clinical investigation.
X-ray CT is used for structural imaging and is made possible due to the differences in 
linear attenuation of x-rays by different types of body tissue and is excellent for imaging 
bone defects (see fig 1.4). However, contrast agents are needed to image blood flow and 
this method provides almost no contrast between white and grey matter in the brain.
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Table 1.1 Comparative advantages and disadvantages of x-ray CT, MRI, PET, SPECT and fMRI for 
scanning of the human brain.
CT - computed tomography, MRI - magnetic resonance imaging, PET - positron 
emission tomography, SPECT - single photon emission computed tomography, BOLD 
-blood oxygenation level dependent, fMRI - functional magnetic resonance imaging, CBF 
- cerebral blood flow, HMPAO - hexamethyl-propylene-amine-oxime.
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Figure 1.4 Three different kinds of imaging modality of an axial slice taken through the basal ganglia; 
x-ray computed tomography (CT), magnetic resonance imaging (MRI-T1) and emission tomography 
(SPECT).
Conversely MRI (also used for structural imaging) provides very good contrast between 
white and grey matter but poor information on bony structures of the skull (fig 1.4). 
MRI, is able to distinguish between different tissue types by manipulating radiofrequency 
pulses to excite hydrogen nuclei within the body. This is done by detecting the 
differences in the resulting radiofrequency emissions due to the different tissue 
environments from the de-exciting nuclei. Functional imaging techniques PET and 
SPECT are based on the ability to detect gamma rays emitted from the human body after 
the introduction of trace radioactive substances or radiopharmaceuticals. By careful 
design of the radiopharmaceutical a range of physiological parameters in the body can be 
measured. In particular cerebral function can be assessed by measuring blood flow (fig. 
1.4) and volume, oxygen extraction, glucose transport and metabolism, and 
neurotransmitter function. For example, radiopharmaceuticals such as 99mxc HMPAO 
and " mTcECD with SPECT are used to image CBF; and (123I)IBZM is used with 
SPECT, to investigate dopamine receptor function. 18F FDG is used with PET to look at 
glucose consumption, and H2150  and C(150)2 to investigate CBF. More recently MRI 
has been able to provide functional information using a scanning sequence referred to as 
blood oxygenation level dependent (BOLD) contrast (5). This MRI technique can be 
used to detect an increase in oxygen levels of blood leaving a region associated with 
increased neuronal activity in the brain. The small changes in the external magnetic field 
produced by the difference in the magnetic properties of oxyheamoglobin and de-
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oxyheamoglobin can be detected when using the appropriate RF pulse manipulations. 
The advantage of this type of functional imaging over emission tomography techniques is 
that it involves no ionising radiation. However, the high magnetic fields used do pose a 
problem when imaging subjects with metal implants and the loud noise during acquisition 
makes mapping of any auditory stimulation difficult. Although a certain degree of spatial 
information is provided by an emission tomography functional image the anatomical detail 
is not apparent and the anatomical location in fMRI is only referenced to its structural 
MRI acquisition provided there is no movement by the subject between the two. As a 
consequence a method of linking structural information from either MR or CT to the 
functional information obtained from either SPECT, PET or fMR images is crucial.
1.6 Image Registration
Diagnostic imaging often involves combining structural images with sequential functional 
images (fig. 1.5) to monitor the progress and treatment of diseases such as dementia, 
cerebrovascular disease and brain tumours. The wide accessibility to these techniques 
has also allowed neuropsychologists to use them to assess brain function in groups of 
normal subjects. Multiple functional (and sometimes structural) images of each subject 
are required during several cognitive processing tasks to provide information for the 
subsequent analysis. Crucial to both these types of comparison is that the scans be 
aligned to precisely the same orientation so that the observer is looking at exactly the same 
view of the brain across all scans from the subject’s data set or the same view across a 
group of subjects. To achieve this, various methods of image co-registration have been 
developed which reorientate one of the scans (the sample scan) until each anatomical 
location corresponds exactly with the other (the reference scan). This process can be 
extended so that the data is also aligned along an accepted anatomical reference line (an 
aligned reference scan) to allow both inter and intra-modality comparisons.
Image registration is the term used to describe the method of determination of one to one 
mapping between co-ordinates in one (reference) image to those in another (sample)
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Figurel .5 Various different types of data that can be registered (yellow) for different comparisons (white).
image such that the points in each correspond to the same anatomical location. The 
simplest mapping or affine transformation is a rigid body transformation and can be 
described in matrix notation as follows:
fsi)
52
53
VJ
( 1 0  0 XtransN 
0 1 0  Ytrans 
0 0 1 Ztrans 
0 0 0 1 y
(r i \
R2
R3
V  J
S = MR (in matrix notation)
A rigid body transform consists of 6 parameters, 3 rotation and 3 translation, and is used 
when the distance between the points within the sample image is to be preserved for 
example for within subject imaging. The affine transform can be extended to 9 parameters 
to account for scaling differences that may be needed for inter-modality registration. 
Further parameters (usually another 3) can be added to transform differences in overall 
brain shape and are the basis of image standardisation techniques.
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The following sections describe the various techniques used to derive the transformation 
described above beginning with the rigid immobilisation techniques used by surgeons 
performing stereotactic surgery to the more sophisticated techniques utilising voxel 
similarity measures and high speed computing.
1.6.1 Image registration by immobilisation
Immobilisation methods are used to locate brain images in 3D space for the purposes of 
stereotactic surgery and radiotherapy. Surgeons use stereotactic frames bolted to the 
patient's skull, to locate lesions within and across different imaging modalities and to 
locate lesions within their operating space (fig. 1.6). These invasive methods are 
acceptable where a general anaesthesia has already been administered for the subsequent 
surgical procedures. For radiotherapy treatment less invasive methods of immobilisation 
have been developed when patient positioning must be reproducible on a daily basis over 
a treatment of 6 weeks. Immobilisation methods for radiotherapy are based on the fitting 
of individual moulds to either a patient's whole head (16) or their teeth (17,18). 
Published data report that reproducibility of positioning is of the order of 2mm (17-19) 
and sufficient for the purposes of radiotherapy beam treatment. Radiologists and 
surgeons commonly use different types of imaging to assist in diagnosis or in the 
planning of treatment. PET/SPECT imaging of a brain tumour may be required alongside 
the patient’s MRI scan for a better representation of the extent of tumour volume or 
assessment of recurrence. MRI and x-ray CT images may be combined for a patient's 
radiotherapy planning so that better delineation of the brain lesion is obtained from the 
MRI while the CT image provides information essential to radiation dose volume 
calculations. Visualising between modalities when using immobilisation devices is easily 
achieved by fixing external markers to the patient's head frame/holder. The markers can 
then be filled with an appropriate material for visualisation between imaging modalities 
e.g. copper sulphate filled tubes and spheres, glass beads, vitamin E tablets,
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Figure 1.6 shows the use of a stereotactic frame visible in both CT (left picture) and MRI (right picture) 
External markers (or Fiducial points) are used to register these two images of the same patient to one 
another.
oil Filled tubes, staples, polyvinyl alcohol gel markers, spheres/discs of " mTc and v- 
shaped markers of aqueous solutions of gadolinium are all suitable.
1.6.2 Image registration by external landmark matching.
Immobilisation devices are not 'patient friendly' and rigid fixation is unacceptable for the 
ever increasing numbers of serial diagnostic scans being carried out and for normal 
subjects being scanned for research studies where the position of the head in the scanner 
for any one scan is not crucial to the treatment/study process. Neuroimaging scientists 
recognised that if fiducial markers could be fitted to immobilisation frames for 
visualisation between imaging modalities (prospective image registration) they could also 
be used to achieve the registration retrospectively. Evans et al at the McConnell Brain 
Imaging centre in Montreal, as part of their optimisation of techniques for the functional 
imaging of patients (20), developed a method that involved the use of a 'soft frame' on 
which to mount the fiducial markers in conjunction with a rigid head mould immobiliser. 
Thin catheters were mounted on elastic strips which could be pulled over the head and 
held in place by elastic chin straps and Velcro. Other groups (21,22) used the skull as the 
frame and fitted fiducial markers directly to the skin in low movement places such as the
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naison (connection between the nasal and frontal bones of the skull) and the preauricular 
points (just in front of the earholes). Registration of the images is then achieved, after 
acquisition, by the user locating the fiducial markers within both image volumes and a 
computer algorithm finding the minimum distance between these point pairs by some 
iterative minimisation calculation.
1.6.3 Disadvantages o f image registration by external landmark matching.
Although markers have the advantage that inter-modality registration is possible as long 
as the marker is visible in each modality this method has a number of disadvantages. 
First there is the problem of movement of the markers from their position between scans 
which will occur whether they are attached to skin or an elastic strap. Secondly all 
scanning needs to take place on the same day to ensure consistency otherwise semi­
permanent ink/tattoo is used to mark the position of the fiducials before they are removed, 
certainly with some degree of inconvenience to the subject. This movement is not 
insignificant Strother et al 1994 (23) declare that in a comparison of 6 different methods 
including principal axes, surface contours and anatomical landmark techniques "fiducial 
markers that are not rigidly fixed to the skull are inaccurate compared to other 
techniques". Thirdly time taken to locate the markers in each image increases with 
number of markers required for accurate registration. Although no expertise is required 
the task can be lengthy and tedious. The errors associated with the location of the centre 
of the marker due to partial volume effects, interslice gaps in the data and point spread 
functions inherent in tomographic scanning can also effect the accuracy of this technique. 
Some groups have developed methods to combat this (21) but require elaborate 
construction of 3d markers. This solution brings with it its own problems. The larger the 
marker the more they may impinge on the data acquisition. For example oil filled beads 
while ideal for achieving a uniform distribution of isotope cannot be used in MRI because 
the chemical shift induced by the field will introduce distortion in the reconstructed image. 
For SPECT, 57Co is the isotope of choice for markers and has an energy of
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Figure 1.7 shows an example of how internal/anatomical landmarks can be used to register two serial 
MR images from the same patient.
120keV while " mTc, the most commonly used SPECT isotope, has an energy of 
140KeV. Dual energy acquisitions are easily obtainable but care must be taken to make 
the activity in the fiducials hot enough that the markers are not swamped by the scatter of 
" mTc but not so hot as to cause streaking in the main body of the image.
1.6.4 Image registration by internal landmark matching
A solution to some of these problems is to use the brain structure itself. Well defined 
anatomical markers (fig. 1.7) inherent in the brain would avoid errors associated with 
skin movement, repositioning and artefact produced by the marker medium. Evans et al, 
who in 1991 (24) had been using the external fiducial marker technique recognised the 
value of the internal marker method and developed a protocol that used 10-20 anatomical 
landmarks (25). Identification of the landmarks took approximately 20-30 mins. per 
subject and included such structures as; head of caudate, thalamus, frontal, temporal, 
occipital poles, sylvian fissure, occipito-cerebellar junction and the superior lateral aspect 
of the parietal lobe. Other groups using these types of methods included Hill et al 1991 
(26) to register CT and MR images as an aid to radiotherapy treatment planning, and Ge 
et al 1994 (27) by identifying the inter-hemispheric fissure.
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Figure 1.8 Contours used to define the surface of the brain for use in the "head and hat" method of image 
registration.
1.6.5 Disadvantages o f  image registration by internal markers
The biggest errors incurred using this type of image registration are associated with the 
mismatch of information between the different image types. It takes skill and time to 
locate enough common landmarks between an MRI and a CBF SPECT image and is 
therefore not entirely suited to use in a busy routine imaging department where time is a 
premium. Nevertheless, they are particularly good for registering images where there is 
not a substantial amount of overlapping information. An alternative method of 
registration using internal markers is to use the surface of the brain itself (28) (fig. 1.8). 
This surface matching technique is more commonly referred to as the "head and hat" 
method, where a set of points defining the surface contours of the brain in one image (the 
hat) is matched to another set of points defining the surface contours in another image (the 
head). The hat is 'put on' to the head by using the same kind of iterative minimisation 
algorithm that the previous marker methods use. The points to be matched are the 
intersections with the head surfaces of a ray drawn from a contour in the transformed hat 
to the centroid of the head surface contour. Surface contour methods are an improvement 
on point landmarking methods for inter-modality registration of whole brain images since 
the surface of the brain is easy to determine, independent of image type. However, they 
do not perform well in situations where there is not much overlapping information. For
example neither MRI or x-ray CT routinely include the whole head surface. Despite this, 
the technique remains popular, with some modifications such as the automatic detection 
of the surface contours using edge detection algorithms (29,30).
1.6.6 Image registration by voxel similarity methods.
The ultimate goal of any image registration method is that it should be objective and 
robust. By replacing the observer/user with a similarity measurement that can be 
evaluated by computer between the two images, automated methods of image registration 
are the ultimate in objectivity, if not robustness. Methods that allow the accuracy of a 
registration to be assessed by matching corresponding voxels between datasets have come 
to be known as voxel similarity measures. Image registration using a voxel similarity 
method is achieved by optimising a measure or cost function based on pairs of overlying 
voxels.
In 1983 Venot et al (31) used a similarity measurement based on an evaluation of a 
stochastic sign change function in order to centre an image with respect to some standard 
axes to correct for rotation in the axial plane. Mintun et al 1990 (32) subsequently 
exploited this method to correct for rotation in the axial and coronal plane before fitting an 
estimate of axes orthogonal to a line through points defined by anatomical landmarks 
(anterior aspect of the corpus callosum, the most anterior point of the frontal lobe and the 
posterior of the occipital lobe). A similar technique was developed by Junck et al 1990 
(33) using an index of similarity that corresponded to maximisation of the cross 
correlation product between the left and right hemispheres. No attempt was made to align 
the images with respect to standard axes, instead the method was used to ensure the 
registration of serial emission tomography images of the same patient.
Over the next decade a myriad of techniques were developed which used the similarity 
measures of two images as a means of registration; stochastic sign change (34,35), 
correlation function (33), correlation coefficient (36), sum of absolute differences (37),
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optical flow (38), edge detection (29) relative entropy (39), variance (40) and sum of 
squares (41). An excellent review comparing some of these techniques are given in the 
book Interactive Image-Guided Neurosurgery (42) and the Journal of Computer Assisted 
Tomography (1996) "Comparison and Evaluation of Retrospective Intermodality Brain 
Image Registration Techniques" (43).
1.6.7. Disadvantages o f image registration using voxel similarity 
measures.
Criticisms levelled at these methods are that they are computationally expensive and 
cannot be employed for intermodality image registration. The former criticism is now no 
longer applicable with the ultra fast generation of co-processors of the order of 300MHz 
and the manipulation of computer algorithms to perform complex matrix operations 
allows registration of image pairs to be performed in a matter of minutes. The latter 
problem of intermodality registration has been tackled by various groups who have used 
pseudo emission tomography images. In this the structural images (usually MR) are 
transformed into emission tomography images (usually H2(150 ) PET) by assigning each 
tissue type (grey and white matter, CSF) a corresponding PET intensity value e.g. a 1:4 
ratio of voxel values in white compared to grey matter, convolving the image with a 
Gaussian spatial smoothing filter and adding noise to produce a pseudo functional image 
of blood flow. This pseudo functional image can then be registered with the true 
functional image, the transformation parameters of which can then be applied to the true 
structural image to achieve registration with the true functional image. This rather 
ingenious way of dealing with the problem (illustrated in fig. 1.9) is now a firmly 
established method of inter-modality image registration (41,44) although other more 
direct methods are available (39). However, with this method of image registration, 
robustness is still a problem and deviations in normal anatomy or truncation of image 
volume still remain a problem for most of these techniques due to the possibility of these 
types of iterative algorithms getting stuck in a local minimum.
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Figure 1.9 shows how inter-modaiity image registration by voxel similarity measures is achieved using 
pseudo functional images.
The goal of all these image registration techniques is to ensure that the signals measured 
accurately reflect the functional location in the corresponding structures. The algorithms 
described above account for differences in alignment of serial images of the same subject, 
location in reference space for inter-subject comparisons and even account for overall 
changes in brain size and shape. However, there still remains a significant error due to 
differences in individual gyral anatomy between subjects.
1.7  Im age standardisa tion  .
As the number of groups involved in neuroactivation imaging studies increased it became 
clear that a common reference frame with which to compare measurements between 
different subjects and imaging centres was needed (fig. 1.10). Fox et al 1984 (45) using
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Figure 1.10 Illustrates how a common reference frame can be used to compare functional scans from 
different subjects.
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Figure 1.11 Show the position of the 'Talairach axes' through the mid sagittal plane. The positive X- 
axis being orthogonal to both Y and Z is orientated out of the page.
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the principles of anatomical landmark image registration developed a method of locating 
functional images within a standard space based on the identification of the line through 
the anterior and posterior commissures (AC-PC line). The orthogonal co-ordinate system 
Fox described had been developed originally by Talairach and Toumoux in 1967 (and 
later published as an atlas in 1988 (46)) to be used in conjunction with an atlas of a 
middle aged, French woman's brain labelled with anatomical references in 4mm thick 
axial slices. This co-ordinate system, now commonly referred to as "Talairach space", is 
set up so that the Y axis runs along the AC-PC line, the Z axis at right angles to this 
through the mid point of the AC-PC to the vertex of the skull and the X axis orthogonal to 
both of these (fig. 1.11). Since the AC-PC line is very difficult to identify on functional 
images Fox et al 1984 (45) transformed the functional data into Talairach space by 
identifying points relative to the AC-PC line. A line drawn through the glabella and inion 
as defined from a lateral skull x-ray film was assumed to be parallel to the AC-PC line 
and used as a reference from which to estimate this line. Results showed that estimation 
of the AC-PC line using this method was robust and that the location of the estimated AC- 
PC line was always rostral to the true AC-PC line and roughly parallel with a mean angle 
1.05°, converging anteriorly. With these adjustments the estimated AC-PC line 
approximated the true AC-PC line well. Since Fox's method required each subject to go 
through an extra procedure, groups wanting to make the whole experience for normal 
volunteers as simple as possible developed methods that avoided the use of structural 
imaging altogether and were able to identify the AC-PC line directly from functional 
images. Friston et al 1989 (47) developed a technique that required the user to identify 
the ventral aspects of the anterior and posterior corpus callosum, the thalamus and the 
occipital pole directly from the coronal slices of a perfusion PET scan. A regression 
calculation was applied to these points to find the best straight line fit which was then 
assumed to be an approximation of the true AC-PC line. Results showed that this method 
agreed well with the accuracies reported by Fox et al in 1985 (45) with the estimated AC- 
PC line being rostral to the true AC-PC line and the mean angle of convergence being 
0.13°. These methods remain popular with modifications to remove user interaction and
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Figure 1.12 The figure above shows how a signal may be 'diluted' when averaging across different 
subjects due to differences in individual gyral anatomy.
extend the algorithms to take account of individual variations in brain shape and structure 
(35,48).
This method of standardising space became fundamental to the expanding field of in-vivo 
functional brain mapping. While the need to locate structure and function within a 
standard reference frame is necessary for individual patient assessment, and in some 
cases their consequent surgery, the facility to match exactly each person's individual gyral 
structure to that of a reference is also important when performing neuroactivation 
experiments across a group of subjects. The standard protocol to maximise the signal 
produced by neuroactivation paradigms is to pool data from multiple subjects. If it were 
possible that all brains could be made identical anatomically by exactly registering them 
with one another then the problem is solved. Unfortunately, even after accounting for 
differences in orientation and size there are still residual errors in individual detail 
anatomy which may have serious consequences for subsequent measurement techniques. 
For a subject with relatively less curvature (red region of interest (ROI) in fig 1.12) than 
the Talairach brain over the frontal lobe, the location of a cortical region as defined by the 
Talairach atlas may in fact lie over extracerebral structures. For an individual with greater 
curvature (blue ROI in fig 1.12) this same Talairach region may lie over white matter. A 
simple solution is to smooth all the images before analysis, using a Gaussian spatial filter 
to reduce this effect of anatomical mismatching by smearing out structures to get more of
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Figure 1.13 A schemtaic of the Rigid body, affine transfoRMS and plastic transformations used for 
image registration.
an overlap between subjects. However, this smearing also has the obvious effect of 
reducing the resolution of the image and diluting the amount of change in measured signal 
in each individual. Groups that had already extended the 6 parameter rigid body 
transformation to a 9 parameter affine transform to allow for scaling in the 3 axes were 
able to extend the transform to 12 parameters (38,49)(fig. 1.13). These 3 extra 
parameters accounted for differences in overall brain shape by introducing shearing 
transformations to the registration method which reduces the problem described above, 
removes the need for such heavy smoothing but leaves the problem of individual gyral 
anatomy, a significant problem when unsmoothed PET images regularly achieve 
resolutions of the order of 6mm.
Matching of images at this level can be achieved using nonlinear or "plastic" 
transformations (bottom row fig. 1.13). These transformations can be carried out by 
matching structures recognisable in both the atlas/template and individual brain image
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anatomical landmarks identified on an MRI 
equivalent landmarks identified on the atlas 
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direction of movement of the atlas markers with respect to the MRI markers.
Figure 1.14 shows how a standard brain template outline can be deformed to fit an individual subject's MR 
scan. Slices taken through the midline sagittal plane of a T1 MRI.
such as points or edges representing anatomical structure (50-52) (fig. 1.14). A standard 
schematic anatomical ROI template derived from the Talairach atlas or a cryosectioned 
post mortem brain (see fig 1.14) can be altered to fit the subject's own anatomical 
structure. A computer algorithm records the changes made in the template and applies 
them to the subjects images so that they now look like the standard template. 
Alternatively, automatic techniques based on pixel intensity distribution (48,53) can be 
used to match a subject's images to a standard image template. A standard image is 
obtained by averaging brain images closely representing Talairach space (see fig 1.15). A 
standard distribution of voxel intensity is derived from the standard image, which can 
then be used to map the distribution of voxel intensities from an individual subject's 
image.
Original standardisation techniques relied on the information provided from a single 
subject’s anatomy (46,52,54). However, more recent methods have attempted to define
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Figure 1.15 shows 3D sections through the sagittal, axial and coronal planes respectively of the PET 
CBF template used by SPM96.
the standard template in teRMS of an average of the general population. The PET template 
used by Friston and colleagues to spatially normalise all emission tomography is an 
average of 6 PET H2(150) images obtained routinely that best represented Talairach space 
on visual inspection (Fig. 1.15). Evans and colleagues (25) expanded their single MRI 
template from a single individual to include 50 high resolution MRI 3D brain images on 
which a team of experts defined various gyral and sub-cortical structures. This template 
can be accessed via the internet where a database of both Talairach labels and statistical 
probability  maps of normal anatom ical structure can be found 
(http://ric.uthscsa.edu/projects/talairachdaemon.html) (fig. 1.16). The anatomy as 
defined by the statistical probability maps is based on regions defined by the 50% 
likelihood of finding a particular anatomical boundary within the population of 50 normal 
MR images of the brain.
1.8 Im age analysis
The end point of this image standardisation is to assess the content of the images, either 
qualitatively or quantitatively. The rest of this section describes two different methods of 
obtaining quanititative data from functional images of the brain; region of interest 
measurements and voxel-wise statistical analysis.
26
Figure 1.16 shows axial slices (ac-pc -16mm, ac-pc +lm m  and ac-pc +20mm) from the Talairach 
Daemon (http://ric.uthscsa.edu/projects/talairachdaemon.html). The atlas is colour coded according to the 
statistical probability maps based on regions defined by the 50% likelihood o f finding a particular 
anatomical boundary within the population of 50 normal MR images of the brain.
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1.8.1 Image analysis by region o f interest methods.
In clinical practice, emission tomography scans are valuable tools where qualitative 
features of an image provide diagnostic and prognostic guidance, but problems arise 
when quantitative data is needed. The immense number of individual picture elements 
(pixels) in each scan means that extensive computation is inevitable and the localisation of 
the quantitative measures in teRMS of their anatomical location assumes expertise in 
neuroanatomy. Conventional methods of analysing brain PET and SPECT images 
involve the placement of a number of regions of interest (ROI) on the image and 
measurement of the mean counts within those regions. Global differences in the overall 
number of counts due to differences in administered dose, uptake fraction in the brain as 
well as physiological changes in the subject (mood changes, physical activity) are 
accounted for either by dividing each ROI value by the average global value or by a 
suitable reference region such as a whole slice ROI value or the cerebellum ROI value. 
Regions of interest drawn either directly on to the emission tomography scan or with 
reference to the same individual's anatomical scan provide both data reduction and a 
means of establishing an anatomical reference (fig. 1.17).
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Figure 1.17. a) ROIs drawn direcdy on to a SPECT image of blood flow and b) the regions 
MRI before superimposing on to the same individual's functional image.
drawn on an
1.8.2 Disadvantages o f  image analysis by region o f  interest methods.
The reduction of data by collapsing a group of contiguous pixel values into a single mean 
value although useful as a data reduction step runs the risk of losing potentially valuable 
information. Large ROIs may lump functionally distinct areas together and so 'hide' 
changes or abnormalities affecting only part of the ROI or if a significant change is 
detected the ROI may cross functional boundaries hiding the true location of the change. 
The anatomical localisation aspects of ROI methods also have certain drawbacks. The 
placing of an ROI is entirely dependent on the investigator's ability to identify brain 
structures and a degree of expertise in human neuroanatomy is needed for this. The size 
and shape of the region is also important since the more closely the dimensions of a 
region conform to the area of change the greater the measured magnitude of change will 
be so a small ROI will detect a regional difference with greater sensitivity than a large 
ROI. Small ROIs, however, have greater chance of missing the area of change altogether 
if the placement accuracy is wrong by even a small amount. Similarly an ROI that 
confoRMS precisely to the shape of the structure will detect a change with greater 
sensitivity than a geometrically regular shape, but accuracy of positioning is paramount to 
this sensitivity.
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In an attempt to combat the limitations of traditional ROI methods of analysis, various 
groups began to develop computer based algorithms designed to make the process more 
objective and less time consuming. Junck et al 1988 (33) used an automated routine to 
draw ROIs directly onto the functional image to remove observer bias in the placement of 
ROIs. Following image registration the cortex of the brain was defined by the automatic 
delineation of the outer rim by thresholding of the voxels at 30% of the global mean and a 
concentric ring 1.5cm inwards. Cortical regions were then defined by 8 regions per 
hemisphere approximately 4cm2 with the cerebellum defined manually. Although 
observer bias is removed using this method there remains the problem of these regions 
'lumping' together functionally distinct regions or crossing functional boundaries. Other 
methods removed observer bias and to some extent removed the problem of 'lumping' 
functionally distinct regions together by using ROI templates defined by a standard 
template of brain structure (20,52,55) that could be warped to fit each individual's scan. 
Evans et al 1988 (20) used a high resolution MRI from a single subject and later (25) an 
average of approximately 50 individual MR scans to define a template with 56 different 
ROIs. Seitz et al 1990 (56), Toga et al 1994 (52) and Bohm et al 1989 (55) all used an 
individual cryosectioned human brain at 4 slices per 1mm to define their ROI template of 
over 250 separate ROIs. High speed computers allowed the lookup tables storing the 
ROIs to be easily usable if not completely objective. The template can be scaled and 
translated to fit the individual's anatomy using powerful graphical tools that, although 
automated require a certain degree of user input. Each ROI can be re-drawn, if needed, to 
fit more closely the subjects anatomy before it is superimposed on to the functional 
image. The functional value for each ROI is calculated as the area weighted average 
which can then be grouped into larger anatomical areas if needed. Further volumetric data 
can be obtained by summing these areas over a number of slices from the image. 
Although these methods of using predefined ROI templates do not need the abilities of an 
expert anatomist, Collins et al (25) noted that misplaced ROIs (due to mis-registration) 
could lead to a reduction of 50% in measured signal. The ultimate solution to problems 
of observer bias and the anatomical versus functional structure definitions is the
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development of voxel based statistical analyses, where the regions are effectively reduced 
to single voxels.
1.8.3 Image analysis by voxel-wise methods.
The methods described above stemmed from the need to find quick, reliable and objective 
methods of handling the vast amount of functional data acquired from patient scans. But 
in another branch of assessing human brain function, scientists were looking to find ways 
of measuring the changes in the brain produced not by disease or drugs but by thought. 
In this area there is no preconceived notion of structure. The original electrical external 
stimulation experiments in the early 20th century had been able to map the cortex 
associated with the senses. Indeed the initial "activation" experiments performed on 
normal humans in the early 80's using straight forward paired functional image 
subtraction and ROIs easily detected the robust regional changes that occur in the primary 
sensory and motor cortex due to some external stimulation (32,57). However, the more 
subtle activations of human functions such as memory or learning were proving to be less 
easily detectable using these methods and required a different "top-down " approach - a 
method that did not depend on anatomically defined ROIs. Instead neuroscientists 
exploited the field of parametric statistics in attempts to maximise the potential information 
contained in the tens of thousands of pixels within each scan (57-61).
The small changes in regional cerebral blood flow that must be produced by neuronal 
activity within the brain when performing higher cognitive processing were proving 
elusive and so groups looked towards the traditional methods of functional brain mapping 
for a way to enhance these small changes against the background of noise. Electrically 
evoked potential studies had long been using methods of signal averaging over time as a 
way of finding the tiny electrical signals produced by the brain in response to a particular 
stimulus. Fox et al 1988 (57) used the same principle to average a detected signal over 
space. By averaging the measured signal across multiple images of the same brain state, 
random background noise will cancel out while consistent focal responses will sum and
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therefore increase the signal to noise ratio. Fox's method reported these regions of local 
minima or maxima as spherical ROIs of fixed size placed at the centre of mass of the 
regional change and its location in three dimensional space. The signal was then 
discriminated from noise using omnibus testing by the gamma-2 statistic. Significance on 
a local level was further determined by performing a t-test on voxels in those regions that 
survived the omnibus testing. The advantage of this approach was that by identifying 
only the location and magnitude of change without attributing shape or extent, this 
technique ensured no signal loss implicit in the use of preselected ROIs. Fox's method of 
locating significant blood flow change in space is referred to as change distribution 
analysis (CDA). Other similar voxel-wise analyses developed subsequently 
(58,59,61,62), owe much to the form that Fox's change distribution analysis takes, their 
final form being dependent on the methods of voxel intensity normalisation, modelling 
variance, testing for local significance and experimental design (group comparisons or 
individual subject assessment).
•  Voxel-wise analysis of individual patient data.
This type of analysis involves the comparison of the patient scan with a normal or disease 
reference data set These voxel comparisons can be expressed as Z-scores (the number of 
unit standard deviations from the reference mean) (63), (64) or in terms of a principal 
components analysis (PCA) (65), (66) where the distribution pattern of voxel intensity in 
the patient scan is compared with the known distribution pattern of voxel intensity in the 
reference scans. Significance is assigned to how well the two patterns match. These 
methods rely on one measure (scan) per subject per brain state and use a proportional 
scaling method to account for global voxel intensity differences.
•  Voxel-wise analysis of different groups.
This type of analysis involves the comparison of groups of scans by testing for the 
differences in the means of the two data sets taking in to account the variance in the data. 
The variance is modelled either at a local level for each voxel included in the analysis
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(59,67) or at a global level using an average variance for all voxels included in the 
analysis (61).
1.8.4 Limitations of image analysis by voxel-wise statistical methods.
The disadvantages of using voxel-wise methods for the analysis of functional brain 
images is that they are very sensitive to any pre-processing of the images and underlying 
statistical assumptions made about this data.
Pre-processing of the images includes image registration/standardisation, spatial 
smoothing and removal of global voxel intensity differences. Errors in standardisation of 
the images are assumed random across a group of subjects and are likely to manifest 
themselves as false negative results (type n  errors) in the statistical analysis, a problem 
not confined to voxel-wise analysis (see the ROI definition displayed in fig 1.12 frontal 
lobe curvature). Spatial smoothing is performed prior to analysis to improve the signal to 
noise ratio, with filter sizes ranging from 10mm FWHM - 20mm FWHM for emission 
tomography images. The amount of smoothing affects the estimate of variance used for 
any subsequent statistical analysis; too much smoothing resulting in type n  errors and too 
little smoothing results in type I errors (false positive results). Differences in global 
intensity voxel values must be accounted for (global intensity normalisation) if the local 
changes in voxel values are to be measured. Global differences can be removed either by 
scaling all the images in the data set to some reference voxel value (much like the method 
used in conventional ROI methods) or by including the global differences in the statistical 
analysis itself by modelling it as a confounding covariate in an analysis of covariance 
(AnCova) method. Traditionally scaling has always been the method of global intensity 
normalisation but for normal subjects where the average global voxel value is not going to 
differ much between subjects it is thought that the AnCova model is more appropriate, 
avoiding the occurrence of type n  errors.
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Statistical assumptions made about the data include the use of parametric analysis 
methods that assume that the population distribution from which the sample is drawn is 
known. This assumption is the basis on which the rest of the analysis rests. The 
variance in the images that remains after the pre-processing steps is calculated either at 
each voxel (59) or an average variance is calculated for all the voxels included in the 
analysis (61) before being used in the statistical test at each voxel. A smoothing estimator 
is then used to calculate the variance (61). This estimation of variance will have a 
profound effect on the subsequent test statistic used. Finally there are differences in the 
interpretation of the significant results obtained from an omnibus testing of the data. 
Significance of regions of change in the presence of multiple statistical tests can be based 
either on the number of voxels (extent) (68) reaching significance after omnibus testing or 
on the value of these voxels (height) (59), bearing in mind the non-independent nature of 
the smoothed voxels included in the analysis. The most recent developments in voxel- 
wise statistical analysis include tests for significance based on both extent and height of 
voxels (69,70).
A considerable amount of investigations have been published using these voxel-wise 
statistical methods. Initial reports confirmed the results of brain lesion studies and some 
PET investigations have been cross-replicated but with the number of investigations 
increasing there appear to be more and more discrepancies. Despite the scope for 
differences in the statistical methods described above it would seem that these 
discrepancies may be more to do with the differences in acquisition parameters and 
paradigm design than with the validity of the voxel based analyses themselves (58). This 
method of image analysis was developed for PET and later extended to fMRI 
investigations of neuroactivation where the ability to perform multiple image replications 
of brain states lends high statistical significance to their results. More recently, however, 
investigations are being performed with fewer numbers of subjects and limited numbers 
of replications per brain task. In particular SPECT studies of neuroactivation, where 
there are difficulties in performing replications of tasks due to the nature of the
33
radiopharmaceutical used with this technique, are vulnerable to false negative errors due 
to the consequently limited degrees of freedom.
1.9 Plan o f  investigations and aims.
The future of functional brain mapping must include the development of a standardised 
system that includes all of the elements described in this chapter; anatomical location in 3 
dimensional space, the applicability of this method across subjects and imaging modalities 
and the careful design of statistical analysis methods used to isolate regions of the brain 
responsible for particular cognitive processes. But "the exchange of information, the 
credibility of results and the power of these techniques will in part be determined by our 
ability to find standardised, reproducible and accurate methods of analysing data from 
these sources", cautions Mazziotta in an extract from his editorial in a 1984 edition of the 
Journal of Cerebral Blood Flow and Metabolism (71). This thesis describes the 
investigations used to establish - from existing methods - a standardised, reproducible 
and accurate method of analysing data from 99mjc HMPAO SPECT images of cerebral 
blood flow.
Chapter 1 outlined the development of functional human brain mapping in both normal 
and abnormal subjects and included a short description of normal human brain function 
with regard to autoregulation of blood flow and its coupling with cognitive function. 
This was followed by a more detailed explanation of the various components of a typical 
FHBM analysis including image registration, image standardisation methods and 
statistical analysis. The advantages and disadvantages of the components were also 
described in order to appreciate fully the context in which the subsequent investigations 
were done. Chapter 2 lists the various steps involved in performing a FHBM analysis 
with SPECT and describes the image acquisition and processing of images used in the 
experiments. Chapters 3 - 7  describe five different experiments linked by the overall 
theme of validating and optimising the methods used when analysing SPECT CBF with 
SPM. Chapter 3 outlines the methods used to create the challenge conditions devised to 
validate the image standardisation facility. The results of these validations are presented
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and discussed in teRMS of providing the best methods of image standardisation for non- 
optimal image data sets. Chapter 4 uses the optimal image standardisation method 
determined in chapter 3 to investigate the application of a SPM analysis to images of 
individual patients presenting with symptoms of dementia. The object was not to use the 
method to automate the diagnostic interpretation of images but to determine whether it 
could provide an objective measurement of abnormality which might assist in the expert 
reading of scans. The results are presented and the routine use of SPM in a nuclear 
medicine department is discussed. Chapter 5 outlines the methods and challenge 
conditions used to modify the acquisition protocol of "H Tc HMPAO SPECT images for 
analysis by SPM methods, in particular whether SPECT studies of neuroactivation might 
benefit from a similar approach used in PET, i.e. increase the number of scans per task 
and accept poorer individual scan quality. The results are presented and discussed in 
teRMS of their suitability for use in neuroactivation studies using SPECT. Chapter 6 
uses the optimal study design determined in chapter 5 to investigate vagal nerve 
stimulation as a treatment for intractable epilepsy. Chapter 7 uses the same design to 
study the role of the medial temporal lobes in novelty detection by contrasting it with their 
role in the encoding and/or consolidation into long-term memory of associative 
information. The results for each of these neuroactivation studies are discussed in teRMS 
of their contribution to the knowledge of human brain function. Finally chapter 8 
outlines the conclusions drawn from each of these experiments and their application to the 
future use of SPECT in functional human brain mapping.
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CHAPTER 2
Image acquisition and image analysis tools.
This chapter describes the various steps involved in using SPECT with the 
functional human brain mapping software (SPM) including image acquisition, 
image registration, image standardisation, image reslicing, smoothing, global 
normalisation, statistical analysis and statistical inference common to all the 
subsequent investigations (Chapters 3-7).
2.1 Im age acquisition
All images were acquired using the SME 810 Novo (Strichman Medical Equipment) 
dedicated SPECT section scanner which consists of an annular array of 12 detectors with 
an 8 inch diameter field of view. There is no rotation of detectors. Each has a point 
focused 800 hole collimator, and performs 3D rectilinear translations orthogonal to its 
axial direction. Each detector of an opposing pair is responsible for scanning the half 
volume nearest to it and produces an image of the radioactive distribution that is in the 
field of focus, which will also contain additional blurring from regions above and below 
the focal plane. An iterative procedure is then used to back project the data and restore the 
activity lost to attenuation. First the head boundary is determined by fitting an ellipse to 
each slice in the image such that the concentration of the activity is zero outside the ellipse 
and non-zero inside. Then, assuming that the attenuation coefficient is homogeneous 
along the absorption length as the photon travels through the brain tissue, skull and scalp
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Figure 2.1 Schematic arrangement of the detectors and the rectilinear motion during scanning of the 
SME810 brain SPECT gamma camera.
and using a 'Chang like' attenuation correction (72) an attenuation map is constructed. 
This map is constructed for each of the 12 detectors and specifies, for every point in the 
field of view, the probability that a photon emerging from that point will reach the 
detector. The map can be applied iteratively (minimum of 1 iteration and a maximum of 3 
iterations) to the raw data to obtain an estimate of the radio-tracer distribution in the head.
The scans were acquired using either 500MBq 99mxc HMPAO described as 1 unit dose, 
slice thickness is 12mm, scanning time is 120secs per slice (1 unit time), and slice 
spacing 6mm (6mm = lunit separation) or 250MBq 99nrpc  HMPAO (1/2 unit dose), slice 
thickness is 12mm, scanning time is 240secs per slice (2 unit time), and slice spacing 
8mm. These acquisition parameters provide an in-plane resolution of 8mm and 
longitudinal resolution of between 10mm and 12mm. For a full description of this 
scanner and the reconstruction algorithm the reader is referred to the paper "New multi­
dimensional reconstructions for the 12-detector, scanned focal point, single-photon 
tomograph." by Stoddart and Stoddart 1992, Physics in Medicine and Biology (36). 
Optimum scan orientation is approximately parallel to the orbito-meatal (OM) line and 
head movement during the scanning procedure is minimized by subject co-operation and 
assisted by placing foam supports either side of the subject's head which are held in place 
by Velcro. 99mjc HMPAO is injected intravenously while the patients are supine on the
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scanning couch under standard resting conditions of eyes closed and minimum auditory 
stimulus, unless the subject is taking part in an activation task in which case they will be 
injected as the experimental protocol requires. Image acquisition begins approximately 
15mins after injection with a total acquisition time 30-60 mins. depending on the slice 
thickness acquisition parameter and the size of the patient's head. After reconstruction all 
scans are converted to ANALYZE™ 1 compatible format using customised MATLAB2 
scripts (courtesy of MG3) and transferred to a SUN ULTRAsparc4 workstation for 
further process/analysis.
2.2 Image analysis - Statistical Parametric Mapping.
There are several voxel-wise analysis techniques available either commercially or as 
freeware (SPM96, MEDx3.0, IDL, AFNI, Hermes)5. The analysis used for the 
investigations presented here was Statistical Parametric Mapping (SPM95/96). Statistical 
Parametric Mapping (SPM) was originally developed by Karl J Friston and colleagues at 
the MRC Cyclotron Unit, Hammersmith hospital, London, UK. The latest versions, 
SPM95 and SPM96, were developed at the Wellcome department of Cognitive 
Neurology, under the direction of Professor Friston. The software is freely available 
from the web site (http://www.fil.ion.bpmf.ac.uk/spm) and is written both in MATLAB 
code to run on a UNIX platform and C programming language to run on a Windows95 
platform. Online technical support is provided by the group via a mailbase service for all 
users (http://www.mailbase.ac.uk/lists/spm).
SPM is software used for the intersubject averaging of functional brain images and their 
statistical analysis (73). It consists of 3 main modules:
*Mayo Medical Ventures, USA (http://wwwjnayo.edu/bir/analyze/ANALYZE_mainJitml
2The Mathworks Co, UK (http://www.camcontrol.co.uk)
3MG-Dr Mike Glabus, neurophysicist, MRC Brain Metabolism Unit, University of Edinburgh, 
Edinburgh, UK.
4SUN Microsystems, London, UK (http://www.sun.co.uk)
5 SPM96 Statistical Parametric Mapping, Wellcome Department of Cognitive Neurology, Inst, of 
Neurology, London, UK (http://www.fil.ion.bpmf.ac.uk/spm)
MEDx3.0 - Sensor Systems Inc., USA (http://www.sensor.com)
IDL - Research Systems Inc., UK (http://www.rsinc.com)
AFNI - Robert Cox, Biophysics Research Inst., Medical College of Wisconsin, USA 
(http://varda.biophysics.mcw.edu/~cox/indexJitml)
Hermes - Nuclear Diagnostics Ltd., Kent, UK.
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•  module one image registration,
•  module two image standardisation (spatial normalisation) and
•  module three statistical analysis.
SPM uses an automatic and general multidimensional non-linear spatial transformation 
technique to standardise brains from different subjects (49). There are two components 
to this transformation; one is spatial and the other involves the intensity values of the 
voxels within an image. The assumption on which this model is based is that the 
differences between the subject's brain (object image) and the standard brain (target 
image) are slowly varying with position in the images. Any physiological/functional 
differences that we are trying to measure manifest themselves as differences in voxel 
intensity values between the two images which are considered to be rapidly changing and 
can be regarded as residual error (48). The statistical analyses used by SPM are based on 
the general linear model (GLM) (59). In its simplest form it can be described as testing 
for the null hypothesis that two mean images are the same using a paired t-test at every 
single voxel in the mean images. The statistical parametric maps that are produced from 
this type of analysis represent the significance changes in rCBF not absolute or relative 
percentage changes in rCBF. The statistical methods used in this module are parametric 
in nature since it is assumed that the underlying probability distribution of the data is 
known.
2.2.1 MODULE ONE:- Image Registration.
Image registration by voxel similarity methods
Spatial transformations for intra-modality, 
intra-subject registration:-
The spatial transformation used to map the object image on to the target image is an affine 
transform which in its simplest form has 6 rigid body parameters describing translation 
and rotation in space. In order to map one image on to another using a transformation the
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parameters must first be calculated. SPM uses a directed iterative least squares calculation 
to do this. The algorithm used (49) is based on a Gauss - Newton optimisation using a 
first order approximation of a Taylor expansion. Since using only the first order 
approximation of a Taylor expansion means that the solution may become trapped in a 
local minimum, the developers of SPM suggest that the starting estimates of the 
transformation parameters are not too far from the solution. This means that the object 
image must already be fairly close to the same orientation as the target image. In addition 
to these close starting parameters the initial iterative steps are performed with smoothed 
images which also reduce the likelihood of the solution becoming trapped in a local 
minimum. Once the registration is close to optimum the calculation can then be continued 
with the unsmoothed images.
Spatial transformations for inter-modality, 
intra-subject registration:-
To achieve registration between two different imaging modalities SPM changes the 
structural image into a pseudo functional image before using a nine parameter transform 
(6 rigid body and 3 scaling) to register this with the true functional image (41). That is 
the structural images (usually MR) are transformed into pseudo emission tomography 
images (usually of blood flow) by assigning each tissue type (grey and white matter, 
CSF) a corresponding PET intensity value e.g. 1:4 whiteigrey matter, convolving the 
image with a Gaussian spatial smoothing filter and adding noise. This pseudo functional 
image can then be registered with the true functional image, the transformation parameters 
of which can then be applied to the true structural image to achieve registration with the 
true functional image.
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2.2.2 MODULE TWO. Image standardisation.
Image standardisation using a voxel similarity method.
Intensity transformations 
for intra-modality and inter­
subject registration
This component uses a 12 parameter transform (6 rigid body, 3 scaling and 3 shearing) 
and an optional non-iterative non-linear resampling of image data to remove non-linear 
differences in brain shape to match to a standard template. Before this can proceed brain 
template must be defined using one of 4 different options a) template defined by an 
average of 305 MR T1 images b) template defined by the SPM95 template derived from a 
single subject PET scan c) template defined by the SPM96 template of an average of 6 
PET scans d) template defined by the user 6. Option a) is preferred since the final 
statistical parametric maps of brain activation can be referred to the on-line probabilistic 
anatomical maps defined by the Talairach deamon also defined by a subset of 305 MR T1 
images (http://ric.uthscsa.edu/projects/talairachdaemon.hunl)
Once the images have been transformed into perfect anatomical register using the 12 
parameter transform to account for overall differences in brain size and shape the user can 
specify a further optional non-linear spatial transformation that adjusts the object image to 
fit the cortical gyral anatomy of the target image more closely (49). The algorithm can be 
described more simply in terms of reducing it to a function which is based on the integral 
of all pixel values in the template image divided by the integral of all the pixel values in 
the object image and an error term which is then convolved with the original pixel values 
in the object image and a Gaussian spatial filter to reduce the errors in the transformation 
due to rCBF differences. A graphical example of this is given in figure 2.2.
6 References to these options can be found in the SPM documentation at web site 
http://www.fil.ion. bpmf.ac.uk/spm/dox.html
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SPM95 implemented this transformation by calculating the sum over all the rows, 
transforming the image and then summing over all the columns and then transforming the 
image again. This made the assumption that the transformation was commutative i.e. 
rows then columns is the same as columns then rows.
SPM96 extended this model to include 3 dimensions avoiding the error introduced by 
assuming the commutative nature of the method (49). This intensity transformation has 
been described by the developers of SPM as being better suited to adjusting cortical 
anatomical differences rather than sub-cortical differences (48). As a consequence only 
the 12 parameter linear transformation is used for image standardisation of " mTc 
HMPAO SPECT images of CBF used in chapters 3-6.
Intensity transformations for 
inter-modality and inter-subject 
registration:-
There are two ways of applying the method described above to standardise structural with 
functional images a) standardise the high resolution structural image to the MR template 
provided with SPM and then use the same transformation on the corresponding 
previously registered functional image or b) standardise the functional image to the PET 
template provided with SPM and then use the same transformation on the corresponding 
previously registered structural MR image.
Since the object MR image must have contrast/acquisition parameters (of which there are 
a huge number of permutations) very close to that of the template or the standardisation 
algorithm will fail, option b) is preferred
Reslice parameters:- Once image registration and image standardisation has been 
completed the registered object images have to be resliced. There are 3 options for the 
interpolation method a) nearest neighbour b) bilinear c) sine interpolation. Option b) is
43
preferred for " mTc HMPAO SPECT rCBF images based on empirical evidence (see 
appendix A) and advice from the SPM developers (personal communication from John 
Ashbumer 26/01/98)7.
2.2.3 MODULE THREE. Statistical Analysis.
Image analysis by voxel-wise methods.
The statistical analyses used by SPM are based on the general linear model (GLM) (59), 
in which a variation in the signal that is being measured can be expressed in teRMS of a 
linear combination of explanatory variables and an error term: i.e.
Y = XB + e (1)
where Y = the response variable (the signal we are trying to measure) X = the 
explanatory variable (cognitive task) B = unknown parameter and e = an error term (that 
includes stochastic noise from the scanner, and biological noise from the subjects, and is 
modelled as a normal distribution).
This means that if the GLM holds true for the data then both data sets will have the same 
distribution and therefore a simple t-test can be used to test for the null hypothesis that 
two mean images are the same using a paired t-test at every single voxel in the mean 
images.
Smoothing:- Before statistical analysis is carried out the images must be spatially 
smoothed using a Gaussian spatial filter so that a) the data conform more closely to a 
Gaussian field model which is used to make statistical inferences about the SPM(t) maps 
produced b) the noise is reduced in the scan by smearing out the signals at higher spatial 
frequencies usually attributable to noise and c) it removes very small differences in the 
functional anatomy between subjects (59).
7SPM-mailbase letter dated Jan/98 at http://www.mailbase.ac.iik/lists/spm/1998-01/0078Jitml
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There is no 'best' smoothing filter, only general guidelines that for the data to be 
compatible with the Gaussian field theory, the full width at half maximum (FWHM) of 
the smoothing filter must be at least twice the voxel size of the original image in all 
directions (61). It should also match the expected extent of the signal (which of course is 
unknown) produced by the change in rCBF. A spatial filter with a small FWHM (i.e. 
less than the extrinsic resolution of the system filter) will preserve amplitude [u] of 
activation but leave some stochastic noise from the scanner and radioactive decay 
processes which will adversely affect the overall signal [c], whereas a larger filter (i.e. 
greater than the extrinsic resolution) will increase the extent, (number of significant 
voxels) [k] of an activation region but may introduce noise from other structures again 
reducing the overall signal [c]. It follows that there must be an optimum filter size for the 
data sets available where u, k and c are at a maximum or in teRMS of the reporting of 
SPM(t) maps pu, Pk and pc are at their most significant where p  is the significance of the 
signal changes in the data.
Review of the literature reveals a range of Gaussian spatial filters used, presumably 
dependent on the machine and/or back-projection method used (which will also include a 
certain degree of spatial filtering). However, it was not possible to simply transfer this 
information supplied by PET or conventional SPECT users of SPM to our data since the 
detector arrangement and performance characteristics of the SME 810 dedicated brain 
SPECT scanner differs from conventional gamma cameras. It was necessary, therefore, 
to decide empirically which filter gave the optimum results for our data sets (see appendix 
A). The optimum filter size determined by our measurements for a unit dose (500MBq) 
of 99mXc HMPAO is 10mm FWHM and for a half unit dose (250MBq) of 99mTc 
HMPAO is 12 mm FWHM.
SPM Experimental Design:- The experimental design is a crucial component in applying 
SPM and there are a number of design options to chose from. The three different designs 
used in this thesis are:
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•  multi-subject; different conditions, (equivalent to a blocked analysis of 
variance)
•  multi-subject; replication of conditions (equivalent to a blocked 
analysis of variance with replications)
•  compare groups; one scan per subject, (equivalent to an analysis of 
covariance or unpaired t-test)
Contrasts:- Contrasts are used to describe the changes that the experiment is searching 
for and consist of matrices containing a series of l's, - l ’s and 0’s (73). For example, 
once the scans have been selected in order of subject and then condition, a multi-subject; 
different conditions experiment of the form A B C D denoting four different cognitive 
tasks would be constructed in the following way to look at a simple subtraction paradigm.
Tasks
A B C D
contrasts r 1 - 1 0 0- 1 1 0  0
0 0 1-1
0 0 - 1 1
A-B
B-A
C-D
D-C
All scans of subjects performing 
task A compared to all scans of 
subjects performing 
task B e tc ..
These contrasts could be extended further to look at the difference in the differences (an 
interaction). For example
Tasks
A B C D
contrasts
(A-B)-(C-D) 
(B-A)-(D-C)
Using this simple notation the comparison of conditions can be constructed in such a way 
as to be more than just a cognitive subtraction (74) (see CH 7).
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Global Intensity Normalisation:- Before the difference in means can be calculated some 
adjustment for differences in global blood flow between scans of the same subject and 
scans of different subjects must be made. These global differences can be attributed to 
differences in administered dose and uptake fraction in the brain as well as physiological 
changes in the subject (mood changes, physical activity). All of these changes will 
interfere with the actual rCBF change that is being measured.
Global CBF (gCBF) is measured as the mean value over all intracerebral voxels, where 
the intracerebral voxels are calculated as being the voxels with a value above 80% of the 
global mean of all voxels in the scan. The statistics are then performed on the voxels that 
survive an 80% threshold of the mean gCBF value (grey matter threshold). This means 
in effect that the volume of the brain analysed will be equivalent to that of the smallest 
volume in any individual brain scan included in the analysis. There are two different 
ways that SPM can remove differences in gCBF a) Proportional Scaling and b) Analysis 
of Covariance (AnCova) (59). Proportional scaling removes differences in gCBF by 
scaling all voxels within a scan to the mean gCBF of each scan and assumes the change in 
rCBF will be dependent on the gCBF. AnCova removes differences in gCBF by 
modelling the mean gCBF for each scan as a confounding covariate and so removes most 
of the error variance due to gCBF leaving only the variance due to the differences in 
rCBF induced by the activation task being investigated. This assumes that the measured 
change in rCBF is an additive effect, the size of which is independent of the gCBF, as 
opposed to proportional scaling which assumes the change will be dependent on the 
gCBF.
For the purposes of normalising 99m j c HMPAO SPECT images option a) is preferred. 
The developers of SPM recommend that for qualitative measures of rCBF (such as 99mjc 
HMPAO scans) where the differences in global counts between subjects can be quite 
large, the proportional scaling method is used in preference to AnCova (personal 
communication from Dr Andrew Holmes 02/02/98)8.
8 SPM-mailbase letter dated feb/98 at http://www.mailbase.ac.uk/lists/spm/1998-02/0001.html
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height
threshold
Figure 2.3 shows a 3d representation of a slice through an SPM (t) to demonstrate the difference between 
significance in activation height and activation extent.
Presentation of Results
After smoothing and global intensity normalisation a t-test is performed on every 
intracerebral voxel to produce a statistical map SPM(t) which represents change 
significance. Having computed a t value for each voxel in the data set (SPM(t)) 
constructed using the appropriate experimental design and contrast, the values are 
transformed to the unit Gaussian distribution and expressed as Z-scores (unit standard 
deviations from a mean of zero). These 'maps' are then displayed as maximum intensity 
projections (MIPS) in 3 planes; axial, sagittal and coronal (see fig 2.4). The data can also 
be rendered on to cortical surfaces or MRI sectional planes. To display the SPM(t) MIPS 
a significance threshold must be selected. All voxels surviving the threshold will be 
displayed.
extent
extent threshold
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0 . 0 0 0 ( 6 . 7 4 ) 0 . 0 0 0 0 . 0 0 0 2 6 5 2 4
H e i g h t  t h r e s h o l d  { u } = 3 .0 9 ,  p = 0 .0 0 1  
E x t e n t  t h r e s h o l d  { k } = 3 .2 5 8 e - 0 1  v o x e l s ,  p = 0 . 5  
E x p e c t e d  v o x e l s  p e r  c l u s t e r ,  E { n } = 0 .8  
E x p e c t e d  n u m b e r  o f  c l u s t e r s  E { m } = 8 1 .2
V o l u m e  { S } = 1 2 1 9 4 2  v o x e l s  
D e g r e e s  o f  f r e e d o m  =  9
Smoothness FWHM {mm}=3.9 3.9 7.4 
{ v o x e l s }  =  2 . 0  2 . 0  1 .9
Figure 2.4 shows the SPM (t) table printed after a typical SPM96 analysis of 3 individual sample scans 
contrasted with a reference group. See text for details.
Height and extent threshold:- The Z-score map that is produced can be considered 
significant on two levels a) height of change significance of rCBF and b) extent of the 
number of voxels with significant change of rCBF (59) (see figure 2.3 for graphical 
representation of peak significance and extent significance).
Corrected significance (multiple statistical tests):- When performing multiple statistical 
tests a correction must be made for the number of tests being performed. Usually this 
takes the form of a Bonferroni correction i.e. the level of significance divided by the
49
number of independent statistical tests performed. In its simplest form this would mean 
that for a voxel-wise analysis the significance level would have to be divided by the total 
number of voxels in the data set, typically tens of thousands and would wipe out any 
statistically reliable activation signals. However, intrinsic resolution of the scans and the 
spatial smoothing filter which is applied to the data prior to analysis means that the voxels 
are not independent of one another. Instead an estimate of smoothness is used so that an 
equivalent number of tests can be calculated and an alternative "Bonferroni type” 
correction for multiple testing is made (59).
Corrected significance based on height and extent:- A further calculation is made that 
combines the significance of the extent of the activation with its height corrected for 
multiple comparisons; so that a change in the voxel height (representing ArCBF) 
although small (<2%) may still be considered a significant region of change if it occurs 
over a significant number of voxels (69).
Statistical Inference:- If one is considering a hypothesis driven experiment where the 
cognitive tasks have been manipulated in such a way that a particular brain region is 
expected to show significant change then the significance threshold can be set at p<0.01 
(uncorrected height threshold) and p=1.00 (uncorrected extent threshold). If the 
experiment is more exploratory then the thresholds can be set at pcO.OOl (uncorrected 
height threshold) and p<0.1 (corrected height threshold) or p<0.05 (corrected extent 
threshold).
Figure 2.4 shows the MIPS viewed on 3 orthogonal sections of a 'glass brain'. To the 
right of this is the contrast representation, in this case ( - 1 1 0  0), and the design matrix 
used commonly by statisticians when performing an AnCova. Below this is the list of 
data defining the location and Z-scores for the most significant voxels surviving a 
predetermined significance threshold. Reading the columns from right to left; column 1 
gives the x, y, z co-ordinates of the most significant voxel in Talairach space, column 2 
lists both the uncorrected significance of the height and the extent of the change in voxel
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value (or ArCBF), column 3 lists both the Z-score and the corrected (for multiple tests) 
significance of the height of the change in voxel value, column 5 lists the Z-score, the 
number of voxels and the corrected significance (multiple tests and extent), column 6 lists 
the significance of the number of clusters of continuously significant voxels detected.
For a more in depth review of all of these steps the reader is referred to 
http://www.fil.ion.bpmf.ac.uk/spm.
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CHAPTER 3
V alida tion  o f  th e  im ag e  s ta n d a rd isa t io n  fa c i l i t y  o f  S P M 9 6  
app lied  to oblique or  incom plete  im age da ta  sets.
This chapter describes the methods used to validate the image standardisation 
facility of SPM96 by performing a series of challenge conditions analogous to 
those present in routine clinical data. Section 3.1 describes the problems inherent 
in validating between subject and between modality image registration in the 
situation in which there is no one-to-one correspondence. Section 3.2 lists the 
steps taken to create the simulated "non-optimal" data sets, i.e. the challenge 
conditions. Section 3.3 describes the assessment of errors and lists the results for 
the overall performance of the image standardisation facility. Section 3.4 
discusses these results in teRMS of finding the optimal method of image 
standardisation for clinical " “ Tc HMPAO SPECT cerebral blood flow images.
3.1 In troduction .
Despite fixed protocols for positioning patients within the field of view of a SPECT 
camera for some seriously ill patients correct positioning is almost impossible. The 
developers of SPM recommend that differences in orientation between scans or with 
respect to a template be no more than a few degrees because of the possibility of the result 
getting stuck in a local minimum. In some seriously ill or elderly patients, positioning 
within the field of view is difficult, and images may have as much as
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Figure 3.1 a show s a section through the mid 
sagittal o f  " mTc HMPAO scan that has a good  
field o f v iew  covering the w hole head.
Figure 3.1 b show s what happens when the 
patient’s head is tilted backwards in the sagittal 
plane (usually caused by the difficulty many 
older patients have in lying on the poorly de­
signed scanning couches when they have a 
marked curvature o f  the spine) which results in 
only the top half o f  the cerebrum being in the 
field  o f  view.
Figure 3. lc  show s what happens when there are 
problem s positioning a seriously ill patient and 
that patient finds it difficult to lie in the scanner 
for any length o f  time. Both the cerebellum  and 
the superior axial slices are m issing from the 
field  o f view.
Figure 3.1 show s how positioning o f  the patient within the confinces o f  the scanner can effect the field o f  
view  and hence the volum e o f  brain contained within the im ages. Figure 3.1 a typical im age from the 
SM Fi81() scanner with good coverage o f  the w hole brain. Figure 3.1b show s what can happen if there are 
problems positioning the patient. Figure 3.1c show s what might happen if  that patient also finds it difficult 
to lie in the scanner for any length o f  time.
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a 20° pitch misalignment from one another or from a standard reference position and 5°- 
10° roll and/or yaw. For a section scanner this results in a loss of data from either the top 
or bottom regions of the brain image data set (axial truncation) and only a small area of 
overlapping data between two images to be registered (be they repeat SPECT/PET scans 
or an ideal template) may be available, as illustrated in figure 3.1. Even for conventional 
rotating gamma cameras positioning of the camera head so that the shoulders of the 
patient are avoided can also result in a loss of information from the lower parts of the field 
of view (the cerebellum). In addition routine MR and CT acquisitions quite often do not 
include the top of the head.
Although whole brain coverage is not essential for the clinical reporting of scans, the 
performance of automated image registration software can be hampered by axial 
truncation. No specific problems have been reported by the developers of SPM96 but 
other developers of image registration software (39) suggest that partial data sets may 
pose a problem for automated registration and the experience of this department suggests 
that in severely compromised data sets there may be a particular problem with alignment 
in the sagittal or coronal planes.
3.1.1 Validation o f accuracy and precision of image registration and 
standardisation methods.
A comprehensive study by Strother et al 1994 (23) comparing the merits of ’correlation of 
similarity' with other methods of image registration found that overall the former method 
was more accurate. Not surprisingly the smallest errors were incurred for intra-modality 
matching, particularly for MR to MR images of the brain. Landmark matching (both 
internal and external) fared particularly badly for inter-modality matching due to the 
difficulties in locating the same points between structural and functional images as well as 
problems locating the centre of a marker in the lower resolution functional images.
The surface contour method performed only marginally worse for inter-modality 
compared with intra-modality matching (2mm for MRI/PET compared to 1mm for
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MRI/MRI ) but was not as good as the correlation of similarity method (1mm for 
MRI/PET compared to 0.25mm for MRI/MRI).
The above study assessed these techniques by their positional accuracy with reference to 
some standard position rather than by the resultant error in computing the significance of 
change or abnormality. Is a 1° error about the x axis better or worse than a 1mm 
translation along the y axis ? To answer this question it is more appropriate to investigate 
directly the effect of positional errors on the parameters used in this study i.e. the 
resulting change in the number of counts in each ROI (40) or the effect on a typical Z- 
score value in a voxel-wise analysis. However, the validation of image registration 
accuracy is not straightforward. As Pelizzari et al 1994 (75) states, "the measurement 
accuracy of co-registration methods on real human studies is inherently difficult". Even 
for intra-subject, within modality co-registration there can be no one-to-one 
correspondence between the data sets due to the natural variability in cerebral blood flow 
and stochastic noise generated by the radioactive decay processes and the detector 
instrumentation. For inter subject co-registration the individual variations in anatomy, 
despite attempts at standardization, will add to the overall mis-registration. In short there 
is no absolute 'gold standard1 against which image registration algorithms can be tested. 
It is better then to consider precision (or relative accuracy) rather than absolute accuracy, 
when considering image co-registration, as any transformation will have residual errors. 
The best that can be achieved is to compare the final co-registration result achieved with a 
full data set with that obtained during any of the situations where only a compromised or 
restricted data set is available. The key to the use of this method of validation is that the 
full data set becomes the 'gold standard' to which the sample (challenge condition) data 
sets may be compared. To measure the precision in an automated co-registration 
algorithm a single data set (sample scan) is manipulated prior to co-registration to provide 
a series of challenge conditions.
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3.2 M ethods
To create the challenge conditions for testing the image standardisation component of the 
software the following method was used:-
•  Create a reference dataset
•  Create the challenge conditions
•  Determine the optimum image standardisation method
3.2.1 Creating a reference data set
The method used to create the reference data set is fully illustrated in figure 3.2. Because 
there is no known result to these challenge conditions the deviations from a known 
constant condition were used to measure the relative accuracy of the image standardisation 
facility. First a reference database of scans was created to provide the reference data set 
against which each of the challenge conditions could be compared. Ten scan pairs were 
selected from a previous study where each subject had been scanned twice . The scans 
in each of these pairs were co-registered with one another and an average image was 
created from each pair. Each of these 10 average scans were then co-registered to the 
image in the group that was most closely aligned with the ac-pc line orientation. These 10 
re-aligned scans were then denoted as the reference group. To create the sample image, 
the reference group was then averaged into one single scan. The challenge conditions 
were then superimposed on to the sample image. Although the premise in this 
investigation was to monitor the effect of each challenge condition against a known 
reference, the use of an averaged scan as a sample image rather than a single image from 
an individual removed any possibility of a systematic result occurring as a consequence of 
that one individual's anatomy.
3.2.2 Creating the challenge conditions
In order to follow the effects of the challenge conditions on the statistical output known 
changes in rCBF had to be created in the sample scan.
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Figure 3.2. A schem atic How diagram show ing the steps involved in producing the sim ulated data for 
validating the im age standardisation facility in SPM 96.
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The pseudo differences between the scans were achieved by using a customised graphics 
package9, to place a region of 'abnormality' in the sample scan. The image data was 
manipulated in ANALYZE™ format as single images representing axial slices through 
the brain. A region was drawn in the left and right parietal lobes on three axial slices 
through the parietal cortex. The mean value of each of these slices was calculated and 
30% of the slice mean was added to each pixel in the designated region in each slice. The 
slice mean was calculated as the number of counts in those pixels with a non-zero value in 
that slice divided by the area (mm2) within the threshold boundary.
Rotations in the sagittal, coronal and axial planes of varying degrees were introduced 
using the display facility in SPM96.
Axial truncation was achieved using a customised graphics program (mri3d)10 by 
removing slices from the inferior parts of the sample image after introduction of a 
rotation.
DIRECTION OF 
ROTATION
DEGREE OF 
ROTATION
AXIAL
TRUNCATION
sagittal 0° Oslices
6°
coronal 9° 3slices (18 mm)
axial 12° 5slices (30mm)
15°
Table 3.1 gives a summary of all the challenge conditions. Each challenge condition was created from 
different permutations of these parameters e.g. direction of rotation: sagittal, degree of rotation: 15°, axial 
truncation: 3slices (18mm).
3.2.3 Determining the optimum image standardisation method:
Three different methods were examined and are illustrated in figure 3.3.
9xpaint is a Xwindows, UNIX application available with Solaris 2.7.
10customised image display software runs on a UNIX platform, courtesy of Martin Connell, Department 
of Clinical Neuroscience, University of Edinburgh, Western General Hospital, Edinburgh, UK.
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Figure 3.3 A schem atic How diagram show ing the 3 different m ethods used to achieve im age standardisa­
tion under a series o f  different challenge conditions.
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The first method involved image standardisation of each of the challenge 
condition sample images by direct matching to the standard PET template supplied with 
SPM96, linear spatial standardisation function.
The second method used a rigid body registration step prior to standardisation. 
Each challenge condition sample image was co-registered to the reference image (the 
sample image no rotation, no truncation) using a 6 parameter rigid body transform before 
it was matched to the PET template.
The third method includes editing of the final standardised sample image after 
co-registration, standardisation and smoothing to remove spurious data contained in the 
smoothed edges.
3.3.1 Reporting image standardisation results:
The results from each of the challenge conditions were analysed using the "compare 
groups: 1 scan per subject" option where group 1 was the 10 average scans in the 
reference data set and group 2 was a single challenge condition sample scan. Global 
blood flow normalisation was achieved using the proportional scaling option and SPM(t) 
maps were generated using the default thresholding of Pu<0.001, and Pk<0.5 
(uncorrected). Results were calculated in teRMS of the average in absolute change in Z 
score and root mean squared error in location (defined by Talairach co-ordinates) of the 
most significant voxel within the two pseudo lesions with respect to that reported in the 
reference scan. Aggregate errors particular to the method of image standardisation used 
or the challenge condition being corrected were used to provide an overall view of the 
performance of the image standardisation facility.
3.3 Results
Figure 3.4 shows the reference results to which all other subsequent results were 
compared. Figures 3.5 - 3.7 show the results of the 3 different methods of image
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Figure 3.4. Reference result Figure 3.5. M ethodl:- spatial normalisation to
PET template directly.
SPM (t) map of the results o f standardising the
reference image to which all other subsequent SPM (t) map of the results of methodl image 
sample scans were compared. standardisation on the significance and location of
the pseudo lesions.
ZL = 4.84 (x y z)L = -40 -40 52
|AZI = 0.59 RMS(x y z) = 53 mm
Zr  =  4.25 (x y z)R = 48 -56 36
Figure 3.6. M eth o d 2 :- co-registration to 
reference sample image prior to spatial 
normalisation.
SPM(t) map of the results o f method2 image 
standardisation on the significance and location of 
the pseudo lesions.
|AZI = 0.82 RMS(x y z) = 9.8 mm
Figure 3.7. Method3:- editing of smoothed edges 
after standardisation but prior to statistical analysis.
SPM(t) map of the results o f method3 image 
standardisation on the significance and location of 
the pseudo lesions.
|AZI = 0.12 RMS(x y z) = 5.7 mm
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standardisation on the challenge condition; direction of rotation: sagittal, degree of 
rotation: 15°, axial truncation: 5 slices (30mm).
The results from the first method (figure 3.5) show that the image standardisation 
procedure has failed to correct for the rotation in the sagittal plane made evident by the 
fact that the pseudo lesions originally located bi-laterally in the parietal lobes are now 
located in the occipital lobe and the appearance of a further significant lesion in the 
anterior frontal lobes bi-laterally. The size of both the average absolute difference in Z- 
score (0.59) and the RMS error in location (53mm) recorded in this example would 
undoubtedly give erroneous information if the same situation had arisen in a clinical scan. 
The results from the second method (figure 3.6) show that the rotation in the sagittal 
plane has been corrected. This is clear from the large reduction in the RMS error in 
location (9.8mm). However, another problem becomes apparent in this case. The large 
areas of significance produced at the top and bottom of the SPM map are a result of the 
statistical calculation detecting voxel values at the edge of the resliced sample scan volume 
as unexplained variance. The consequence of this is that the significances of the voxel 
values in the pseudo lesion are reduced (causing a larger difference in absolute in Z-score 
than in method 1) with respect to the reference group as a direct affect of the increased 
overall variance of the resliced sample scan. Finally the results of using method 3 on this 
example are shown in figure 3.7. The voxel values produced by the interpolation of edge 
information after reslicing of the sample image are removed by manually editing these 
parts of the scan. This allows the pseudo lesion voxel values to be identified at a higher 
significance level, differing from the original z-score value by just 0.12 but doesn't 
entirely remove the RMS error in location (5.7mm). The residual differences in both Z 
score and RMS could be a result of the interpolation of the voxel values within the lesion 
itself after reslicing and therefore some caution must be observed when interpreting SPM 
maps produced from clinical scans if acquired under the same situations of extreme 
rotation and axial truncation.
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Although the results illustrated in figures 3.5-3.7 are from one of the most extreme 
challenge conditions and consequently show the largest errors, this pattern of being able 
to reduce the error in Z score and location by applying method 3 is consistent for all 
challenge conditions. To gain an overall view of this result all the measurements of 
average absolute differences in Z score were summed over all directions of rotation for 
each axial truncation depending on the method of image standardisation used. For 
example the IAZI for all the rotations sagittal, coronal and axial at 15°, 12°, 9°, 6°, 0° for 
the ax ial tru n ca tio n  o f 30mm w ere sum m ed to g e th e r (e.g . 
0.69+0.74+0.79+0.82+0.09+0.11+0.82+0+0.49+0.48+0.48+0.48 = 5.99) then the 
same for the axial truncation of 18mm and finally for 0mm. These aggregate results are 
shown in figure 3.8 and provide a performance measure of each of the image 
standardisation methods under investigation regardless of the direction or size of rotation 
but affected by the amount of axial truncation present in the sample image. Both figures 
3.8a and 3.8b show that all methods are poor when performed on severely truncated data. 
Method 3 produces the most improvement in terms of Z-score difference but methods 2 
and 3 work equally well with regard to improvement in RMS error in location.
A further overall view of the results of this investigation in to the image standardisation 
facility are shown in figure 3.9 and illustrate the type of situations (challenge conditions) 
that will produce the biggest errors regardless of the method of image standardisation 
used. This investigation shows that because there still remains a residual error in location 
even after using image standardisation method 3, any SPM analysis of images that 
contain a restricted amount of data because of large rotations in the sagittal or coronal 
planes (axial truncation = 30mm and sagittal rotation 15° i.e. no cerebellum) must be 
interpreted with caution. A complete listing of results for each of the challenge conditions 
are included in appendixB.
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The results of the investigation in to the spatial normalisation facility of the SPM software 
demonstrated that relying on the spatial normalisation facility (method 1) alone was 
unreliable in situations where starting parameters were far from ideal (axial truncation = 
30mm and sagittal rotation 15° i.e. no cerebellum). Results were improved by 
performing a rigid body co-registration of the sample images to an average " m j c 
HMPAO SPECT reference image prior to spatial normalisation (method 2). A further 
reduction in errors could be made if the smoothed edges (containing spurious voxel 
values) were removed after spatial normalisation but prior to statistical analysis (method 
3).
3.4 Discussion
This study investigated three different methods of image standardisation for use with non- 
optimal image data sets. The chronology of the methods were such that the second 
method was developed as a solution to the problems incurred using the first method (the 
SPM96 image standardisation facility) and the third method was developed as a solution 
to the problems encountered using the second method. They have been presented 
together for clarity.
The method of validation described requires that a full data set becomes the 'gold 
standard' to which the sample (challenge condition) data sets may be compared. To 
measure the precision in an automated co-registration algorithm a single data set (sample 
scan) was manipulated prior to co-registration to provide a series of challenge conditions. 
These challenge conditions were chosen to reflect those present in routinely acquired 
clinical data (large rotations from a standard reference position resulting in axial truncation 
of the image volume). This method is similar to that employed by Minoshima et al 1991 
(35). A series of simulated PET images were used to apply a number of challenge 
conditions, involving both rotations and translations, to a sample image before employing 
a correlation of similarities method (stochastic sign change evaluation) to register this 
sample image to the original reference image. Results show that the precision accuracy 
for this method gave a mean rotational error of 0.03° and a translation error of 0.5 pixels.
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In anticipation of using this method to register images of abnormal brains they also 
simulated various lesions (typical of the clinical groups they would be investigating) 
within the sample image before applying additional rotation and translation. The 
consequential mis-registration errors tended to increase with larger lesion volumes, with 
the largest error (>1.0°) due to rotation in the coronal plane and a single lesion volume of 
32% of the total brain volume. Minoshima et al concluded from this that their method of 
image registration would still perform well in the presence of large lesion deficits typical 
of an abnormal brain. Similarly, Studholme et al 1997 (39) tested the precision of their 
image registration by correlation of similarities method (maximum entropy) by re­
registering clinical images to themselves after the introduction of random rotations and 
translations. An additional challenge of axial truncation of these images was introduced 
to model the problem that section scanners have when trying to obtain images of the 
whole brain. They found the test registrations carried out using their technique failed 
when used on these truncated image volumes. Friston et al 1991 (48) used a similar 
concept of precision accuracy to validate their method of image standardisation by 
measuring the precision with which stereotactic anatomical locations could be defined 
within and between subjects registered to a standard template. They were able to show 
that the residual error after both within subject and between subject matching was reduced 
after a plastic transformation was performed, concluding that better image standardisation 
was achieved by the use of a plastic image transformation. Assumptions needed for 
Friston's method to work are that the functional residual differences, (e.g. the differences 
in rCBF that are actually being measured) are small. This is because the premise on 
which the final image registration result is based is that the observed distribution of voxel 
intensities within the sample image will correspond to that of the reference 
image/template. If this is not the case then differences in rCBF due to lesion deficits, for 
example, may result in the plastic transformation trying to compensate by shifting voxel 
values to fill the gap. This condition has not been explicitly modelled by Friston et al in 
their validation of automated image standardisation.
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In the present study the image standardisation facility of SPM96 performed adequately in 
the most extreme conditions as long as appropriate modifications to the process were 
made. The maximum errors or changes in Z-score and location were induced by severe 
truncation of volume coupled with rotations in the sagittal plane and the coronal plane 
corrected by spatial normalisation to the PET template alone. For example, for a 
particular challenge of 30mm axial truncation +15° axial rotation the maximum error in 
absolute Z-score in the pseudo primary lesion was IAZI=0.89 and therefore likely to affect 
the acceptance of this region as significant at the default threshold levels of Pu<0.001 and 
Pk<0.5. This errors was reduced to IAZI=0.48 by initially co-registering the sample scan 
with the reference scan prior to spatial normalisation. Although method 2 coped well 
with large rotations the statistical analysis proved a little more sensitive. As a result of the 
initial extreme orientations and missing data new edges appeared in the interpolated and 
resliced data. The new edges become a problem when each image is smoothed prior to 
analysis, 'smearing' the edges and creating spurious voxel values. Despite the 
thresholding of voxels and the masking of images to ensure matching volumes across 
comparisons in the statistical analysis, some of this smeared edge information is included 
in the analysis and inherently includes lower values in these voxels than in the reference 
group. The inclusion of these lower value voxels alters the overall global mean value so 
that the previously significant change in voxels within the lesion is no longer significant. 
Instead it is these 'edge' voxels that are mapped as significant swamping the true lesion 
significance in the main body of the scan. This problem has recently been reported by 
others in the SPM user community (personal communication from B Swartz, 02/04/98)11 
and the next version of SPM (SPM99) will prevent the inclusion of these smeared edges 
in the analysis12. By preventing voxels with zero intensity being included when the 
image is being convolved with a spatial smoothing kernel the creation of false information 
will not occur. In the meantime, however, the only way around this problem is to 
intervene manually and edit the smeared edges from each slice in each individual scan (see 
figure 3.10). These new edited scans can now be run through the same statistical
11 SPM help line letter dated - http://wwwjnailbase.ac.uk/lists/spm/1998-04/0014.html
12SPM technical notes http://www.fil.bpmf.ion.ac.uk/spm/spm99.html
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Figure 3.10 Shows how the scans were edited to remove the smoothed edges containing spurious voxel 
values from a standardised and smoothed sample scan.
analysis as before, this time without the interference of false information. Further 
correction can be made (reducing the error from IAZI=0.48 to IAZI=0.09) by removing the 
smeared edges from the co-regislered and spatially normalised sample scan. Time taken 
to perform method 3 takes approximately 15 minutes per sample scan.
The biggest changes in location of the voxel with maximum Z-score were of the order of 
55mm and may present a more serious limitation in the location of the primary lesion with 
respect to known anatomical structure, (e.g. a move of 55 mm could place the lesion in 
the occipital cortex instead of the parietal cortex - see fig 3.4 and 3.5) but by following 
the co-registration and editing procedure the RMS error was reduced from 55mm to 9mm 
and in most cases to zero. If there is potential for error (e.g. when analysing images that 
are non-optimal) the facilities provided by SPM96 allow the user to "click" around the 
significant region. Rather than rely solely on the location of maximum Z-score voxel, 
one can use the whole structure of the significant region to determine in which anatomical 
structure most of the contiguous voxels lie. Of course this is subjective and may diminish 
the overall automation of the process unless one recognises that the match between 
Talairach and Toumoux atlas and the template used for spatial normalisation is at best a 
good estimate (personal communication from Karl Friston 23/06/98)13. In recognition of 
the problem of defining a standardised anatomical map Collins et al 1994 (25) set up their
13SPM help line letter dated - http://www.mailbase.ac.uk/lists/spm/1998-06/0076
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own standard map based on the co-ordinate convention used by Talairach and Toumoux 
1988 (46) but with additional information provided by the collection of anatomical data 
delineated by experienced neuro-anatomists from over 50 normal high resolution 3D MRI 
scans. The new atlas is expressed in terms of probability maps and the borders of 
anatomically distinct areas delineated at the 50% probability mark. The reported errors in 
Z score that these results predict for certain starting conditions become less significant 
when one views them in the context of the data provided by Collins and colleagues.
3.5 Conclusion
This investigation showed that when data from a severely restricted (non-optimal) image 
volume of CBF 99mTc HMPAO are to be analysed using SPM96 the image 
standardisation procedure must be modified to include:-
•  a rigid body co-registration between the non-optimal data set and an 
ideal reference optimal data set of the same imaging modality and 
acquistion parameters.
•  manual editing of the voxel values created by the interpolation of edge 
information (this should be after image standardisation and smoothing 
prior to statistical analysis).
70
CHAPTER 4
In vestiga tion  o f  S P M 96  as an a id  to the d ifferen tia l  d iagnosis  
o f  dem entia using " m  j c H M P A O  S P E C T  im ages o f  rC B F .
This chapter describes the application of SPM96 analysis to clinical image data 
using the optimal method of image standardisation determined in chapter 3. 
Section 4.1 describes the difficulties in making a differential diagnosis of 
dementia both clinically and with imaging and the benefit that an objective method 
might make. Section 4.2 describes the methods and materials used to establish 
any benefits of using SPM96 on clinical images of cerebral blood flow. Section 
4.4 discusses the role that SPM96 may have in the routine reporting of diagnostic 
images of cerebral blood flow.
4.1 In troduction
In most hospitals the reporting of images is done by an experienced consultant in nuclear 
medicine and neuroradiology (sometimes with the participation of an experienced imaging 
physicist). This is generally sufficient to arrive at the desired interpretation of the image 
being reported. In the specific case of the interpretation of 99mxc HMPAO CBF scans it 
is not difficult to spot the perfusion deficit produced by, for example, a massive cerebral 
infarct, or the typical CBF pattern of a patient in the later stages of dementia of the 
Alzheimer's type (DAT). Even the more subtle differences between an ictal and inter-ictal 
scan of an epilepsy sufferer can, with experience, be reliably detected visually.
However, there are some cases where this is not always so and interpretation of the scan 
is more difficult. For example patients in the earlier stages of DAT might exhibit the 
classical pattern of reduced perfusion bilaterally in posterior temporal and parietal cortex. 
Those patients in later stages of the disease might also have superimposed vascular 
abnormalities that would result in a less obvious match to the typical DAT CBF SPECT 
pattern. Would an objective and consistent method of image analysis be of value in 
interpreting these scans ? This investigation focused on whether the application of a 
voxel-wise image analysis technique (SPM96) could impact on the reading of scans. To 
do this SPM96 was used to aid in the differential diagnosis of dementia from SPECT 
images of CBF. A measure of inter observer agreement was used as an indicator of the 
software's usefulness, where an improved level of agreement would be interpreted as a 
positive finding (less equivocal diagnoses) and a lowered level of agreement a negative 
finding.
The measurement of regional cerebral blood flow (iCBF) using SPECT has been shown 
to contribute to the differential diagnosis of dementia due to the different perfusion 
patterns detected in the classical foRMS of each condition (76-83) and it has been proved 
useful for the differential diagnosis of dementia. SPECT images of probable Alzheimer's 
disease (PAD) as defined by DSMIV R criteria (84) show regional deficits in the parieto­
temporal cortex (sometimes asymmetrical) (42,63,85), those of dementia of the frontal 
lobe type (DFLT) show characteristic reductions in the anterior regions of the cortex 
including anterior aspects of the temporal lobe (86) while multi-focal lesions throughout 
the cortex indicate the presence of dementia of the vascular type (DVaT) (63,87). Using 
these characteristic SPECT rCBF patterns new automated techniques for analysing 
cerebral blood flow scans are being developed with the goal of obtaining an objective and 
accurate method of analysis to enhance the diagnostic performance of this procedure.
A number of automated methods have been reported in the literature (42,63,79,85,87- 
91), with some spectacular results (sensitivity and specificity in some studies of 85-95%) 
but most have relied on testing their methods using patients fulfilling strict clinical criteria
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and in whom diagnositic probability was already high. Those studies less restrictive with 
their patient groupings have found more mediocre sensitivity and specificity of a 
diagnosis based purely on neuroimaging information (sensitivity and specificity of 43- 
60% and 60-75% respectively (92-94)). However, these less successful methods 
although correct in their patient selection used conventional ROI methods of reporting and 
did not take full advantage of the extensive and sophisticated image analysis packages 
currently available free from the internet or commercially (SPM96, MEDx3.0, Hermes) 
for this kind of study.
Very few of the studies listed above had post mortem confirmation of dementia type (with 
the exception of Bonte et al 1997 (90) and Jobst et al 1995 (85)) preferring instead to use 
the diagnosis given clinically at a follow up investigation of between 10 months and a few 
years after initial presentation of symptoms. The present study also lacks post mortem 
confirmation, however, it differs fundamentally from the other studies mentioned. 
Rather than using the new voxel-wise image analysis to improve correct diagnosis of 
dementia the method is being investigated for its potential as an aid to improve the 
consistency of visual interpretation of CBF scans between observers i.e. it assessed the 
confidence rather than the correctness of classifying scans.
Having established a set of working criteria for use with routine 99mTc-HMPAO SPECT 
scans, SPM96 was then applied to images of individual patients presenting with 
symptoms of dementia. The aims were:-
•  To determine whether SPM maps could be produced which were 
consistent with the original scans.
•  To ascertain whether they could assist in the reading of scans by 
reducing inter-rater variability.
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4.2 Methods
4.2.1 Recruitment o f Subjects.
Patients:- 39 patients who had been referred to the Institute of Neurological Sciences by 
"Old Age Psychiatrists" or Neurologists during the period April 1994 to December 1996 
whose differential diagnosis included dementia, were recruited retrospectively for the 
purposes of this study. Ethics permission for the study was given by the Southern 
General Hospital-NHS Trust ethics committee. Scans of patients were included 
regardless of the results of initial investigation and therefore this unselected group was 
typical of those seen routinely in the department for diagnostic assessment of dementia. 
Initial examination included neuropsychological evaluation, neurological examination and 
"m Tc - HMPAO SPECT scan.
Controls:- In order to perform a voxel-wise statistical analysis on each patient a database 
of 32 (number of patients recommended for a reference data base - personal 
communication from Karl Friston, 02/12/97)14 99mTC HMPAO SPECT scans was 
constructed from archived scans of patients referred to the department for investigation 
between March 1993 and March 1998 whose SPECT scans were subsequently reported 
as normal and who had had no further history of neurological investgation. To account 
for systematic differences in rCBF due to age, of approximately 100 scans reviewed only 
scans of the 32 controls over the age of 45 were included, (age range 46-68). Other 
criteria for inclusion concerned the quality of the archived scans; images had to include 
the whole brain (from below the cerebellum to the top of the head) and low extra-cerebral 
uptake. To confirm no missed abnormalities in these scans we used a jackknife analysis 
(63) of testing each scan against the rest of the normal group using SPM96. First, 
normal reference data were calculated from 31 subjects excluding one subject. SPM(t) 
maps of the excluded subject were then calculated in comparison to the normal reference 
data created from the rest of the normal controls. This procedure was repeated 32 times 
to generate individual SPM(t) maps for each normal control.
14SPM help-line http://www.mailbase.ac.uk/lists/spm/1997-12/0009.html
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D em entia o f the A lzheim er’s Type (DAT) -
PL,pTL,(bilateral, occasionally  unilateral) FL involved  in advanced disease,
D em entia o f the A lzheim er’s Type (DAT) - asym m etrical defects
Dem entia o f the Frontal Lobe Type (DFLT) - M ed, Lat iFL (bilateral, obvious  
atrophy) aTL (bilateral)
D em entia o f the Vascular Type (DVaT) - M ultiple small cortical perfusion defects, 
Clear M CA territory (usually the insula), C lassic watershed region infarction.
iPL - Inferior parietal Lobe, pTL - posterior temporal lobe, iFL - inferior frontal lobe, 
aTL - anterior temporal lobe, M ed - m edial, Lat - lateral, M CA - m iddle cerebral 
artery, CBF - cerebral blood flow, SF - sylvian fissure.
Figure 4.1 show s axial slices o f  different 99mTc HMPAO scans o f  C B F to illustrate the guidelines used for 
the categorisation o f  dem entia in terms o f  C B F pattern.
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4.2.2 Data Analysis
Visual reporting:- Qualitative reporting was done using Strichman Medical Equipment 
display software, provided with the scanner, run on an Apple Macintosh computer, 
system 7.5 or less. Each scan was reconstructed and displayed on a colour monitor in 
axial slices at a thickness of 6mm. The SME software allows 3D manipulation of the data 
sets providing a manual adjustment facility, to allow axial slices to be resliced parallel to 
the plane through the anterior and posterior commisure for assessment. The colour scale 
used for display purposes is an 8bit scale with white representing maximum activity and 
blue/black representing minimum. During reporting the colour level was interactively 
manipulated by the observer. Following this review probabilities were assigned to each 
of the following diagnostic categories: dementia of the Alzheimer’s type (DAT), dementia 
of the frontal lobe type (DFLT), dementia of the vascular type (DVaT), some other 
dementia e.g. Korsakoff's (other), normal (normal). The reading of the scans was 
assisted by comparison with an "ideal” 99mjc HMPAO SPECT scan and followed 
specific guidelines as described by Holman et al 1992 (77) and Talbot et al 1997 (78). 
(These guidelines are given in Figure 4.1. along with corresponding CBF SPECT data). 
The "ideal" scan (figure 4.2.) was constructed from 10 scans in the control database, 
spatially normalised to the PET template and then averaged to produce a mean normal 
scan. Images were interpreted by two independent observers, experienced in the 
interpretation of cerebral perfusion images of patients with dementia and normal control 
subjects, using the procedure described above and knowledgeable of the criteria for 
abnormality but without prior knowledge of the clinical data. The location and severity of 
the perfusion defects were noted and a percentage likelihood of final diagnosis as 
interpreted from the rCBF data was reported.
Image processing of individual SPECT data:- Image registration and smoothing was 
performed on each patient’s scan. Any non-optimum starting estimates (see chapter 3) 
had to undergo a certain amount of image processing before statistical analysis could be 
performed. As defined by the results from the previous chapter (Chapter 3 -Validation o f 
the image standardisation facility ofSPM96), this involved a rigid body co-registration of
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Figure 4 .2 . Average normal SPECT scan used for visual reporting, constructed from 10 seans in the control 
database, spatially norm alised to the PHT template and then averaged to produce a mean normal scan-
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each of the non-optimal images to an "ideal" SPECT scan, prior to image standardisation. 
The co-registered and standardised images were then exported to a customised graphics 
package (mri3d) after smoothing so that partial axial slices could be edited to delete the 
spurious voxel information produced by smoothing of edges.
Voxel-wise statistical analysis:- Once the images had been edited the statistical option 
"compare groups, 1 scan per subject" available with the SPM96 statistics module was 
used to compare each individual patient data to a reference data base. These SPM(t) 
results were then used by the two observers in conjunction with the original scans to give 
a revised diagnostic estimate. To quantify the agreement between the 2 observers, a 
Kappa (K) statistic was calculated (95).
4.3 Results.
The results of the percentage differential diagnosis from each of the observers for the 39 
patients are listed in appendix C. Some of these cases are described. Both the original 
CBF scan and the corresponding SPM(t) map are included to demonstrate how typical 
CBF patterns for the five dementia categories are represented in significance space 
(SPM(t)).
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Figure 4.3 show s 10 axial slices from above and below  the ac-pc line o f  a ""Te-HM PAO scan acquired from  a 
patient w hose clinical differential diagnosis included dem entia. B elow  this is the glass brain display o f  the 
results (SPM (t)) calculated by the SPM 96 analysis option '‘com pare groups; 1 scan per subject". The results are 
thresholded at PucO.OOl and Pk<0.5 (uncorrected).
The case show n in figure 4.3 was originally reported by observer 1 (20%  DVaT + 80%  
normal) and observer 2 (100%  normal) based on the C BF SPECT scan information alone. 
This diagnosis remained unchanged with evidence from SPM (t) for observer 1 but changed  
for observer 2 (10% DVaT + 90% normal).
The small areas o f  reduced perfusion in the cortex located by the SPM (t) map are in the area 
o f  the insula in both hem ispheres. This area is often im plicated in cases o f  cerebral vascular 
disease w hich is why observer 1 and 2 reported the possible presence o f  DVaT from evidence  
provided by the SPM (t).
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F ig u re  4 .4  sh o w s  10 ax ia l s lic e s  f ro m  a b o v e  a n d  b e lo w  th e  a c -p c  lin e  o f  a  " “ T c -H M P A O  sc a n  a c q u ire d  f ro m  a 
p a tie n t w h o s e  c lin ic a l d if fe re n tia l  d ia g n o s is  in c lu d e d  d e m e n tia . B e lo w  th is  is the  g la s s  b ra in  d isp la y  o f  th e  
re su lts  (S P M (t) )  c a lc u la te d  by  th e  S P M 9 6  a n a ly s is  o p tio n  “c o m p a re  g ro u p s ;  1 sc a n  p e r  s u b je c t” . T h e  re s u lts  a re  
th re sh o ld e d  at PucO .O O l an d  P k < 0 .5  (u n c o rre c te d ) .
The case show n in figure 4 .4  was originally reported by observer 1 (100%  normal) and 
observer 2 (100%  normal) based on the CBF SPECT scan inform ation alone. This diagnosis 
remained unchanged with evidence from SPM (t) for observer 1 but changed for observer 2 
(10% DVaT + 90% normal).
The sm all areas o f  reduced perfusion in the cortex located by the SPM (t) map are in the area 
o f  the insula in both hem ispheres. Again this prompted observer 2 to report the possible  
presence o f  DVaT from evidence provided by the SPM (t).
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F ig u re  4 .5  sh o w s  10 ax ia l s lic e s  f ro m  a b o v e  an d  b e lo w  th e  a c -p c  lin e  o f  a  " T c - H M P A O  sc a n  a c q u ire d  
fro m  a p a tie n t w h o se  c l in ic a l d if fe re n tia l  d ia g n o s is  in c lu d e d  d e m e n tia . B e lo w  th is  is th e  g la s s  b ra in  d isp la y  
o f  the  re su lts  (S P M (t) )  c a lc u la te d  b y  the  S P M 9 6  a n a ly s is  o p tio n  “c o m p a re  g ro u p s ;  1 sc a n  p e r  s u b je c t” . T h e  
re su lts  a re  th re sh o ld e d  a t PucO .O O l an d  P k < 0 .5  (u n c o rre c te d ) .
The case shown in figure 4.5 was originally reported as DAT by observer 1 (100% ) and 
observer 2 (100%  DAT) based on the CBF SPECT scan inform ation alone. This diagno  
sis was confirm ed with evidence from SPM (t) with observer 1 (100%  D A T ) and observer 
2(1 0 0 %  DAT).
Areas o f  reduced perfusion in the cortex evident in the C BF SPECT scan that match up 
with areas located by the SPM (t) map are labelled with green arrows (A ). T hese areas 
are the parietal lobes (A ) with the right hem isphere being slightly worse than the left and
are consistent with areas associated with DAT reported by other im aging studies.
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F ig u re  4 .6  sh o w s  10 a x ia l s l ic e s  f ro m  a b o v e  a n d  b e lo w  th e  a e -p c  lin e  o f  a " T c  H M P A O  sc a n  a c q u ire d  
f ro m  a p a tie n t w h o se  c l in ic a l d if fe re n tia l d ia g n o s is  in c lu d e d  d e m e n tia . B e lo w  th is  is th e  g la s s  b ra in  d is p la y  
o f  the re su lts  (S P M (t) )  c a lc u la te d  by  th e  S P M 9 6  a n a ly s is  o p tio n  “c o m p a re  g ro u p s ; 1 sc a n  p e r  s u b je c t” . T h e  
re su lts  a re  th re sh o ld e d  a t PucO .O O l an d  P k < 0 .5  (u n c o rre c te d ) .
The case shown in figure 4 .6  was originally reported by observer 1 (30%  DAT +
10% DFLT + 30% DVaT + 30% other) and observer 2 (40%  DAT + 20% DFLT + 20%  
DVaT + 20% other) based on the CBF SPECT scan information alone. This diagnosis  
was later changed, with evidence from SPM (t), to 90% DAT + 10% DVaT by both 
observers.
Areas o f  reduced perfusion in the cortex evident in the CBF SPECT scan that match up 
with areas located by the SPM (t) map are labelled with green arrows (A ,B ). T hese areas 
are the frontal lobe(A ) and bilateral parietal lobes (B) and are consistent with areas asso­
ciated with DAT reported by other im aging studies. Reduced perfusion in the frontal 
lobes has been reported in later stages o f  the disease.
CASE 5 
RIGHT LEFT
F ig u re  4 .7  sh o w s  10 ax ia l s lic e s  fro m  a b o v e  an d  b e lo w  th e  a c -p e  lin e  o f  a  " mT c -H M P A O  se a n  a c q u ire d  fro m  a 
p a tie n t w h o s e  c l in ic a l  d if fe re n tia l  d ia g n o s is  in c lu d e d  d e m e n tia . B e lo w  th is  is th e  g la s s  b ra in  d is p la y  o f  the 
re su lts  (S P M (t) )  e a lc u la te d  by  th e  S P M 9 6  a n a ly s is  o p tio n  "‘c o m p a re  g ro u p s ;  1 sc a n  p e r  s u b je c t” . T h e  re su lts  a re  
th re sh o ld e d  at PucO .O O l an d  P k < 0 .5  (u n c o rre c te d )  in th e  firs t ro w  an d  th en  P u < 0 .0 1  a n d  P k < 0 .5  (u n c o rre c te d )  
in th e  se c o n d  row ..
The case shown in figure 4.7 was originally reported as DAT by observer 1 (100% ) and 
observer 2 (90% DAT + 10% DVaT) based on the CBF SPECT scan inform ation alone. 
This d iagnosis was confirm ed with evidence from SPM (t) with observer 1 (90% DAT + 
10% D V aT ) and o b se r v e r  2 (95%  D A T  + 5% N o r m a l) .
Areas o f  reduced perfusion in the cortex evident in the CBF SPECT scan that match up 
with areas located by the SPM (t) map are labelled  with green arrows (A ,B ,C ). T hese  
areas are the medial temporal lob e(A ), anterior cingulate (B ) and parietal lobe (C ) and
are c o n s is te n t w ith  areas a sso c ia ted  w ith  DAT reported by other im a g in g  stu d ies .
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F ig u re  4 .8  sh o w s 10 ax ia l s lic e s  fro m  a b o v e  an d  b e lo w  th e  a c -p c  lin e  o f  a  WmT c -H M P A ()  sc a n  a c q u ire d  
fro m  a p a tie n t w h o se  c l in ic a l  d if fe re n tia l  d ia g n o s is  in c lu d e d  d e m e n tia . B e lo w  th is  is th e  g la s s  b ra in  d isp la y  
o f  the  re su lts  (S P M (t) )  c a lc u la te d  b y  th e  S P M 9 6  a n a ly s is  o p tio n  “c o m p a re  g ro u p s ;  1 sc a n  p e r  su b je c t" . T h e  
re su lts  a re  th re sh o ld e d  al PucO .O O l an d  P k < 0 .5  (u n c o rre c te d ) .
The case shown in figure 4.8 was originally reported by observer 1 as 90% DFLT + 10%
DAT and observer 2 as 100% DFLT based on the CBF SPECT scan inform ation alone.
This diagnosis was later changed with evidence from SPM (t) with observer 1 (90%
DFLT + 10% DAT) and observer 2 (30% DFLT + 70% DVaT).
Areas o f  reduced perfusion in the cortex evident in the CBF SPECT scan that match up
with areas located by the SPM (t) map are labelled with green arrows (A , B). These areas
are the anterior temporal lobes (A ) - the right is worse than the left - and the anterior
cingulate(B) and are consistent with areas associated with DFLT reported by other imaging
studies. 84
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Figure 4.9  show s 10 axial slices from above and below  the ac-pc line o f  a " mTc HM PAO scan acquired 
from a patient w hose clinical differential d iagnosis included dem entia. B elow  this is the g lass brain display  
o f  the results (SPM (t)) calculated by the SPM 96 analysis option “com pare groups; 1 scan per subject” . The 
results are thresholded al PucO.OOl and Pk<0.5 (uncorrected).
The case shown in figure 4.9 was originally reported as DFLT by observer 1 (100% ) 
and observer 2 (60% DFLT + 20% DVaT + 20% other) based on the C BF SPECT scan 
inform ation alone. This d iagnosis remained unchanged with evidence from SPM (t).
Areas o f  reduced perfusion in the cortex evident in the CBF SPECT scan that match up 
with areas located by the SPM (t) map are labelled with green arrows (A ,B ). These  
areas are the anterior cingulate (A ), and left frontal lobe (B ) and are consistent with 
areas associated with DFLT reported by other im aging studies.
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Figure 4 .10  show s 10 axial slices from above and below  the ac-pe line o f  a lWmTc-H M PA () scan acquired from 
a patient w hose clinical differential d iagnosis included dem entia. B elow  this is the glass brain display o f  the 
results (SPM (t)) calculated by the SPM 96 analysis option "compare groups: 1 scan per subject”. The results 
are thresholded at PucO.OOl and Pk<0.5 (uncorrected).
The case show n in figure 4 .10  was originally reported as DVaT by observer 1 (100% ) 
and observer 2 (100%  DVaT) based on the CBF SPECT scan inform ation alone. This 
diagnosis remained unchanged with evidence from SPM (t).
Areas o f  reduced perfusion in the cortex evident in the C BF SPECT scan that match up 
with areas located by the SPM (t) map are labelled with green arrows (A , B). T hese  
areas are the right parietal lobe (A ), and right anterior frontal lobe (B). Their 
appearrance is consistent with that associated with DVaT reported by other im aging  
studies.
86
CASE 9
RIGHT LEFT
‘H O LLO W ’ LESION
Figure 4.11 show s 10 axial slices from above and below  the ac-pc line o f  a " “Tc-HM PAO  scan acquired from a 
patient w hose clinical differential diagnosis included dementia. B elow  this is the glass brain display o f  the 
results (SPM (t)) calculated by the SPM 96 analysis option "compare groups; 1 scan per subject”. The results are 
thresholded at PucO.OOl and Pk<0.5 (uncorrected).
The case show n in figure 4.11 was originally reported by observer 1 and observer 2 (100%  
DVaT) based on the CBF SPECT scan information alone. This diagnosis remained unchanged 
with evidence from SPM (t).
The area o f  reduced perfusion in the cortex is the site o f the main cerebral infarction in the 
right frontal lobeand is clearly visib le in the SPM (t) map. This case is a good exam ple o f  how  
the thresholding facility that SPM 96 uses to include only intra-cerebral voxel values can fail. 
In this case the values o f  the voxels representing the infarct have such a low  value they are 
not included in the statistical analysis and this results in the lesion  looking ‘h o llo w ’ on the
SPM (t) map (green arrow).
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Figure 4 .12 show s 10 axial slices from above and below  the ac-pc line o f  a 'WmTc-HM PAO scan acquired from 
a patient w hose clinical differential diagnosis included dementia. B elow  this is the glass brain display o f the 
results (SPM (t)) calculated by the SPM 96 analysis option "compare groups; 1 scan per subject”. The results are 
thresholded at PucO.OOl and Pk<0.5 (uneorrected).
The case show n in figure 4 .12  was originally reported by observer 1 (60% DVaT + 20% other 
+ 20% normal) and observer 2 (20% DVaT + 80% normal) based on the C BF SPECT scan 
information alone. This d iagnosis later changed with evidence from SPM (t) to observer 1 
(20% DFLT + 60% DVaT + 20% other) and observer 2 (40%  DVaT + 60% normal).
Areas o f  reduced perfusion in the cortex evident in the C BF SPECT scan that match up with 
areas located by the SPM (t) map are labelled with green arrows (A , B). T hese areas are the
anterior parts o f the temporal lobe bilaterally (A), and the inter-hem ispheric fissure (B).
To quantify the agreement between the 2 observers for the two different reporting 
methods (visual and visual+SPM96), a Kappa (K) statistic was calculated and is defined 
a s :
K = (Po - Pe)/(1 - Pe) (2)
where Po = observed proportional agreement, Pe = chance proportional agreement 
which includes a correction for the fraction of agreements expected by chance. K=1 only 
when complete agreement is observed. Interpretation of the level of agreement is as 
follows; 0.0 - 0.2, slight; 0.2 - 0.4, fair; 0.4 - 0.6, moderate; 0.6 - 0.8, substantial, and 
0.8-1.0, almost perfect. Values below zero represent less agreement than expected by 
chance. The K statistic was computed for between observers agreement of visual 
reporting of " mTc HMPAO SPECT scans before and after SPM96 revised reporting. 
The K statistic was calculated by categorising the diagnosis with the highest score (and 
reassigned a value of one) to be taken as the actual diagnosis for each patient (see 
appendix C). The K statistic for this overall assessment is listed in the first row of Table 
4.1.
Disease observerl 
/observer 2
observerl*
/observer2*
+overall 0.584 0.507
DAT 0.593 0.543
DFLT 0.682 0.4
VD 0.591 0.498
normal 0.54 0.53
Table 4.1. Lists the measured agreement between observers.
+ overall kappa statistics where the highest score in a diagnostic category was assumed to be the actual 
diagnosis and given a value of one.
* using SPM96 results.
K = Kappa 0-0.2 poor, 0.2-0.4 fair, 0.4-0.6 moderate, 0.6-0.8 Good, 0.8-1.00 very good.
The weakness of this calculation is that it takes no account of the degree of disagreement 
since all disagreements are treated equally. Instead a weighted Kappa statistic can be 
calculated where observations near to the diagonal, representing a difference of only one 
category, are considered less serious than those where a discrepancy is two or more
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categories. A weighted K statistic was calculated for the agreement between observers 
for each disease category and are listed in full in appendix C. Results for this test are 
shown in table 4.1 rows 2-4 and give similar values to that obtained from the overall 
measure. In all categories the level of agreement is lowered when using additional 
information from the SPM96 analysis.
The likelihood of diagnosis for each subject given by observer 1 and observer 2 for both 
methods of reporting are listed in appendix C along with the kappa tables and calculations 
used to calculate the levels of agreement between the observers.
4.4 Discussion
Before SPM(t) maps could be calculated for each individual patient a normal database had 
to be constructed. Official bodies responsible for monitoring the administration of 
radioactive substances are understandably keen to keep unnecessary exposure of the 
general population to a minimum. It was therefore not possible to build "from scratch" a 
new database of 99m j c HMPAO scans of the normal general population. Instead the 
database was constructed from archived scans of patients referred to the department from 
neurologists and psychiatrists for the investigation of suspected transient ischaemic 
attacks (TLA) and mild memory problems, between March 1995-March 1998 but whose 
SPECT scans were subsequently reported as normal. Justification of this method is 
needed. Apart from ensuring that the scans included in the database were from 
individuals who were not subsequently found to have any abnormality a jackknife type 
method (63) of testing each scan against the rest of the normal group using SPM96 was 
used to check for rCBF abnormalities that may have been missed by visual reporting 
(there were none). Other criteria for a scan's inclusion in the database included low extra 
cerebral uptake and good coverage of brain including cerebellum.
Further justification for this method of constructing a normal database is obtained by 
reference to the more usual approach of advertising (both internally and externally) for 
volunteers. In this situation we were able to examine retrospectively each scan initially
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reported as normal. There was no bias from the subjects themselves for their reason to be 
included in the study. One has to question the reasons why an individual would 
volunteer themselves as subjects. Family members of patients who wish to contribute 
whatever they can to help their suffering relative are few and far between. It is more 
likely that those presenting themselves as subjects are concerned about their own physical 
and mental health. Only after a lengthy battery of tests, which all subjects recruited for a 
study must undergo, can those subjects who are genuinely worried and may turn out to 
be "not normal'’ be weeded out. Using this method of retrospective selection we were 
better able to establish a representative database of normal CBF scans from our own 
archives without incurring the difficulties involved in subject recruitment
To account for the global differences in cerebral perfusion across subjects it is necessary 
to globally normalise the voxel intensities within an image. There are two options for 
doing this in SPM96; AnCova and proportional scaling (see CH2 pg47). For the 
purposes of this study the proportional scaling method was used in preference to AnCova 
since use of the latter method with data where similar global uptake of the 
radiopharmaceutical cannot be guaranteed is not recommended. In our control group the 
mean global counts ranged from 61.2 to 123.3 and in the patients 33.8 to 128.5. The 
proportional scaling method of accounting for global CBF differences uses whole brain 
as the reference region to which to normalise. Other reference regions commonly used 
include, calcarine cortex, cerebellum, thalamus and basal ganglia (42,63,88,96). 
Although the SPM96 proportional scaling normalisation facility does not allow other 
reference regions to be defined it is possible (using MATLAB scripts, courtesy of MG)15 
to pre-normalise the data prior to SPM analysis and then switch off the normalisation 
facility within SPM96. It was decided however, that this would not be appropriate and 
that global mean value would be used as the normalisation factor for two reasons. 
Firstly, the cerebellum could be rejected as suitable reference regions quite simply 
because in some of the images all or part of this information was missing and in one
15 Dr Mike Glabus Neurophysicist, MRC Brain Metabolism Unit, Royal Edinburgh Hospital, 
Edinburgh, EH10 5HF, UK.
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image the lower part of the calcarine cortex was missing. Secondly, normalising to the 
thalamus and basal ganglia while adequate for assessment of DAT, since these areas are 
relatively spared in the progression of the disease, would not always be appropriate in the 
case of DVaT. For example, small infarcts in the perforators branching from the middle 
cerebral artery will almost certainly result in lowered perfusion in the thalamus. 
Minoshima et al 1995 (63), Bartenstein et al 1997 (42) make allowances for this by only 
using the higher value thalamic activity from either hemisphere. However, this would 
need apriori knowledge of the disease state which would have been unacceptable for the 
purposes of this study.
The results from this study failed to show that SPM could improve/enhance the 
interpretation of CBF scans as an aid in the differential diagnosis of dementia. The study 
results of the inter observer reliability (overall agreement measured K= 0.584 and 
KSpm=0.504) in fact show a slight decrease in overall agreement between the observers. 
This was also reflected in the measurements made using the weighted kappa statistic for 
each disease category. Although SPM aided reporting seemed to increase the amount of 
disagreement between observers overall, anecdotal evidence from both the observers 
suggested that the SPM(t) maps strengthened the confidence of the initial percentage 
probability diagnosis based on evidence from the scan alone and therefore speeded up the 
process of visually reporting the scans. In addition further inspection of the results of 
CBF SPECT scans and their associated SPM(t) maps from 10 cases out of the original 39 
shows that the SPM analysis was robust in detecting blood flow abnormalities in the 
cerebral cortex but that the interpretation of these maps by the two observers could be 
different It is useful to study these cases in more detail.
Case 1 and 2 are good examples of the CBF SPECT scans that were reported normal on 
visual inspection alone. The SPM(t) map detects areas of reduced perfusion (with respect 
to the reference group) in the insula for both scans, an area often implicated in cases of 
cerebral vascular disease. Looking at the scans again it is clear that there is a widening of 
the left sylvian fissure for case 1 and bilaterally in case 2. This may have been initially
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dismissed as localised atrophy in this area consistent with the patients' age but other 
studies using SPM have confirmed that relative blood flow deficits detected in this way 
cannot be attributed solely to the effects of atrophy (97). The SPM results confirmed 
observer l's suggestion that DVaT may be present in easel and introduced the possibility 
of DVaT in case 2. Observer 2 had originally reported both scans as 100% normal but 
introduced the possibility of DVaT on evidence from the SPM(t) for both case 1 and 2.
Case 3 was originally reported as 100% DAT by both observers and remained unchanged 
with the evidence from the SPM(t). This result is interesting because neither the CBF 
SPECT scan or the SPM(t) show any evidence of reduced blood flow in the area of the 
medial temporal lobe an area associated with structural abnormalities detected in CT and 
MRI as decreases in the thickness of the cortex (85). This absence of medial temporal 
lobe reduced perfusion has also been recently reported by a study using PET with 
2(18F)FDG to examine the differences between normal controls and patients with 
probable mild DAT (98,99).
Case 4 is a good example of how an SPM analysis can help in some particular cases 
where the diagnosis based on the CBF SPECT scan remains equivocal. Initially this scan 
was reported by both observers of having an almost equal likelihood of any of the 
dementias [obsl - (30% DAT, 10% DFLT, 30% DVaT, 30% other) obs 2 - (40% DAT, 
10% DFLT, 20% DVaT and 30% other)]. The evidence from the SPM(t) map for this 
case shows significant reductions in the parieto-temporal regions and a slight reduction in 
the medial temporal area, all implicated in DAT and making the likelihood of DAT much 
more probable (90%). The patchy appearance of the rest of the cortex, however, also 
suggests the presence of DVaT superimposed on the classic DAT pattern reflected by both 
observer 1 and observer 2 including it as a possible diagnosis (10%).
Case 5 was originally reported as a definite case of DAT with the suggestion of the 
presence of DVaT by observer 2. The SPM(t) map, however, shows much smaller 
numbers of voxels with significant reduction in the parieto-temporal regions evident in the
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previous two cases, although the abnormalities in the SPECT scan are quite clearly 
located in the map. This SPM(t) map was re-thresholded at a lower significance of 
Pu<0.01 (Pk<0.5) and the classic DAT pattern in CBF became more apparent. This case 
highlights the problems that may occur should an SPM(t) map be used without the 
original evidence from the CBF scan and without the appreciation of the various 
parameters that can be adjusted within SPM96. If an SPM analysis is to be used to 
assess the CBF pattern in an individual patient, as confirmation of an already suspected 
diagnosis, a choice should be made as to what significance threshold should be used. 
The developers of SPM provide the guidelines that, the results of an apriori hypothesis 
can be thresholded at Pu<0.01 and Pk=1.00 but that an exploratory investigation must 
always be displayed at a higher threshold of Pu<0.001 and Pk<0.5. Interpreting these 
guidelines for the SPM analysis of an individual patient's scan, rather than for studies of 
neuroactivation, where groups of scans are analysed together and the changes in blood 
flow being measured are only a few percent, choosing a less strict threshold would seem 
valid. In some cases however, if the blood flow deficit is very widespread an SPM(t) 
map at this level would show almost all the voxels analysed as being significant and 
therefore, hide any predominant pattern. It is more appropriate in this case to use a higher 
significance level. This might give the impression that the choice is arbitrary but the 
guideline should be:-
•  if the possibility of false negatives is to be minimised then a lower 
threshold should be used,
•  if this results in too many voxels being significant and so obscuring 
localised information within the SPM(t) map then a more stringent 
threshold should be applied.
Cases 6 and 7 were both initially reported as DFLT based on the CBF SPECT scan 
information alone. For case 6 the SPM(t) map quite clearly shows the perfusion deficits 
in the anterior cingulate and anterior parts of the temporal lobe both areas are consistent 
with that reported in the literature (100). This result confirmed the diagnosis for observer 
1 but caused observer 2 to change the definite DFLT diagnosis to possible DVaT (70%),
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highlighting that the lack of agreement between the two observers is not that the 
abnormalities are not being detected by them and the SPM analysis but rather it is 
dependent on the interpretation of this information. In the SPM(t) map of Case 7 again 
there is a good correspondence between the abnormalities seen in the cortex and those 
detected by SPM, confirming the original diagnosis for both observers.
Case 8 and 9 are both examples of a definite diagnosis of DVaT quite clearly evident in 
the CBF SPECT scan of both patients and confirmed with evidence in the SPM(t) maps. 
Case 9 shows a good example of a particular problem inherent in SPM when measuring 
gross deficits in blood flow. As described in Chapter 2 pg47 a SPM analysis only 
includes what is considered to be intra-cerebral voxels. The voxel values within this 
lesion fall well below this threshold and are therefore not included in the analysis and as a 
result the lesion displayed looks hollow on the SPM(t) map. The way round this problem 
is to reset the threshold for intra-cerebral voxels using a facility in the SPM software. 
However, for the purposes of this study where the location of the lesion was more 
important than the size this step was not necessary. If, however, the SPM(t) map was to 
be used as a means of measuring the size of the lesion volume then the intra-cerebral 
voxel level would have to be reset and a sensible level would have to be determined.
Case 10 is a good example of where the diagnosis remained equivocal even after the 
information from the SPM(t) was made available. In the first instance both observers 
included the possibility of the presence of DVaT (60% and 20% respectively) based on 
the appearance of the insula regions in the SPECT scan which are often involved when 
infarcts occur in the middle cerebral artery. However, the blood flow deficits detected by 
the SPM analysis appears to put these areas more firmly in the anterior parts of the 
temporal lobe. The SPM(t) map also shows a deficit in the area of the anterior cingulate 
possibly reflecting the widening of the inter-hemispheric fissure clearly evident in the 
CBF SPECT scan. Perfusion deficits in both these areas have been described as typical 
of the CBF patterns seen in patients suffering from DFLT. While observer 1 still gave 
the most likely cause for this CBF pattern to be DVaT the possibility of DFLT (20%) was
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also included based on the SPM(t) result. Observer 2 on the other hand, whose original 
diagnosis had been normal (80%) with the possible presence of DVaT (20%), increased 
the likelihood of vascular dementia as a diagnosis on the evidence from SPM(t) DVaT 
(40%) with normal (60%) remaining as the most likely diagnosis. As with case 6 the 
problem here is not whether this method of using SPM96 is capable of detecting blood 
flow deficits in the cortex of individual CBF SPECT scans but rather the observer's 
ability to use this information to make a diagnosis.
An SPM type analysis of individual patients clearly does not remove the observer 
variability in interpretation. These results may be interpreted therefore, not as the inability 
of the SPM method to find significantly abnormal regions of CBF - indeed the SPM(t) 
maps presented in the results section certainly confirm the validity of the SPM technique 
in detecting areas of abnormal cortical perfusion in individual patients - but rather in 
teRMS of the observers uncertainty in interpreting these patterns with respect to dementia 
type. It might be that in future each observer may have to ascend a learning curve with 
regard to the incorporation of information from a SPM(t) map to the routine visual 
reporting procedure. The "ideal" " “ Tc HMPAO scan created for this study is now being 
routinely used to train junior radiologists and physicists in the visual reporting of CBF 
SPECT scans.
Finally it may be that an objective image analysis software of this kind could prove 
valuable as a way of monitoring the progress of a disease like dementia. Often it is 
difficult to visually interpret the amount of change that has taken place when comparing 
serial diagnostic scans of the same patient. The example in figure 4.13 shows the case of 
a patient whose consultant psycho-geriatrician requested a 99mTc HMPAO CBF SPECT 
scan for confirmation of DAT. The initial scan, without additional information from an 
SPM(t) map, was reported as normal taking into consideration the patient's age.
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Figure 4 .13  a) and b) show 10 axial slices from above and below  the ac-pc line o f  a WmT c-H M PA () scan acquired 
from a patient w hose clinical differential diagnosis included dem entia taken 29 months apart. B elow  this is the 
glass brain display o f  the results (SPM (t)) calculated by the SPM 96 analysis option “com pare groups; 1 scan per 
subject”. The results are thresholded at PucO.OOl and Pk<0.5 (uncorrected).
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However, the clinical symptoms became progressively worse and the patient was re­
scanned at 29 months following. The visual reporting of both scans failed to confirm the 
presence of a progressive reduction in rCBF. On the basis of the results obtained using 
the SPM96 analysis on individual patients suffering from dementia it was reasoned that if 
an abnormality was present in either of the scans it would be detected and the number of 
significant voxels within the abnormality could be used to give an indication of the 
progression of the abnormality. Figure 4.13 shows two CBF SPECT scans of the same 
patient taken 29 months apart with their corresponding SPM(t) maps. The SPM analysis 
was able to detect an abnormality in the right parietal lobe (Zmax = 4.12, no. of voxels = 
421) in the original scan (figure 4.13a), an area associated with CBF patterns reported in 
patients with DAT clinical symptoms by other studies. Figure 4 .13b shows that the SPM 
analysis confirmed the progression of the rCBF decrease located in the area of the right 
parietal lobe (Zmax = 4.61, no. of voxels = 788) and detected an additional abnormality 
in the left parietal lobe (Zmax = 3.65, no. of voxels = 110). The SPM(t) maps confirmed 
the progression of the rCBF decrease associated with progression of clinical symptoms of 
DAT. However, any changes observed between the two maps must be interpreted with 
caution as there is not yet sufficient data on the reproducibility of SPM(t) maps of " “ Tc 
HMPAO scans of the same patient in the absence of physiological change. It is possible 
that a continuing clinical audit over many years, preferably involving histology, could be 
used to re-investigate the findings of this study to determine whether the additional SPM 
information shifted probabilities closer to the correct diagnosis.
4.5. Conclusions.
This investigation failed to show that there was any benefit to using an SPM96 analysis 
of individual patient data as an aid to the differential diagnosis of CBF SPECT scans. 
However, further use of this technique for the analysis of serial SPECT scans of a single 
patient provided evidence that the analysis may have potential for the objective monitoring 
of the progression of disease affecting blood flow in the cerebral cortex.
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•  There is no evidence to support the routine use of SPM96 at present in 
reporting CBF SPECT scans of dementia.
•  SPM96 analysis of serial CBF SPECT scans of the same patient may 
provide an objective way of assessing for progression of disease when used 
in conjunction with both clinical and other imaging information.
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CHAPTER 5
M odifica tion  o f  9 9 m  j c H M P A O  S P E C T  a cq u is i t io n  p r o to c o l  
f o r  S P M  typ e  a n a ly s is  o f  n e u ro a c t iva t io n  s tu d ie s :  Im a g e
quality  versus s ta tis t ica l  pow er.
This chapter describes the investigation to determine empirically whether an 
increase in statistical power, gained by using a scan replication paradigm, is 
significant enough to warrant the use of poorer image quality, due to decreased 
administered activity per scan, in neuroactivation studies. Section 5.1 describes 
the benefits of obtaining multiple images of a subject during one scanning 
session. Section 5.2 lists the materials and methods used for this investigation. 
Section 5.3 presents the results and section 5.4 and 5.5 discuss the implications 
and consequences of using a multiple scan paradigm with SPECT.
5.1 In troduction
These investigations focused on whether CBF SPECT studies of neuroactivation might 
benefit from an approach similar to that used in PET, i.e., increase the number of scans 
per task and accept poorer individual scan quality. When neuroactivation has been 
studied by emission tomography, PET (positron emission tomography) rather than 
SPECT (single photon emission computed tomography) has always been the modality of 
choice due to its higher sensitivity, better resolution and the shorter half life of [150 ] 
water which enables repeated measurements to be made. In practice up to 12 scans can
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Figure 5.1 SPECT has its ow n unique features which make it attractive for neuroactivation  
work. In particular the trapping m echanism  o f  the cerebral blood flow  agents used in SPECT  
cerebral blood flow  (C BF) studies provides the facility o f  performing tasks outwith the con ­
fines o f  the scanner in a more ‘natural setting’ as illustrated in the picture above.
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be manipulated to obtain multiple data sets from one individual subject during one PET 
scanning session (101). SPECT, however, does have its own unique features which 
make it attractive for neuroactivation work. In particular the trapping mechanism of the 
cerebral blood flow agents used in SPECT studies provides the facility of performing 
tasks outwith the confines of the scanner in a more ‘natural setting’ (102) as illustrated in 
figure 5.1. The problems of setting up test equipment to provide tasks for the subjects to 
perform while lying in a scanner is not an insignificant problem faced by users of PET, 
and even more so for functional magnetic resonance imaging (fMRI) (103). The 
resolution of good neuroSPECT cameras is now approximately 7mm so inherently it 
should be possible to use SPECT for neuroactivation work and take advantage of the 
benefits which it offers at the task/scanning interface. The problem of obtaining multiple 
data sets and therefore the ability to assess within subject variance has not been tackled so 
far. To date a serious limitation of SPECT has been the poverty of information on within 
subject variation within the experimental paradigms which have been used. Most studies 
have only involved two measurements - baseline and activation.
The ability to detect change in regional CBF is dependent on (i) the noise in the imaging 
technique (statistical fluctuations, natural variation in CBF, variations in activation 
patterns), (ii) the signal i.e. the magnitude of the activation and the resulting change in 
CBF and, (iii) the measures taken to increase the signal/noise ratio (averaging between 
subjects). Parameter (ii) is unknown but is assumed to be directly related to the cognitive 
task being performed (73). For parameter (iii) the number of subjects can be estimated by 
using power analysis (104) if assumptions are made about the magnitude of activations 
that are expected. However, variations in the exact activation pattern between subjects are 
likely to make this an inexact science and the benefits of an increase in the number of 
subjects is not straightforward (105) since the differences in function and anatomy 
between subjects may start to impinge on the ability to detect change as described in 
parameter (i). These factors pertain to iCBF measurements whether PET or SPECT are 
used as the imaging modality. The main advantage of PET over SPECT has
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been the ability to utilise multiple task within subject repetition paradigms which enable 
different aspects of a task to be studied and more importantly within subject variability of 
measurements to be estimated (104). Conventionally, SPECT studies use a non- 
replication paradigm i.e. one scan for each task (see fig5.2a). In PET studies of CBF it 
is common to obtain multiple data sets from each task, by including up to 12 scans in one 
scanning session (see fig5.2b). It is noticeable that the image quality of an individual 
neuroactivation PET CBF scan is not as good as that of many good quality SPECT scans 
obtained from trapped single photon emitters (IMP, UMPAO and ECD), mainly due to 
the longer data acquisition times which can be used with trapped compounds. 
Nevertheless, when these multiple task PET data sets are processed using a statistical 
parametric mapping (SPM) method, a high level of confidence can be achieved when 
measuring changes in regional functional activity (104).
Kapur et al 1995 (104) have shown using PET that to obtain reliable results for a single 
task design (non-replication paradigm) one should have a minimum of 15 subjects and for 
a repeat task design (replication paradigm) 9 subjects, based on a regional change in 
blood flow of 3% interpreted at a significance threshold of p<0.01. Most reported 
neuroactivation studies using SPECT currently involve 6 - 2 0  subjects performing two 
different cognitive tasks where one scan per task is produced. The total radiation dose 
received by a subject for research purposes is required to be as low as reasonably 
achievable. Most studies in the UK currently use 500MBq per scan although higher 
administered doses are common elsewhere. A few studies have used 250MBq of " “ Tc 
HMPAO per scan for activation studies involving a non-replication paradigm. The lower 
count rate of using half the activity normally available for a single scan can be 
compensated for by using longer scanning times. Image quality is poorer using this dose 
protocol due to the increase in background noise as a consequence of prolonged 
acquisition times, nevertheless successful neuroactivation studies have been completed 
(13-15,106).
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Radiation dose limits impose a ceiling on the amount of activity administered to each 
subject. Within that constraint the only factors available for manipulation are 
administered activity per scan and scanning time. This study investigates whether it is 
possible to manipulate these SPECT parameters in such away as to also obtain multiple 
data sets per cognitive task while achieving a significant return in statistical power when 
analysing data using a statistical parametric method.
5.2 Methods
In order to compare paradigms a controlled activation of known effect is required. A data 
simulation method was used to determine empirically whether an increase in statistical 
power, gained by using a replication paradigm, is significant enough to warrant the use of 
poorer image quality, due to decreased administered activity per scan.
As with chapter 3 the principle adopted in this study was to use 'real' clinical scans and 
superimpose a region of rCBF change on these data. Scans were chosen at random from 
those acquired in every day practice using 99mTc-HMPAO. The scans demonstrated no 
major abnormality. Duplicate copies of real scans were made for the purposes of this 
study, in order to have a paired data set that did not include noise due to natural variability 
of CBF or anatomy between subjects. This imposed condition of no anatomical variation 
makes the distinction between the paradigms clearer by removing noise due to inter and 
intra-subject variability without introducing bias in favour of any particular paradigm. To 
create the different experimental designs for testing the hypothesis the following method 
was used:-
•  Create the acquisition parameters
•  Create the image data sets
•  Create the different paradigms
5.2.1 Creating the acquisition parameters.
The neuroactivation studies were simulated from past and current study protocols using 
the acquisition parameters
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•  unit dose per scan (500MBq) and unit scan time per slice (120 secs)
•  half unit dose per scan (250MBq) and unit scan time per slice (120 secs)
•  half unit dose per scan (250MBq) and double scan time per slice (240 secs)
For each of the three conditions a single SPECT scan was selected as representative of the 
conditions being tested. Scans were chosen at random from those acquired in every day 
practice using " “ Tc-HMPAO. The scans used in the first study simulation (study 1) of 
10 subjects imaged under two cognitive conditions were created from a previously used 
study protocol using an activity of 1 unit dose per scan and standard scanning time. A 
second study (study 2) was simulated as a 1/2 dose scan with standard acquisition time to 
investigate the benefits of a repeat task design in conjunction with the disadvantage of a 
drop of roughly half in the counting statistics. This was done in order that a replication 
paradigm might be offered that would keep the total acquisition time as standard thus 
minimising the discomfort to the volunteer. A further study (study 3) was simulated from 
another previous study protocol where the subjects had received 1/2 unit dose per scan 
with the scan acquisition time adjusted to obtain a similar number of total counts as a unit 
dose scan, however, the total scan time was chosen in light of experience to be the 
maximum acceptable duration of subject compliance. The procedure for study 2 and 3 
simulated a replications paradigm of the activation tasks being investigated and so two 
scans for each condition were created. The maximum total radiation activity received by 
each simulated subject in all three groups was 2 unit doses, an effective dose of 
approximately 9.0 mSv (107). A summary of the study paradigms are given in table 5.1.
Study NO. OF 
SUBJECTS
DOSE UNITS 
PER SCAN
SCANS PER 
SUBJECT
UNITS OF 
SCAN TIME
1 10 1 2 (A 3) 1
2 10 1/2 4 (A,B,A,B) 1
3 10 1/2 4 (A,B, A,B) 2
Table 5.1. Summary of scanning parameters used to simulate 3 different SPECT neuroactivation 
paradigms. All scan paradigms have been designed to deliver the same total radiation dose per subject.
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5.2.2 Creating the image data sets.
The procedure for creating the image data sets is illustrated in figure 5.3. For each of 
these three paradigms simulating regional activations were introduced as follows. An 
exact copy of the original scan was made, in order to have a paired data set to represent 
two cognitive tasks, A and B, which did not include changes between the scans due to 
natural variability in CBF. The activation or difference between the two scans was 
achieved by using a customised graphics package, HIPS (108), to place a region of 
'activation' in the duplicate scan. The image data was manipulated in HIPS format as a 
stack of images representing contiguous slices through the brain. An axial slice through 
the basal ganglia was chosen in which to place the region of activation. A rectangular 
region of interest was drawn in the left frontal lobe of size 9x11x1 voxels (1.56mm 
x 1.56mm x6mm). The mean value of this slice was calculated and to each pixel in the 
designated region was added 3.0% of the slice mean. (The slice mean having been 
calculated as the number of counts in those pixels surviving an 80% threshold of the 
maximum number of counts in that slice divided by the area (mm2) within the threshold 
boundary). Both scans, 'activation' and 'baseline', were then copied another 9 times in 
order to produce 10 SPECT scan pairs in total in order to exclude differences in anatomy 
between subjects. Gaussian noise was added to each of the 20 scans using a HIPS 
software facility, to emulate scanner noise across scans for each subject. The Gaussian 
noise generator function in HIPS adds pseudo-random, independent, identically 
distributed noise to an image. The noise values have zero-mean Gaussian distribution 
and the standard deviation of the noise must be specified. To provide a different 
Gaussian noise distribution for each stack of images a different seed for the pseudo­
random number generators must be provided for each subject. For multiple frames, the 
normal operation of this function is to generate a noise frame for the first frame, and 
randomly permute its rows and columns for subsequent frames. Finally the images were 
re-formatted to ANALYZE™ compatibility for further analysis using SPM95.
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Figure 5.3 show ing a schem atic flow  diagram o f  the procedure used to create the different study 
paradigms.
108
5.2.3 Creating the different paradigms.
The procedure described created a group of 10 subjects each with an activation scan (A) 
and a baseline scan (B) and is referred to as study 1. The same procedure was followed 
with the appropriate modifications; the original scan copied 4 times producing a total of 
40 scans per study to which Gaussian noise was then added as before, to simulate the 
other paradigms involving a total of 4 scans per subject (ABAB). The simulated 
paradigms were then repeated using a 2.5%, 2.0%, 1.5% and 1.0% increased signal 
respectively, in the region of activation.
5.2.4 Reporting the different paradigm results.
In order to establish the statistical effects of the differences between the paradigms, the 
data sets were put through the SPM95 statistics package. Although all the scans were 
copies from an original single scan and therefore not anatomically different, before 
statistical analysis could be performed the scans had to be spatially standardised using the 
SPM95 linear spatial normalisation function and smoothed. Study 1 data was analysed 
using the software option ‘multi-subject and different conditions’ with global blood flow 
normalisation achieved using the proportional scaling option. Studies 2 and 3 were 
analysed using the option ‘multi-subject with replications’, global blood flow 
normalisation as before. The Z-score information was extracted from the SPMt.mat files 
produced by the SPM95 statistical analysis. The mean Z-score calculations were confined 
approximately to those voxels ‘activated’ in the original activation scans by using 
MATLAB.
5.3 Results
Results shown in Table 5.2 are the mean and standard deviation Z-scores for both the 
single task (study 1) and repeat task designs (study 2 and 3). The mean Z-scores for 
study 1 and study 3 were significantly different at p< 0.000001 (independent t-test, one 
tailed) for changes in regional cerebral blood flow of 3.0%, 2.5% and 2.0% . No 
significant differences were found at changes in rCBF < 1.5%. Significant differences
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were found between the mean Z-scoies for study 1 and 2 at p<0.003 (independent t-test, 
one tailed) for changes in regional cerebral blood flow of 3% and 2.5 % only.
These results indicate that the best experimental design would be one that included 
replications of tasks. Within the limits set regarding the allowable total dose per subject 
the study design including replications combined with higher count rates associated with 
the increased scan time in study 3 gave the optimum Z-score results.
study 1 study 2 study 3 UNPAIRED ONE 
TAILED t-TEST
% change in 
rCBF
Z -sc o re  
mean and std
Z -sco re  
m ean and std
Z -sco re  
m ean and std
significant
differences
3.00% 4.79 +/-0.84 5.83 +/-4.66 8.36 +/- 4.93 pi,3 < 0.000001
pi,2 < 0.003
2.50% 4.15 +/-0.6 5.83 +/-4.66 8.22 +/- 4.91 pi,3 < 0.000001 
pi,2 < 0.0001
2.00% 3.34 +/-0.51 3.8 +/-1.06 5.46 +/- 0.84 Pi,3 < 0.000001 
Pi,2 < N.S.
1.50% 3.32 +/-0.51 2.4 +/-0.24 3.24 +/- 0.93 Pi,3 < N.S. 
Pi,2 < N.S.
1.00% 2.3 +/-0.27 2.4 +/-0.27 3.3 +/- 0.64 p i 3 < N.S. 
PL2< N.S.
Table 5.2. List of mean and standard deviation z-score for successive changes in rCBF in each paradigm 
listed in table 5.1.
5.4 Discussion .
This simulation was able to show that when an SPM investigation is used for data 
analysis, study replication is more important than the individual image quality typically 
available from a high performance SPECT system. Despite a reduction in administered 
activity per scan thus degrading the overall image quality, both studies 2 and 3 showed an 
improvement over study 1 (p<0.003 and p<0.000001 respectively). The reduction in 
administered activity per scan is partly compensated for in study 3 by increasing the 
scanning time. The image quality, however, is not fully restored since the increased 
scanning time also increases the fraction of background noise contained within the signal. 
Nevertheless this method used for study 3 obtains a gain in statistical power over studies
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1 and 2 by using a replication paradigm that far outweighs the disadvantage of poorer 
image quality. This is not necessarily the case for low performance SPECT systems, 
where count rate is more of a limiting factor. However, the introduction of double and 
triple headed gamma cameras, coupled with the higher administered activity allowances in 
the rest of Europe and the US should make it possible for " mTc-HMPAO SPECT to 
make valid contributions to the field of functional human brain mapping by following the 
methods presented here.
The experimental protocol selected for this study used a condition of no anatomical 
variation between scans. This should not affect the relative differences between the 
results of the different paradigms used. It should be noted, however, that the absolute 
significance values obtained are higher than one would expect for a neuroactivation study 
involving a similar number of different normal controls. Although the time taken to scan 
a single slice was defined as an independent acquisition parameter, it was actually defined 
by the total scan acquisition time of one hour which was chosen in the light of experience 
to be the maximum acceptable duration of subject compliance.
Adoption of a four study protocol does undoubtedly introduce logistical difficulties. It is 
important to consider the limiting factors in emission tomography studies of 
neuroactivation. The factors which must be considered are cost, number of volunteers 
who can be recruited, radiation dose, scanning time and consequently acceptable scan 
duration. Clearly a 4 scan paradigm is preferable but if it is not possible to arrange four 
independent scanning sessions then an alternative may be considered. One alternative 
would be to use two split dose studies, where up to one half of the dose is administered 
during one condition, obtaining the first scan, and then, on the same day administering 
the remainder of the dose during the second condition and obtaining the second scan (15). 
Another alternative would be to use two dual isotope acquisition studies. This would 
involve the administration of a half dose of one imaging agent (e.g. 123I-IMP) during 
one condition and then another imaging agent (e.g. " mTc HMPAO) is administered 
during another condition immediately following the first (109). A single scanning
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session with two energy window settings would then be performed to obtain two images 
of the two different conditions. Fundamental to both these techniques, however, is the 
problem of noise from the initial scan/imaging agent interfering with the second 
scan/imaging agent.
A four scan design will be advantageous to SPECT studies of neuroactivation, which to 
date, have used two scan protocols (13,15,110). Within this context, the application of 
two additional scans could benefit neuroactivation studies of both patients and normal 
subjects. With respect to the former, one of the main limitations of the neuroactivation of 
for example, brain-injured patients, is the degree of neuroanatomical variability that is 
often present, even in patients displaying similar clinical or neuropsychological profiles. 
Therefore while grouping patients might be unwise in some circumstances, individual 
patients may present excellent opportunities to test specific neuropsychological 
hypotheses. However, in a two scan single case study, the reliability of the data may be 
limited, and in this case, the addition of two further scans, allowing for each condition to 
be replicated (i.e. ABAB), would greatly increase confidence in the results and their 
interpretation. With respect to the latter, the power of investigation of neuroactivation 
studies involving groups of normal healthy subjects, could be greatly enhanced by the 
addition of one, or perhaps two, additional cognitive conditions (i.e., ABAC or ABCD 
respectively). This would enable more subtle differences in cognitive processing to be 
investigated.
5.5 Conclusions.
This investigation was able to show that when using voxel-wise statistical data analysis, 
study replication is more important than the individual image quality typically available 
from a high performance SPECT system.
•  When using CBF SPECT a 4 scan paradigm with the appropriate 
adjustment in scanning protocol should be used for neuroactivation 
studies.
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CHAPTER 6
A pplica tion s o f  the 4  scan S P E C T  pa rad igm  to neuroactiva tion  
studies: I. Investigation into the mechanisms o f  vagal nerve stimulation  
fo r  the treatment o f  intractable epilepsy, using 99m Tc HM PAO SP E C T  
brain images.
This chapter describes the application of the multiple scan paradigm determined in 
chapter 5 for neuroactivation studies that use 99mjc HMPAO SPECT scans of 
cerebral blood flow. Section 5.1 provides a background to epilepsy and the newest 
form of treatment by stimulation of the vagal nerve (VNS). Sections 5.2 and 5.3 
list the methods and the results of applying the 4 scan paradigm to the investigation 
of the affect of VNS on CBF using an SPM analysis. Section 5.4 discusses the 
benefits of using a repeat task design for this experiment and the implications that 
these results may have on explaining the action of VNS on rCBF.
6.1 In troduction
The previous chapter was able to show that SPECT studies of neuroactivation would 
benefit from a multi-task paradigm even though image quality would have to be 
compromised. This chapter describes the application of the 4 scan paradigm to 
investigate the stimulation of the vagus nerve for the treatment of epilepsy.
Epilepsy is a transitory disturbance of the function of the brain which develops suddenly, 
manifesting in uncontrolled movements or actions, ceases spontaneously and reoccurs at
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Figure 6.1. Schematic representation of the position of the implanted Cyberonics vagal nerve stimulator.
variable frequency in different patients. It is a common disorder affecting as many as 1 in 
200 people in the USA and Europe. Epilepsies can be divided into two broad categories; 
those which are generalised, in which seizures appear to affect the whole brain and often 
have a genetic substrate, and those which are focal, in which seizures originate from a 
specific region (or regions) of the brain. The great majority of adult epilepsies are focal, 
most originating in the medial temporal lobe. About 20% of these are not brought under 
satisfactory control using drug treatment and surgical resection of the discrete region of 
the brain identified as the seizure focus is used in selected patients (111). Functional 
imaging has played a major part in improving the accuracy of localisation of such 
epilepsies, and in reducing the use of invasive (and hazardous) EEG techniques. In 
particular the SPECT CBF tracers (IMP, ECD and HMPAO), due to their unique trapping 
mechanism, provide the only means of imaging brain function during a seizure. 
However, surgery carries significant risks and for many patients is not suitable treatment 
(112) and alternative therapies are needed. One such treatment is the stimulation of the
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vagus nerve using an implantable programmable device to decrease the frequency of 
seizures.
An implanted, programmable (Cyberonics Inc.)16 electronic simulator is implanted in the 
left chest (infraclavicular subcutaneous pocket). The stimulating lead electrode contacts, 
embedded in silicone rubber, are wrapped around the left vagus nerve in the low cervical 
area. The vagus nerve is chosen for its absence of pain sensation. Once implanted, the 
stimulator can be programmed to deliver regular stimulation 24 hours a day regardless of 
seizure activity. Patients can also activate extra 'on demand' stimulation with a handheld 
magnet. Clinical studies have demonstrated VNS therapy to be a safe and effective mode 
of treatment when added to the existing treatment regimen for severe, refractory patients 
with epilepsy. Efficacy ranges from seizure free to no response with about half reporting 
a 50% reduction in seizure frequency (113,114). The side-effect profile includes 
stimulation-related sensations in the neck and throat (112,114).
The mechanism of action through which VNS modulates seizure activity is not clearly 
understood although two theories have emerged. First, the "direct connection" theory 
hypothesises that the anticonvulsant action of VNS is caused by a threshold raising effect 
within specific brain structures (114). The second is the concept that chronic stimulation 
of the vagus nerve increases the amount of inhibitory neurotransmitters and decreases the 
amount of excitatory neurotransmitters, basically calming down "hyperexcited" nerve 
cells and reverting the brain back to its normal patterns (115).
The vagus nerve is known to have connections through the nucleus of the solitary tract 
and so sites receiving projections from this area may also have changes in overall synaptic 
activity during VNS. Since the monitoring of cerebral blood flow using emission 
tomography has been shown to reflect changes in motor, sensory and cognitive 
processes, it should be possible to image the changes in blood flow induced during VNS
16 Cyberonics Europe, S.A., Belgicastraat 2,1930 Zaventem, Belgium.
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and so use this information to provide clues as to the action of VNS on the central 
nervous system and its role in controlling or modifying epileptic seizures.
6.2 M eth ods
To confirm the hypothesis that the addition of two further scans, allowing for each 
condition to be replicated (i.e. ABAB), would greatly increase confidence in the results 
and their interpretation, the 4 scan paradigm was used to investigate the stimulation of the 
vagus nerve for the treatment of epilepsy. Ethics permission for the study was given by 
the Southern General Hospital-NHS Trust ethics committee and ARS AC (administration 
of radioactive substances advisory committee).
6.2.1 Subjects and VNS techniques.
Vagus nerve stimulation blood flow SPECT studies were performed in 6 subjects with 
intractable epilepsy. All patients had consented to participating in the protocol for Vagus 
Nerve Stimulation sponsored by Cyberonics. The group included 2 males and 4 females 
with a mean age of 29.5 range 21 - 39. Imaging was commenced 2 days after 
implantation. The protocol required that each patient had medically refractory epilepsy 
occurring 3 or more times monthly. 1 patient had primary generalised epilepsy causing 
generalised tonic clonic seizures, the remaining 5 patients had localisation related 
epilepsy, causing complex partial seizures. No patients had undergone cerebral resection. 
Each patient received 1 minute of VNS to establish the stimulator current level for each 
patient. The stimulation began at VNS current levels of 0.25mA and was increased to 
just enough to cause sensation in the throat to induce coughing. The shape of the 
stimulating waveform was square wave pulses of 500psecs of duration at 30Hz.
6.2.2 Image acquisition.
Four CBF SPECT scans were acquired in four separate sessions for each subject, 2 scans 
when the stimulator was on and two when the stimulator was off. The time between 
consecutive scans was no less than 2 days and no more than 14 days No seizures 
occurred during injection of isotope but one subject had a seizure during an imaging
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session. The scan was stopped and then repeated. CBF was imaged using 250 MBq of 
" mTc HMPAO (1/2 unit dose) per scan. The images were acquired using the SME 810 
scanner (described in chapter 2) with scanning parameters set at a slice acquisition time of 
240 seconds (2 unit time) and a slice separation 8mm. Injection of 99mTc HMPAO was 
given at 2 mins of stimulation during which time the subject lay without speaking and 
eyes closed in a quiet environment. Patient movement during scanning was minimised as 
described in chapter 2.
6.2.3 Image analysis.
The reconstructed images were converted to ANALYZE™ format, spatially standardised 
and smoothed as described in chapter 2. The statistical analysis was performed using the 
"multi subject: replication of conditions" option to check for the main effect of condition 
as well as the "multi subject: different conditions" to check the validity of a repeat task 
design. Proportional scaling to the global mean activity in each subject was used for 
global normalisation (see chapter 2). All results were displayed at a significance 
threshold of Pu<0.001 and Pk<0.5 (uncorrected).
6.3 Results
The contrasts used in this experiment were designed to look at:-
•  the main effect of condition with repeat scans of tasks. (AA - BB)
•  the main effect of condition with single scans of tasks. (A - B)
•  the validity of repeated conditions. (A - A, B - B)
The first contrast investigated directly the effects (both increases and decreases) of VNS 
on CBF. The second contrast also showed the effect of VNS on CBF but this time with 
only a single scan per condition. This was used to look at the increase in statistical 
significance gained by an increase in the degrees of freedom of using a repeat scan design 
as opposed to a single scan design. The third contrast used a subtraction paradigm to 
check for the null hypothesis between two scans of the same task to confirm that the brain 
state had been replicated.
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6.3.1 The main effect o f condition with repeat scans o f tasks.
Subtraction between activation states (A) and baseline states (B) with replications .
For the main effect of conditions the "multi subject: replication of conditions" option was 
used with the contrast (1 -1) to look for increases in blood flow in the stimulus condition 
with respect to the baseline condition and then (-1 1) to look for decreases in blood flow 
with respect to the baseline condition (figure 6.2).
The Z-score and location of the most significant voxel is listed below each SPM(t) map 
thresholded at Pu<0.001 and Pk<0.5 (uncorrected). For clarity, these maps are 
superimposed onto axial slices of the single MRI T1 template supplied with SPM96.
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(xyz) = -32 -90 0 
increased BF in occipital cortex
2*baseline- 2*activation 
Z= 5.07 K= 366 voxels 
(xyz) = -14 -2 64
decreased BF in superior frontal gyrus 
(Brodmann 6)
Figure 6.2 The SPM(t) map of the subtraction of activation and baseline scans are displayed. The map 
on the left hand side shows the increases in rCBF in the activation condition (VNS) relative to the 
baseline condition (rest). The map on the right shows the decreases in rCBF in the activation condition 
relative to the baseline condition.
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6.3.2 The main effect o f condition with single scans o f each task.
Subtraction between activation conditions (Al, A2) and baseline conditions (Bl, B2) 
without replications
For the main effect of four conditions (A l, A2, B l, B2) the "multi subject: different 
conditions" option was used with the contrast of ( 1 0 - 1 0 )  and (0 1 0 -1) to look for 
increases in blood flow in the stimulus condition with respect to the baseline condition 
and then (-10 10) and (0-1 0 1) to look for decreases in blood flow with respect to the 
baseline condition (figure 6.3 a and b).
The Z-score and location of the most significant voxel is listed below each SPM(t) map 
thresholded at Pu<0.001 and Pk<0.5 (uncorrected).
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1 *activation -1 * baseline
Z= 4.18 K= 158 (xyz) = -30 -90 -4
BF increases in occipital cortex
B2 - A2
1* baseline - l*activation 
Z= 4.17 K= 59 (xyz) = -10 -4 64 
BF decreases in L Superior Frontal Gyms 
Brodmann 6.
Figure 6.3a shows the SPM(t) maps of the subtraction of activation from baseline scans on the left and 
the subtraction baseline from activation scans on the right.
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Figure 6.3b shows the SPM(t) maps of the subtraction of activation from baseline scans on the left and 
the subtraction baseline from activation scans on the right.
6.3.3 The validity o f  repeated conditions.
Subtraction within activation condition (Al, A2) and baseline condition (Bl, B2).
To confirm the replication of conditions, the "multi subject: different conditions" option 
was used with contrasts designed to look at the subtractions between scans of the same 
condition. The SPM(t) maps (figure 6.4) confirm the null hypothesis that there are no 
differences in CBF between scans of the same condition.
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Figure 6.4 Shows the SPM(t) maps produced by the contrast of the subtraction o f within conditions 
(baseline - baseline) and (activation - activation).
6 .4  D iscu ssion .
The results of this investigation into the mechanisms involved in the anti-seizure effect of 
VNS confirm the hypothesis that more robust results can be found by sacrificing image 
quality for statistical power. The SPM(t) maps of the increases in CBF with respect to 
the baseline condition using only 2 scans show that the major activation region shows a 
corrected significance based on extent and height of Pu?k<0.01 thresholded at Pu<0.001 
and Pk<0.5 (uncorrected). With 4 scans this corrected significance improves (to 
Pu,k<0-0001 at the same thresholds) by a factor of 100, strengthening the conviction that 
an activation has occurred. This becomes especially important when considering the 
omnibus nature of this test since there was no apriori definition of activation pattern 
requiring the application of a stringent thresholding to account for multiple statistical tests.
Neuronally active regions in the brain have been shown to be associated with increased 
levels of blood flow and so clues to the actions of VNS on the CNS may be made by
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witnessing, in-vivo, the effect of VNS on blood flow to the brain. PET studies to date 
show inconsistent findings in response to VNS but this may be due to differences in 
study design, patient population, duration of VNS therapy and other factors confounding 
the measurement of rCBF. One study showed that changes occurred in the ipsilateral 
anterior thalamus and cingulate gyrus but two of the subjects out of five had seizures 
during scanning (116). Another study showed involvement of the ipsilateral cerebellum, 
contralateral thalamus and contralateral temporal lobe cortex but two of these subjects had 
already undergone cerebral resection (117). In a study that investigated patients 
immediately after insertion of the device changes in rCBF were evident bilaterally in the 
hypothalami, insular cortices, and inferior cerebellum as well as increased flow to the 
contralateral thalamus and post central gyrus (118). Furthermore PET studies on the 
sensation of pain in the throat, a side effect associated with the activation of the 
stimulator, have reported the following activation patterns, on the sensation of pain; 
increased blood flow in the central sulcus, bilateral insular cortices and frontal-parietal 
operculum and anterior cingulate gyrus (119). This pattern would seem to account for at 
least some of the activation seen in other studies investigating the VNS alone.
The results of this study into the effect of VNS on CBF does not confirm any of the CBF 
patterns described above. Differences in protocol with regard to the timing between 
imaging and the switching on of the stimulator as well as the randomisation of the 
baseline and activation conditions may well account for these differences. However, the 
location of the main activated region in the occipital cortex might simply be explained by 
the fact that the scanning protocol of eyes closed during the injection of 99mTc HMPAO 
was not adhered to for every subject. A study of the variability of activation results 
during cognitive processing by Crivello et al 1995 (120) point out that if an activation 
occurring in just one subject is very strong it will remain significant even when included 
in the group analysis. Studies of visual stimulation (109,110) have reported rCBF 
changes of between 15-20% in the occipital cortex during stimulation. Measurements in 
the occipital cortex of the 6 subjects (13.12%, 23.24%, 1.35%, 4.08%, 8.6%, 14.91%)
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in this study show that at least 3 of the subjects had a significant increase in the occipital 
region between the two conditions indicating that the protocol had not been adhered to. 
In addition a further study to investigate specifically the differences in rCBF of having 
eyes open compared to eyes closed (appendix D) showed that there was significant 
change in the occipital cortex that did not require the application of intense visual 
stimulation in the eyes open condition. The percentage changes in iCBF associated with 
VNS have not been reported but are no doubt much less than those reported for the 
changes observed in the occipital cortex.
The SPM(t) maps of the decreases in CBF with respect to the baseline condition also 
show a similar increase in corrected significance but in this case the location of the most 
significant voxel in each of these separate contrasts using the single scan design is not 
stable. However, the most significant voxel for the original contrast of the main effect 
using the replication of conditions design is located in the superior frontal gyrus 
(Brodmann area 6) an area known to be affected by the stimulation of the sympathetic 
nervous system as shown by evoked potential experiments in animals (121). It has been 
suggested that these results could be proof that the stimulation of the parasympathetic 
nervous system by VNS causes inhibition in Brodmann area 6 an effect that has not been 
measured by evoked potential experiments (personal comm, from Dr Peter Julu)17. 
Clearly more subjects need to imaged with a tighter control on the visual stimulation 
status to confirm this result
6.5 Conclusion.
This study was able to confirm that SPECT studies of neuroactivation would benefit from 
a multi-task paradigm even though image quality is compromised. This application of a 4
scan paradigm demonstrates that:-
•  it can be used in practice
•  the results are robust (as can be seen in the validity of repeated conditions 
contrast).
17Dr Peter 0 .0  Julu, university lecturer, Department of Neurology, Central Middlesex Hospital, London, 
UK.
123
CHAPTER 7
A pplica tion s o f  the 4 scan S P E C T  parad igm  to neuroactiva tion  
studies: II. Contrasting the role o f  the medial temporal lobes in novelty 
detection with their role in the encoding and/or consolidation into long­
term memory o f  associative information.
This chapter describes the application of the multiple scan paradigm determined in 
chapter 5 to neuroactivation studies that use 99mjc HMPAO SPECT scans of 
cerebral blood flow. Section 7.1 provides a background to current opinion of the 
role of the medial temporal lobes in memory processing and an explanation of how a 
typical neuroactivation paradigm might be designed to investigate certain aspects of 
this role. Section 7.2 describes the design of the cognitive tasks and the image 
analysis used to isolate specific components of these tasks. Section 7.3 presents the 
results of applying the 4 scan paradigm and sections 7.4 and 7.5 discuss the findings 
and benefits of using a repeat task design.
7.1 I n t r o d u c t io n
Chapter 5 hypothesised that a multi-task paradigm used with SPECT studies of 
neuroactivation could be greatly enhanced by the addition of one, or perhaps two, 
additional cognitive conditions and that this would enable more subtle differences in 
cognitive processing to be investigated. This chapter illustrates how the addition of two 
additional cognitive tasks to the conventional two-task SPECT paradigm enabled the role
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of the medial temporal lobe in novelty detection to be contrasted with its role in the 
encoding of associative information into long term memory.
There exists good evidence, obtained from PET and fMRI studies, that the encoding of 
information from pictures or faces produces activations within the medial temporal lobes 
(MTL) (122-126). The reliability of this MTL finding is strengthened by the fact that the 
studies adopted a variety of different comparison baselines. However, it remains unclear 
exactly what processes are producing the MTL activations. They could be a result of 
novelty alone, the encoding and/or consolidation of associative information into long­
term memory, or both of these. A recent study using verbal stimuli (127), has concluded 
that the left MTL is responsible for novelty detection and not directly for the processes 
involved in the formation of new associations. While the study used a task which 
manipulated novelty of associations it did not strictly match associative encoding across 
the conditions. The present study manipulated novelty while stringently matching levels 
of associative encoding across novel and familiar conditions, with two major aims:
•  To test whether associative encoding and/or consolidation alone is 
responsible for the MTL activations or whether novelty alone can also produce 
such an activation.
•  To investigate what activation pattern is produced in the frontal and parietal 
cortex when contrasting the processing of novel and familiar stimuli using 
different levels of encoding.
Memory refers to the brain processes of encoding, storage and retrieval of facts and 
events for later use. Traditionally psychologists were confined to cognitive investigations 
of memory (and other cognitive processes) whereby manipulations within memory tasks 
allowed the testing of cognitive hypotheses by observing resultant behaviour under 
different conditions. This type of investigation has been carried out both with normal 
healthy controls and with patients with organic amnesia. The comparison of normal 
subject and patient data in this way has allowed neuropsychologists to investigate the
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neural basis of memory by relating cognitive deficits to underlying neuropathology (128). 
Over the years this type of investigation has been enhanced by developments in structural 
imaging, particularly that of MRI, since this has provided researchers with detailed 
confirmation of the location and extent of the brain lesion. However, lesion research is 
limited for two related reasons. First, human brain lesions are rarely selective to the 
extent that is required for testing specific functional hypotheses. Second, patients with 
selective brain lesions, when they do occur, occur in small numbers and therefore work 
on such patients is limited. The advent of functional neuroimaging and the development 
of techniques to study changes in CBF (SPECT) and corresponding changes in glucose 
metabolism and oxygen extraction (PET and fMRI) known to be associated with areas of 
neuronal activity, neuropsychologists have been provided with a “window to the brain” 
through which they can “observe” the neuronal activity associated with particular 
cognitive processes. In order to do this, however, studies require very careful cognitive 
design to ensure that the cognitive process of interest is indeed ’’isolated” by the 
experiment
The first generation of neuroactivation experiments employed a simple subtraction 
paradigm, where the functional images acquired during one brain state were subtracted 
from the functional images in another brain state (45) in order to isolate the process of 
interest. But this model has it limitations. Although two tasks might be carefully 
designed to isolate a single cognitive process, the standard subtraction paradigm assumes 
that the interaction between this and the other components of the task is negligible, but 
this is probably not the case. Using newly developed voxel-wise statistical analysis 
techniques that are now available the subtraction paradigm can be extended further to 
investigate the interaction between different memory processes (129). By introducing 
more than two tasks into one experiment it is possible to use "cognitive conjunctions" to 
strengthen the power of the activations and "factorial designs" to investigate the 
interaction between processes. A conjunction analysis combines a series of subtractions 
that have a single cognitive process common to all task subtractions (130). A factorial 
design involves investigating two or more factors within a task. The interaction between
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these factors identifies changes in rCBF brought about by another processing demand. 
For example if we consider the difference between naming familiar objects and 
categorising familiar objects compared to naming novel objects and categorising novel 
objects, the single subtractions will tell us about the differences between naming and 
categorising but will not be able to show the effect of the nature (familiar or novel) of the 
objects in the task. A conjunction analysis instead, will show us both the common 
difference between the two tasks i.e. naming vs. categorising, independent of the nature 
of the objects (novel or familiar) and the common difference attributable to the nature of 
the objects independent of the task . A factorial analysis will inform us of the interaction 
between the tasks and the nature of the objects.
7.2 Methods
7.2.1 Subjects
SPECT scans were performed on ten healthy right-handed subjects, 5 male and 5 female, 
age range 27-54. Normal memory performance was established using the Doors and 
People Test (131).
7.2.2 Cognitive Activation tasks
Four conditions were designed to manipulate both level of associative encoding and level 
of novelty. Two forced-choice matching-to-sample tasks were used, in which a sample 
complex scene and two choices were presented simultaneously. Each task was carried 
out under two different conditions of novelty (novel and familiar). The design was 
counterbalanced with respect to stimuli, task order and novelty condition.
Thematic Matching Task (TMI. In this task, the three pictures were different 
perceptually, but similar in terms of meaningful content. However, one of the two 
choices shared a theme (e.g., family life, greeting, instruction) with the sample picture 
which the other picture did not portray. The subjects were required to identify this 
matching picture (left or right) by studying the pictures in a way that would identify
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Figure 7.1 a. The material used in the thematic matching task. In this exam ple the left 
hand im age m atches with the top im age as they are both ice sports
Figure 7.1 b. The material used in the perceptual matching task. In this exam ple the right 
hand im age m atches with the top im age since the left hand im age has been translated to 
the left slightly.
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themes within the pictures, not focusing on individual items alone. The nature of this 
processing therefore involved high level semantic associative encoding.
Perceptual Matching Task (PM1. In this task, all three pictures were extracted from a single 
original picture with the sample and one of the two choices being identical while the non­
matched picture involved a slight shift (vertical or horizontal) from the other two. Subjects 
were required to decide which of the two choices (left or right) was identical to the sample 
picture. The three pictures were identical in teRMS of meaningful content so any attention 
paid to the theme of the pictures would not help discriminate between them and subjects were 
encouraged to use a low level superficial scanning strategy to compare the pictures.
Novelty conditions (familiar (F) and novel fNfi Each task was carried out twice (using 
different stimuli) once with familiar stimuli and once with novel stimuli. Familiarity was 
established by displaying the stimuli to the subjects 8 minutes prior to the activation task, 
subjects were instructed to point quickly and accurately to the centre of activity or interest, in 
each picture. Piloting of this familiarisation procedure ensured that exposure times produced 
equal and high familiarity levels (>90%) across the two matching tasks.
Behavioural data
Following each activation task, performance on an associative recognition test was 
measured to establish the extent of associative encoding that had taken place. The level of 
associative encoding was significantly greater during the Thematic Matching (TM) tasks 
than in the Perceptual Matching (PM) tasks (p<0.0001). Subjects were also debriefed 
regarding their awareness of the use of novel or familiar stimuli in each task. The results 
suggest that subjects were aware when novel stimuli were used. Moreover, subjects' 
thematic matching performance on the TE task was found to be significantly better in the 
familiar condition (p<0.007) compared to novel. This indirectly confirms that subjects 
accurately differentiated between novel and familiar stimuli.
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7.2.3 Image acquisition
1 minute into each cognitive task, a maximum dose of 250 MBq 99mTcHMPAO was 
injected intravenously through a forearm cannula while the subject performed the task. 
Each subject received 4 SPECT scans, one for each cognitive condition. Scanning was 
commenced 15-30 mins after the injection. The images were acquired using the SME 
810 scanner (described in chapter 2) with scanning parameters set at a slice acquisition 
time of 240 seconds (2 unit time) and a slice separation 8mm. Patient movement during 
scanning was minimised as described in chapter 2.
7.2.4 Image analysis
The reconstructed images were converted to ANALYZE™ format, spatially standardised 
and smoothed as described in chapter 2. The statistical analysis was performed using the 
"multi subject: different conditions" option to check for the main effect of condition. 
Proportional scaling to the global mean activity in each subject was used for global 
normalisation (see chapter 2). Clusters of contiguous voxels greater than 40, activated at 
an overall threshold of p<0.01 (uncorrected), with peak z-scores > 3.0, were considered 
significant. All results were displayed at a significance threshold of Pu<0.01 and Pk<1.0 
(uncorrected).
7.3 Results.
The contrasts used in this experiment were set up to look at:-
•  the main effect of associative encoding
•  the main effect of familiarity
•  the main effect of novelty
In order to explore the independent effects of encoding and novelty, as well as the 
interaction between the two, the following subtraction and conjunction analyses were 
carried out.
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7.3.1 The main effect o f associative encoding.
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Figure 7.2c
Figure 7.2 and 7.3 show the contrasts of the main effect of associative encoding. Figure 7.2a shows the 
SPM(t) map produced by the conjunction analysis (combining TM familiar - PM familiar with TM novel 
- PM novel). Figure 7.2 b and c show the two major activations superimposed on the T1 MRI template. 
Figure 7.3a shows SPM(t) map produced by the single subtraction contrast (TM familiar - PM familiar). 
Figure 7.3 b shows the cerebellum activation superimposed on the T1 MRI template.
This conjunction of contrasts (figure 7.2 - (TM-PM)f + (TM-PM)n) produced activations 
in the left medial temporal lobe (parahippocampal gyrus) and left parietal cortex and are 
displayed above. A subtraction analysis of (TM-PM)f (figure 7.3) produced encoding- 
specific familiarity activations in the left cerebellum. This activation is also displayed 
superimposed on the corresponding axial slices of the T1 MRI template supplied with 
SPM96 (figure 7.2 a, b and figure 7.3 b).
131
7.3.2 The main effect o f familiarity
TM familiar (TMp), PM familiar (PMp), TM novel (TMn), PM novel (PMn).
(TMf-TMn) + (PMf-PMn)
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Figure 7.4 (a,b,c) and 7.5 show the contrasts of the main effect of familiarity. Figure 7.4 a shows the 
SPM(t) map produced by the conjunction analysis (combining TM familiar - TM novel with PM 
familiar - PM novel). Figure 7.4 b and c show the two major activations superimposed on the T1 MRI 
template. Figure 7.5a shows SPM(t) map produced by the single subtraction contrast (TM familiar - TM 
novel).
This conjunction of contrasts (figure 7.4 - (TMf -TM n ) + (PMf -PMn )) produced 
significant bilateral superior frontal activations activations. A subtraction analysis of 
TM f -TM n revealed that these activations were a result of the encoding-specific 
familiarity condition. These activations are also displayed superimposed on the 
corresponding axial slices of the T1 MRI template supplied with SPM96 (figure 7.4 a, 
b).
Right superior frontal lobe
Left superior frontal lobe
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7.3.3 The main effect of novelty detection
TM familiar (TMp), PM familiar (PMp), TM novel (TMn), PM novel (PMn).
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Figure 7.6 a, b, c show the contrasts of the main effect of novelty detection. Figure 7.6a shows the 
subtraction (PMn  - PMp) and Figure 7.6b shows the subtraction (TMn  - TMp). Figure 7.6c shows the 
conjunction analysis ( combining TMn  - TMp with PMn  - PMp)
This conjunction of contrasts produced no significant activations. Separate subtraction 
analyses also revealed no novelty activations for either task. This finding is clearly 
illustrated in the SPM(t) maps above.
7A  Discussion.
The left MTL is involved in the associative encoding of both novel and familiar stimuli 
[see contrast "The main effect of associative encoding" - (TM-PM)p + (TM-PM)n] as 
reported in the literature (121-126). Novelty alone (when encoding is stringently 
matched) does not produce MTL activations [see contrasts 'The main effect of novelty 
detection' - (PMn-PMf) + (TMn-TMf)], or any other neuroactivation. This suggests 
that novelty itself did not produce the activations seen previously (126,132), but rather
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the processes generally driven by novelty (i.e. spontaneous encoding) did. The left 
parietal cortex is involved in the associative encoding of complex scenes irrespective of 
level of familiarity [contrast conjunction (TM-PM)f + (TM-PM)n ]. While memory- 
related parietal activations have been reported before (124), the strength of this finding is 
remarkable and should encourage further investigation. The activations in the bilateral 
superior frontal regions are involved in the processing of familiar material only, 
irrespective of the level of associative encoding [see contrast "The main effect of 
familiarity conjunction" - (TMf -TM n ) + (PMf -PM n )]. Again, these results are 
consistent with the literature (129, 133, 134, 135) and moreover, the involvement of 
bilateral frontal regions, rather than right-sided frontal regions alone, in processing 
familiar material, both in the encoding and matching tasks, will itself be, an important 
contribution to the literature.
These findings clearly illustrate that
•  the MTL is involved in the associative encoding of pictures, whether novel 
or familiar. Moreover, the results also suggest that
•  the MTL does not respond to the detection of novelty alone as might be 
suggested by the work of Knight 1996 (136).
The use of the 4 condition SPECT procedure allowed these two conclusions to be drawn 
from within one experiment. A 2 condition paradigm could only have addressed one 
question., and two, two-condition experiments would have introduced unwanted inter­
subject variability, and greatly reduced the impact of these important findings.
7.5 Conclusions.
This experiment was able to confirm that a multi-task paradigm greatly enhances the 
power of a SPECT CBF neuroactivation by the addition of two cognitive conditions 
enabling more subtle differences in cognitive processing to be investigated.
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CHAPTER 8
Conclusions
Aim:
Objective 1:
Conclusion 1:
Objective 2:
Conclusion 2:
Objective 3:
and future developments.
To investigate whether the functional brain mapping technique 
(SPM) can be extended to embrace the widely available imaging 
technique of SPECT and to determine whether the combination can 
contribute to routine diagnosis of abnormalities in brain function and 
to research investigations involving functional neuroactivation.
To assess the use of the SPM technique in analysing CBF SPECT 
images of individual subjects, and therefore whether it would be 
applicable to routine diagnosis.
Providing that the procedures described in chapter 3 are followed, 
i.e. rigid body transformation of non-optimal images to an ideal 
CBF SPECT image prior to image standardisation followed by 
manual editing of blurred edges, adequate results were obtained.
To investigate SPM96 as an aid in a specific diagnostic area i.e. the 
differential diagnosis of dementia using 99nrpc HMPAO SPECT 
images of rCBF.
There is no evidence that the use of SPM96 improved inter-observer 
agreement in this study.
To investigate the potential benefits of using a 4 scan paradigm 
compared to a 2 scan paradigm in CBF SPECT neuroactivation
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Conclusion 3:
Objective 4:
Conclusion 4:
studies within the constraints of the total allowed radiation dose per 
subject.
The addition of a replication of condition allowed by the 4 scan 
paradigm significantly increased the statistical power of an SPM 
analysis.
To apply the 4 scan paradigm with a replication of conditions to 
an exploratory study of the affect of vagal nerve stimulation (as a 
treatment for intractable epilepsy) on rCBF and investigate
•  the reliability of the rCBF pattern within the replication of 
conditions
•  the localisation of rCBF increases and decreases produced 
by VNS
Application of the four scan paradigm to investigate the effect of 
VNS on rCBF was able to show that the stimulation of the 
parasympathetic nervous system by VNS causes inhibition in 
Brodmann area 6.
Objective 5: To apply the 4 scan paradigm with multiple conditions to contrast
the role of the medial temporal lobes in novelty detection with 
their role in the encoding and/or consolidation into long-term 
memory of associative information.
Conclusion 5: Application of the multi scan paradigm was able to show that the
medial temporal lobe is involved in the associative encoding of 
pictures, whether novel or familiar and that this activation is not 
due to the detection of novelty alone.
This thesis has shown that the SPM technique originally developed for use with positron 
emission tomography (PET) radiolabelled water studies of normal brain function during 
neuroactivation experiments can be used with 99mTc HMPAO SPECT images.
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The use of SPM for the assessment of individual patient data while not of obvious benefit 
in reporting CBF SPECT scans of dementia, did focus attention on the involvement of the 
temporal lobes in frontal lobe dementia and therefore played a role in the continuing 
eductation of scan interpretation. SPM had no problems detecting the abnormal areas of 
cortical perfusion within the images. The limited benefit found in this study could be due 
in part to the fact that the observers were very familiar with the standard image display but 
had relatively little experience of SPM displays. It is possible that a study like this should 
be repeated in a few years time as familiarity with SPM image presentation grows. This 
could be accelerated by using SPM(t) maps produced from CBF images showing the 
classic patterns associated with a particular dementia type as part of an extended learning 
process of visual reporting for junior radiologists and/or physicists. Familiarity with the 
SPM results could lead to the robust information provided by the SPM(t) map being more 
easily incorporated into the existing knowledge base of disease (including post mortem 
data) and the associated CBF pattern.
The results from this thesis strongly recommend the adoption of a 4 scan paradigm for 
use with CBF SPECT scan studies of neuroactivation. Although adoption of this 
protocol will undoubtedly place an increased demand on the subjects, the ability to gain 
more information for the same effective radiation dose as a 2 scan protocol justifies this 
inconvenience.
When designing neuroimaging experiments consideration must always be made as to the 
most suitable technique available. With the growing availability of fMRI capabilities of 
most MR scanners the newest activation experiments are being designed for this 
environment. The most obvious advantage of this technique is that it involves no ionising 
radiation and potentially an unlimited number of acquisitions per subject. However, there 
are cases where the MR scanner environment is unsuitable. For example, the study 
described in chapter 6 of VNS stimulation as a treatment for epilepsy could not have been 
carried out in a MR scanner. Instead PET could have been the modality of choice but the 
limited clinical application of PET, because of its expense has limited its availability for
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use by most groups and as a consequence those groups using PET find that their access 
to patients is limited. For the investigation of neuroactivation experiments in the clinical 
population SPECT is ideally placed and the trapping mechanism of SPECT blood flow 
tracers also means that neuroactivation experiments can be carried out in a more natural 
setting. The development of this 4 scan technique allows CBF SPECT images to be 
analysed using powerful voxel-wise techniques such as SPM.
This thesis has focused on cerebral blood flow images. The application of SPM methods 
to images of neuroreceptor function may be more important in the future and cannot be 
obtained with MR techniques. The images obtained using tracers such as 123I QNB 
which map muscarinic receptors in the cerebral cortex could be analysed using the SPM 
method. Studies looking at the differences in muscarinic receptor distribution between 
patients suffering from dementia and a normal reference database could be used to 
monitor the progress of a particular treatment For example, covariate analysis of voxel 
intensities could be used to study the relationship between cognitive response to an anti­
dementia drug (e.g. Donepezil18. used in Alzheimer's disease) and receptor binding 
potential.
The results from these investigations, both the individual assessment of clinical images 
and the 4 scan neuroactivation paradigm, have shown that valid results can be obtained 
from 99mTc HMPAO SPECT images of the brain. Although PET has advantages as an 
imaging modality for this type of analysis because of the better resolution and the shorter 
half life of radiolabelled water (enabling repeated measurements to be made) use of SPM 
as developed here can help to make SPECT a viable option. This should not place 
SPECT in direct competition with PET, but it should bring the two modalities closer 
together, each contributing their specific advantages to the study of human brain function.
18 donepezil -Aricept™ Pfizer Inc., New York, NY 10017, USA.
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APPENDIX A
There are 3 options for the interpolation method used to reslice the images after spatial 
normalisation, a) nearest neighbour (Figure A.l) b) bilinear (Figure A.2) c) sine 
interpolation (Figure A.3). Option b) is preferred for 99nrrc HMPAO SPECT rCBF 
images based on empirical evidence. SPM results generated using option a) are noisier, 
i.e. there are more single voxels that are significant. Results generated using sine 
interpolation seem to be no less noisy than using option b) but the registration algorithm 
takes much longer (approx. 30 mins per scan) to compute.
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APPENDIX A
Figure A .I. 3D  section display o f  CBF im age after standardisation where the im ages have been resliced  
using the nearest neighbour interpolation with the corresponding SPM (t) map o f  results below.
Figure A .2 3D  section display o f C B F im age after standardisation where the im ages have been resliced using  
the bilinear interpolation with the corresponding SPM (t) map o f  results below.
Figure A .3 3D  section display o f  C B F im age after standardisation where the im ages have been resliced using  
the sincinterpolation with the corresponding SPM (t) map o f  results below.
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Empirical determination of the spatial smoothing filter
The method used to determine empirically which was the best smoothing filter to use with 
the CBF SPECT scans acquired from the SME810 scanner is described below. To do 
this a dataset of scans was simulated to represent a subtraction paradigm of activation 
minus baseline with 10 subjects with 2 scans each (1 scan per task). A pseudo lesion 
was introduced in order to follow the effects of the different spatial filters on the resulting 
SPM(t). Two different sized lesions were investigated (99 and 199 voxels respectively). 
In the first instance the effect of different smoothing filters was investigated in scans 
acquired using a standard 500MBq dose of Tc99m HMPAO and secondly using a half 
standard dose of Tc99m HMPAO. The results of those investigations are listed below in 
tables A1 and A2.
smoothing 
filter 
xyz mm
LESION SIZE 99 VOXELS 
region size amplitude Zmax * K 
(K) (Zmax)
LESION SIZE 199 VOXELS 
region size amplitude Zmax * K 
(K) (Zmax)
0 N/S N/S
8 129 4.77 615.33 222 6.95 1542.9
10 152 7 .6 7 1 1 6 5 .8 4 2 4 4 8 .0 9 1 9 7 3 .9 6
12 123 7.62 937.26 236 8.2 1935.2
14 104 7.9 821.6 203 8.9 1806.7
16 68 4.52 307.36 165 8.21 1354.65
18 55 4.55 250.25 121 7.94 960.74
20 36 3.74 134.64 88 7.95 699.6
22 N/S 11 4.41 48.51
Table A .l. Data showing effect of smoothing filters on region size and maximum z-score for a 500MBq 
dose scan original activation region size a) 99 voxels and b) 199 voxels (1 voxel = 1.57xl.57x6mm) 
PucO.OOl, Pc< 0.1
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smoothing 
filter 
xyz mm
LESION SIZE 99 VOXELS 
region size amplitude Zmax * K 
(K) (Zmax)
LESION SIZE 199 VOXELS 
region size amplitude Zmax * K 
(K) (Zmax)
0 46 5.51 253.46 104 5.70 592.8
8 188 8.16 1534.08 352 9.95 3502.4
10 207 19.96 4131.72 395 19.57 7730.15
12 2 0 8 2 2 .5 2 4 6 8 4 .1 6 429 28.45 12205.05
14 197 23.51 4631.47 436 26.76 11667.36
16 185 8.73 1615.05 43 2 3 0 .7 8 1 3 2 9 6 .9 6
18 169 8.81 1488.89 399 33.3 13286.7
20 140 7.38 1033.2 355 31.37 11136.35
22 11 5.72 62.92 349 31.22 10895.78
72 5.45 392.4 10 5.14 51.4
Table A.2. Data showing effect of smoothing filters on region size and maximum z-score for a 250MBq 
dose scan original activation region size a) 99 voxels and b) 199 voxels (1 voxel = 1.57xl.57x6mm) 
PucO.OOl, Pc< 0.1
The nature of the statistical analysis carried out in SPM95/96 means that the calculation of 
Z-scores is inherently dependent on the spatial filter used to reduce the variance in the data 
across each image and across all subjects. The empirical results showed that the 
optimum, filter based on maximum region size, is different from that with regard to 
optimum Zmax score. Instead a product of Zmax and region size (Zmax * K) gives an 
overall view of optimum filter size. The optimum filter size for a standard (500MBq) 
" mTc HMPAO dose is determined as 10 FWHM for both sizes of activation. The 
optimum filter size for a half standard (250MBq) 99mTc HMPAO dose is determined as 
12mm FWHM for an activation size of 99 voxels and 16 FWHM for an activation size of 
199 voxels. If the 12mm FWHM spatial filter is used then the error in this choice in 
teRMS of Zmax * K for an estimated ROI of 99 voxels is zero and for 199 voxels is 1091 
(Zmax * Ki6 - Zmax * K12 = 13296 - 12205 = 1091). If the 16mm FWHM spatial filter
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is used then the error in this choice is zero for an estimated ROI size of 199 voxels and 
3069 for 99 voxels (Zmax * K12 - Zmax * Ki6 = 4684-1615 = 3069). Due to the 
unknown size of the activation region in a "real" neuroactivation experiment a choice of 
12mm FWHM filter size was chosen for the half dose scans as it gave the smaller error.
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APPENDIX B
The results are listed below (Tables B 1-3) for each of the challenge conditions analysed 
using the "compare groups: 1 scan per subject" option where group 1 was the 10 average 
scans in the reference data set and group 2 was a single challenge condition sample scan. 
Global blood flow normalisation was achieved using the proportional scaling option and 
SPM(t) maps were generated using the default thresholding of Pu<0.001, and Pk<0.5 
(uncorrected).
METHOD 1
AZ RMS
DIRN. OF AXIAL TRUNCATION
ROTN.
(degrees) 0 18 30
SAG 0 0 0.33 0.89
6 0.09 0.32 0.67
9 0.07 0.3 0.54
1 2 0.46 0.3 0.56
1 5 0.33 0.46 0.59
COR 0 0 0.33 0.89
6 0.09 0.28 0.09
9 0.12 0.27 1.03
1 2 0.17 0.21 1.03
1 5 0.14 0.15 1.05
AX 0 0 0.33 0.89
6 0.03 0.32 0.89
9 0.01 0.33 0.89
1 2 0.01 0.32 0.89
1 5 0.01 0.32 0.89
DIRN. OF 
ROTN.
(degrees)
AXIAL TRUNCATION 
0 18 30
SAG 0 0.00 9.17 52.95
6 0 5.66 52.95
9 0 5.66 52.95
1 2 9.17 52.95 52.95
1 5 52.95 52.95 52.95
COR 0 0.00 9.17 52.95
6 5.66 5.66 5.66
9 5.66 5.66 52.95
1 2 5.66 5.66 52.95
1 5 5.66 5.66 52.95
AX 0 0.00 9.17 52.95
6 0 9.17 43.86
9 0 9.17 43.86
1 2 0 9.17 43.86
1 5 0 9.17 43.86
Table B l. List of all the error teRMS of the average in absolute change in Z score (AZ) 
and root mean squared (RMS) error in location (defined by Talairach co-ordinates) of the 
most significant voxel within the two pseudo lesions with respect to that reported in the 
reference scan for the first method of image standardisation. The first method involved 
image standardisation of each of the challenge condition sample images by direct 
matching to the standard PET template supplied with SPM96, linear spatial 
standardisation function.
144
METHOD 2
AZ
DIRN. OF AXIAL TRUNCATION
ROTN.
(degrees) 0 18 30
SAG 0 0 0.33 0.89
6 0.25 0.22 0.69
9 0.23 0.26 0.74
1 2 0.34 0.3 0.79
1 5 0.09 0.34 0.82
COR 0 0 0.33 0.89
6 0.11 0.29 0.09
9 0.07 0.33 0.11
1 2 0.08 0.4 0.82
1 5 0.11 0.59 N/A
AX 0 0 0.33 0.89
6 0.12 0.11 0.49
9 0.12 0.1 0.48
1 2 0.12 0.09 0.48
1 5 0.12 0.09 0.48
RMS
DIRN. OF AXIAL TRUNCATION
ROTN.
(degrees) 0 18 30
SAG 0 0.00 9.17 52.95
6 0 7.48 5.66
9 0 7.48 5.66
1 2 7.48 7.48 9.80
1 5 5.66 7.48 9.80
COR 0 0.00 9.17 52.95
6 0 2 0
9 0 2 2
1 2 0 2 2
1 5 0 2 N/A
AX 0 0.00 9.17 52.95
6 0 4.47 4.47
9 0 4.47 4.47
1 2 0 4.47 4.47
1 5 0 4.47 4.47
Table B2. List of all the error teRMS of the average in absolute change in Z score (AZ) 
and root mean squared (RMS) error in location (defined by Talairach co-ordinates) of the 
most significant voxel within the two pseudo lesions with respect to that reported in the 
reference scan for the second method of image standardisation. The second method 
used a rigid body registration step prior to standardisation. Each challenge condition 
sample image was co-registered to the reference image (the sample image no rotation, no 
truncation) using a 6 parameter rigid body transform before it was matched to the PET 
template.
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METHOD 3
AZ
DIRN. OF AXIAL TRUNCATION
ROTN.
(degrees) 0 18 30
SAG 0 0 0.33 0.89
6 0 0.09 0.36
9 0 0.09 0.21
1 2 0.03 0.04 0.2
1 5 0.03 0.04 0.12
COR 0 0 0.33 0.89
6 0 0.02 0
9 0 0.03 0.34
1 2 0 0.1 0.35
1 5 0 0.24 0.51
AX 0 0 0.33 0.89
6 0 0 0.12
9 0 0 0.09
1 2 0 0 0.1
1 5 0 0 0.09
RMS
DIRN. OF AXIAL TRUNCATION
ROTN.
(degrees) 0 18 30
SAG 0 0.00 9.17 52.95
6 0 9.80 5.66
9 0 9.80 5.66
1 2 0 9.80 5.66
1 5 5.66 9.80 5.66
COR 0 0 9.17 52.95
6 0 5.65 0
9 0 0 2
1 2 0 2 2
1 5 0 2 2
AX 0 0 9.17 52.95
6 0 0 4.47
9 0 0 4.47
1 2 0 0 4.47
1 5 0 0 4.47
Table B3. List of all the error teRMS of the average in absolute change in Z score (AZ) 
and root mean squared (RMS) error in location (defined by Talairach co-ordinates) of the 
most significant voxel within the two pseudo lesions with respect to that reported in the 
reference scan for the third method of image standardisation. The third method 
includes editing of the final standardised sample image after co-registration, 
standardisation and smoothing to remove spurious data contained in the smoothed edges.
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APPENDIX C
Percentage likelihood of diagnosis from CBF SPECT Scan
information only.
Case
no.
obsl
DAT
obs2 obsl
DFLT
obs2 obsl
DVaT
obs2 obsl
Othr
obs2 obsl
Norm
obs2
1 100 90 0 0 0 1 0 0 0 0 0
2 30 40 1 0 20 30 20 30 20 0 0
3 0 0 0 0 90 70 1 0 0 0 30
4 0 0 0 50 0 0 0 0 100 50
5 20 1 0 0 0 40 20 0 0 40 70
6 80 20 0 0 20 80 0 0 0 0
7 100 100 0 0 0 0 0 0 0 0
8 0 90 0 0 1 0 1 0 0 0 90 0
9 0 1 0 50 80 50 0 0 0 0 1 0
1 0 0 0 40 100 60 0 0 0 0 0
1 1 0 0 90 100 1 0 0 0 0 0 0
1 2 0 0 100 80 0 0 0 20 0 0
1 3 0 0 0 0 100 100 0 0 0 0
1 4 0 0 0 0 60 20 20 0 20 80
1 5 1 0 0 0 0 50 70 40 0 0 30
1 6 1 0 0 0 0 70 1 0 0 0 20 90
1 7 0 0 0 0 0 0 0 0 100 100
1 8 0 0 0 0 80 60 20 0 0 40
1 9 20 30 0 0 0 0 0 30 80 40
20 0 0 0 0 50 60 0 0 50 40
21 0 0 0 0 20 20 0 0 80 80
22 20 0 0 20 60 80 20 0 0 0
23 0 0 0 0 20 1 0 0 0 80 90
24 0 0 0 0 100 100 0 0 0 0
25 0 0 0 1 0 70 20 0 0 30 70
26 0 0 0 1 0 0 20 0 0 100 70
27 0 0 0 1 0 50 0 0 0 50 90
28 50 0 0 50 50 50 0 0 0 0
29 0 0 20 20 80 80 0 0 0 0
30 0 1 0 0 0 100 90 0 0 0 0
31 0 20 0 0 0 0 0 0 100 80
32 0 0 0 0 100 100 0 0 0 0
33 0 0 0 30 40 70 0 0 60 0
34 50 80 0 0 0 20 0 0 50 0
35 0 30 0 0 100 70 0 0 0 0
36 0 0 0 0 100 80 0 0 0 20
37 0 0 0 0 20 0 0 0 80 100
38 80 80 0 0 20 20 0 0 0 0
39 0 0 20 1 0 20 80 20 0 40 1 0
DAT - Dementia of the Alzheimer's type, DFLT - Dementia of the frontal lobe type,
DVaT - Dementia of the Vascular type, othr - other dementia, norm -normal (no 
abnormalities)
Table C l. Percentage likelihood of diagnosis from CBF SPECT Scan information only for observer 1 
and 2.
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Percentage likelihood of diagnosis from CBF SPECT scan with 
additional information from SPM analysis
Qxte
no.
obsl
DAT
obs2 obsl
DFLT
obs2 obsl
DVaT
obs2 obsl
Othr
obs2 obsl
Norm
obs2
1 90 95 1 0 0 0 0 0 0 0 5
2 90 90 0 0 1 0 1 0 0 0 0 0
3 0 0 0 0 100 80 0 0 0 20
4 0 0 0 70 0 0 0 0 100 30
5 40 0 0 0 60 20 0 0 0 80
6 80 0 0 0 20 80 0 0 0 20
7 100 100 0 0 0 0 0 0 0 0
8 1 0 100 0 0 1 0 0 0 0 80 0
9 0 1 0 50 1 0 50 80 0 0 0 0
1 0 0 0 50 60 50 0 0 0 0 40
1 1 0 0 90 30 1 0 70 0 0 0 0
1 2 0 0 100 60 0 20 0 20 0 0
1 3 0 0 0 0 100 100 0 0 0 0
1 4 0 0 20 0 60 40 20 0 0 60
1 5 20 0 0 0 70 90 1 0 0 0 1 0
1 6 30 20 0 0 60 20 0 0 1 0 60
1 7 0 0 0 0 0 1 0 0 0 100 90
1 8 0 0 0 0 70 70 30 0 0 30
1 9 1 0 0 0 0 0 0 0 0 90 100
20 50 0 0 0 40 40 0 0 60 60
21 20 0 0 0 20 70 0 0 60 30
22 1 0 0 0 0 70 80 20 20 0 0
23 0 0 0 0 0 0 0 0 100 100
24 0 0 0 0 100 100 0 0 0 0
25 30 70 0 0 70 20 0 0 0 1 0
26 0 0 0 0 20 30 0 0 80 70
27 0 0 20 0 30 1 0 0 0 50 90
28 50 0 0 0 50 70 0 0 0 30
29 0 0 20 0 50 60 30 40 0 0
30 0 1 0 0 0 100 90 0 0 0 0
31 0 0 0 0 0 30 0 0 100 70
32 0 0 0 0 100 100 0 0 0 0
33 0 0 0 0 60 100 0 0 40 0
34 40 0 0 0 40 100 20 0 0 0
35 0 60 20 0 80 40 0 0 0
36 0 1 0 0 0 100 90 0 0 0
37 0 0 0 0 20 1 0 0 0 80 90
38 80 20 0 0 0 80 20 0 0
39 0 0 30 0 30 80 20 0 20 20
DAT - Dementia of the Alzheimer's type, DFLT - Dementia of the frontal lobe type, 
DVaT - Dementia of the Vascular type, othr - other dementia, norm -normal (no 
abnormalities)
Table C2. Percentage likelihood of diagnosis from CBF SPECT Scan and additional information from 
SPM(t) map for observer 1 and 2.
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AGREEMENT OF RESULTS FROM CBF SPECT DATA 
ONLY.
KAPPA calculation for overall agreement (95).
obs2
DAT DFLT DVaT othr norm expected
DAT 3 1 4 (5x4)/39 0.513
DFLT 3 1 4 (3x4)/39 0.308
DVaT 2 1 3 1 2 18(18x1 8) / 3 9 8.308
othr 1 1 (1 x2)/39 0.051
Norm 4 8 12(12x1 6)/39 3.385
5 3 1 8 2 1 1 39 12.56
Table C3a. Frequency table for a kappa calculation of agreement between 2 observers of 
diagnosis from CBF SPECT data only.
K = (sum obs-sum exp)/(N-sum exp)
= (3+3+13+1+81 - (0.51+0.3+8.3+0+3.391
39- (0.51+0.3+8.3+0+3.39)
K =  (28 - 12.56)7(39 - 12.56) = 0.584 moderate agreement
AGREEMENT OF RESULTS FROM CBF SPECT AND SPM(t) 
DATA .
KAPPA calculation for overall agreement
obs2*
DAT DFLT DVaT othr NORM expected
DAT 3 2 5 (5x7)/39 0.897
DFLT 2 2 4 (4x3)/39 0.308
DVaT 2 1 3 3 1 8(18x18)/39 8.308
othr 1 1 (1 x0)/39 0
NORM 2 1 8 1 1 (11x11 )/39 3.103
7 3 1 8 0 1 1 39 12.62
Table C3b. Frequency table for a kappa calculation of agreement between 2 observers of 
diagnosis from CBF SPECT data and additional information from SPM(t) map.
K = (sum obs-sum exp)/(N-sum exp)
= (3+2+13+0+81 - (0.9+0.3+8.3+0+3.11 
39- (0.9+0.3+8.3+0+3.1)
K = (26 - 12.62)7(39 - 12.62) = 0 .507 moderate agreement
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Weighted KAPPA (Kw) calculations for agreement between
observers of diagnosis.
K(w) = (Po(w) " Pe(w))/d “ Pe(w))
and
Wy = 1 - ( l i - j l / g - 1)
where i is the row number and j the column number and g the number of categories or 
rating levels.
Po(w) = (1/n ) ( 2  2  Wij*fjj)
Pe(w) = (1/n2 ) ( 2  2  Wij*Fi*Fj) 
where fy is the entry in the frequency table for row i and column j. 
where Fj is the total number of observations entered in the frequency table for row i. 
where Fj is the total number of observations entered in the frequency table for column j.
Weighted
Kappa
0 1 2 3 4 5 6 7 8 9  10
0 1 0 9 0.8 0 7 0.6 0 5 0.4 0.3 0 .2 0 1 0
1 0 9 1 0.9 0 8 0.7 0 6 0.5 0.4 0 .3 0 2 0 .1
2 0 8 0 9 1 0 9 0.8 0 7 0.6 0.5 0 .4 0 3 0 .2
3 0 7 0 8 0.9 1 0.9 0 8 0.7 0.6 0 5 0 4 0 .3
4 0 6 0 7 0.8 0 9 1 0 9 0.8 0.7 0 6 0 5 0 .4
5 0 5 0 6 0.7 0 8 0.9 1 0.9 0.8 0 7 0 6 0 .5
6 0 4 0 5 0.6 0 7 0.8 0 9 1 0.9 0 8 0 7 0 .6
7 0 3 0 4 0.5 0 6 0.7 0 8 0.9 1 0 .9 0 8 0 .7
8 0 2 0 3 0.4 0 5 0.6 0 7 0.8 0.9 1 0 9 0 .8
9 0 1 0 2 0.3 0 4 0.5 0 6 0.7 0.8 0 .9 1 0 .9
1 0 0 0 1 0.2 0 3 0.4 0 5 0.6 0.7 0 8 0 9 1
Table C4. Weighting values used to calculate a weighted kappa measure of agreement.
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Weighted KAPPA (Kw) calculations for agreement between
observers of diagnosis.
K (w)= (Po(w) " Pe(w)V(l “ Pe(w))
and 
Wy = 1 - (li - jl /  g -1)
where i is the row number and j the column number and g the number of categories or 
rating levels.
Po(w) = (1/n ) ( I  £  Wjj*fjj) 
Pe(w) = (1/n2 ) ( 2 1
where f  is the entry in the frequency table for row i and column j.
Cl* VoUJL W* o f  obro>/oJb\'ers»4 ^ ovj t*
fri* i*i 0-4- H.° Sy ©bMrv voJt*Vw-*» W < •
Weighted 1 °
Kappa
0 1 2 3 4 5 6 7 8 9 1 0
0 1 0.9 0.8 0.7 0.6 0.5 0.4 0.3 0.2 0.1 0
1 0.9 1 0.9 0.8 0.7 0.6 0.5 0.4 0.3 0.2 0.1
2 0.8 0.9 1 0.9 0.8 0.7 0.6 0.5 0.4 0.3 0.2
3 0.7 0.8 0.9 1 0.9 0.8 0.7 0.6 0.5 0.4 0.3
4 0.6 0.7 0.8 0.9 1 0.9 0.8 0.7 0.6 0.5 0.4
5 0.5 0.6 0.7 0.8 0.9 1 0.9 0.8 0.7 0.6 0.5
6 0.4 0.5 0.6 0.7 0.8 0.9 1 0.9 0.8 0.7 0.6
7 0.3 0.4 0.5 0.6 0.7 0.8 0.9 1 0.9 0.8 0.7
8 0.2 0.3 0.4 0.5 0.6 0.7 0.8 0.9 1 0.9 0.8
9 0.1 0.2 0.3 0.4 0.5 0.6 0.7 0.8 0.9 1 0.9
1 0 0 0.1 0.2 0.3 0.4 0.5 0.6 0.7 0.8 0.9 1
Table C4. Weighting values used to calculate a weighted kappa measure of agreement.
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0
1
2
3
4
5
6
7
8
9
1 0
Tat
obs
0
1
2
3
4
5
6
7
8
9
1 0
Tat
obs
0
1
2
3
4
5
6
7
8
9
1 0
ement for the dementia of the Alzheimers type category 
CBF SPECT Scan information only
obs2
0 1 1 0
22 3 1 0 0 1 0 0 0 0 0 27
2 0 1 0 0 0 0 0 0 0 0 3
1 0 0 0 0 0 0 0 1 0 0 2
1 0 1 1 0 0 0 0 0 0 0 3
0 0 0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 1 0 0 1
1 0 0 0 0 0 0 0 0 0 1 2
0 0 0 0 0 0 0 0 0 0 1 1
27 3 3 1 0 1 0 0 2 0 2 39
25. Frequency table of agreement for the disease category DAT.
obs2
0 1 2 3 4 5 6 7 8 9 1 0
22 2.7 0.8 0 0 0.5 0 0 0 0 0
1.8 0 0.9 0 0 0 0 0 0 0 0
0.8 0 0 0 0 0 0 0 0.4 0 0
0.7 0 0.9 1 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 1 0 0
0.1 0 0 0 0 0 0 0 0 0 0.9
0 0 0 0 0 0 0 0 0 0 1
0.91
26. Frequency table of weighted agreement
obs2
0 1 2 3 4 5 6 7 8 9 1 0
676 70.2 62.4 18.2 0 1 3 0 0 10.4 0 0
70.2 9 8.1 2.4 0 1.8 0 0 1.8 0 0.6
41.6 5.4 6 1.8 0 1.4 0 0 1.6 0 0.8
54.6 7.2 8.1 3 0 2.4 0 0 3 0 1.8
0 0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0 0
0 0 0 0 0 0 0 0 0 0 0
5.2 0.9 1.2 0.5 0 0.7 0 0 2 0 1.6
5.2 1.2 1.8 0.8 0 1.2 0 0 3.6 0 3.6
0 0.3 0.6 0.3 0 0.5 0 0 1.6 0 2
21. Frequency table of the weighted agreement expected by chance.
Kw = (0.91 -0.78)/(l-0.78) = 0.59
0.78
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Agreement for the dementia of the frontal lobe type category 
from CBF SPECT Scan information only.
DFLT J
obs2
obsl 0 1 2 3 4 5 6 7 8 9 1 0
0 30 0 1 0 0 0 0 0 0 0 0
1 0 1 1 0 0 0 0 0 0 0 0
2 2 0 0 0 0 1 0 0 0 0 0
3 0 0 0 0 0 0 0 0 0 0 0
4 0 0 0 0 0 0 0 0 0 0 0
5 0 0 0 0 0 0 0 0 0 0 0
6 0 0 0 0 0 0 0 0 0 0 1
7 0 0 0 0 0 0 0 0 0 0 0
8 0 0 0 0 1 0 0 0 0 0 0
9 0 0 0 0 0 0 0 0 0 1 0
1 0 0 0 0 0 0 0 0 0 0 0 0
32 1 2 0 1 1 0 0 0 1 1
Table 2%. Frequency table of agreement for the disease category DFLT.
obs2
obsl 0 1 2 3 4 5 6 7 8 9 1 0
0 29 0 0.8 0 0 0 0 0 0 0 0
1 0 1 0.9 0 0 0 0 0 0 0 0
2 1.6 0 0 0 0 0.7 0 0 0 0 0
3 0 0 0 0 0 0 0 0 0 0 0
4 0 0 0 0 0 0 0 0 0 0 0
5 0 0 0 0 0 0 0 0 0 0 0
6 0 0 0 0 0 0 0 0 0 0 0.6
7 0 0 0 0 0 0 0 0 0 0 0
8 0 0 0 0 0.6 0 0 0 0 0 0
9 0 0 0 0 0 0 0 0 0 1 0
1 0 0 0 0 0 0 0 0 0 0 0 0
Table C9. Frequency table of weighted agreement
obs2
obsl 0 1 2 3 4 5 6 7 8 9 1 0
0 930 27 48 0 1 8 1 5 0 0 0 3 0
1 55.8 2 3.6 0 1.4 1.2 0 0 0 0.4 0.2
2 74.4 2.7 6 0 2.4 2.1 0 0 0 0.9 0.6
3 0 0 0 0 0 0 0 0 0 0 0
4 0 0 0 0 0 0 0 0 0 0 0
5 0 0 0 0 0 0 0 0 0 0 0
6 12.4 0.5 1.2 0 0.8 0.9 0 0 0 0.7 0.6
7 0 0 0 0 0 0 0 0 0 0 0
8 6.2 0.3 0.8 0 0.6 0.7 0 0 0 0.9 0.8
9 3.1 0.2 0.6 0 0.5 0.6 0 0 0 1 0.9
1 0 0 0 0 0 0 0 0 0 0 0 0
31
2
3
0
0
0
1
0
1
1
0
39
0.953
0.851
Table CIO. Frequency table of the weighted agreement expected by chance.
Kw = (0.953 -0.851)/(1-0.851) = 0.685
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Agreement for the dementia of the vascular type category from 
CBF SPECT Scan information only.
DVaT
obs2
1 0obsl
1 0
62 2 2 3 18 2 7 3 3
1 1 
4 
6 
1 
0 
1 
2
4
5 
2 
3
39
Table C l 1. Frequency table of agreement for the disease category DVaT. 
obs 2
1 0obs 1
0.9 0.8
1 0.9
0.6
0 0.4
0.6 0.5
0.9
0.8 0.8
0 .8
0.7 0.8 0.8 0.7
0 0.8 
0 0.9
0.80.8
0.9
1 0
0.832
Table C l2. Frequency table of weighted agreement 
obs 2
obs 1 0 1 2 3 4 5 6 7 8 9 1 0
0 88 19.8 52.8 23.1 19.8 1 1 8.8 6.6 6.6 1.1 0
1 28.8 8 21.6 9.6 8.4 4.8 4 3.2 3.6 0.8 2.4
2 38.4 10.8 36 16.2 14.4 8.4 7.2 6 7.2 1.8 7.2
3 5.6 1.6 5.4 3 2.7 1.6 1.4 1.2 1.5 0.4 1.8
4 0 0 0 0 0 0 0 0 0 0 0
5 4 1.2 4.2 2.4 2.7 2 1.8 1.6 2.1 0.6 3
6 3.2 1 3.6 2.1 2.4 1.8 2 1.8 2.4 0.7 3.6
7 9.6 3.2 1 2 7.2 8.4 6.4 7.2 8 10.8 3.2 16.8
8 8 3 1 2 7.5 9 7 8 9 1 5 4.5 24
9 1.6 0.8 3.6 2.4 3 2.4 2.8 3.2 5.4 2 10.8
1 0 0 0.6 3.6 2.7 3.6 3 3.6 4.2 7.2 2.7 1 8
0.589
Table C l3. Frequency table of the weighted agreement expected by chance.
Kw = (0.832 -0.589)/(l-0.589) = 0.591
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Agreement for the normal category from CBF SPECT Scan 
information only.
norm
obs 2
obs 1 0 1 2 3 4 5 6 7 8 9 1 0
0 1 8 0 0 0 0 1 0 0 0 0
1 1 0 0 0 1 0 0 0 0 0 0
2 1 0 0 0 0 0 0 0 0 0 0
3 2 0 0 0 0 0 0 0 0 0 0
4 1 0 0 0 0 0 0 0 1 0 0
5 0 0 0 0 0 0 0 0 0 0 1
6 0 0 0 0 0 0 0 0 0 0 0
7 0 0 0 1 1 0 0 0 0 0 1
8 0 0 1 0 0 0 0 0 1 0 1
9 0 0 1 0 0 1 0 0 1 0 0
1 0 0 0 0 0 0 0 0 0 1 1 1
23 0 2 1 2 1 1 0 4 1 4
Table C14. Frequency table of agreement for the normal category.
obs 2
obs 1 0 1 2 3 4 5 6 7 8 9 1 0
0 1 8 0 0 0 0 0 0.4 0 0 0 0
1 0.9 0 0 0 0.7 0 0 0 0 0 0
2 0.8 0 0 0 0 0 0 0 0 0 0
3 1.4 0 0 0 0 0 0 0 0 0 0
4 0.6 0 0 0 0 0 0 0 0.6 0 0
5 0 0 0 0 0 0 0 0 0 0 0.5
6 0 0 0 0 0 0 0 0 0 0 0
7 0 0 0 0.6 0.7 0 0 0 0 0 0.7
8 0 0 0.4 0 0 0 0 0 1 0 0.8
9 0 0 0.3 0 0 0.6 0 0 0.9 0 0
1 0 0 0 0 0 0 0 0 0 0.8 0.9 1
0.836
Table C l5. Frequency table of weighted agreement 
obs 2
obs 1 0 1 2 3 4 5 6 7 8 9 1 0
0 437 0 30 13.3 22.8 9.5 7.6 0 1 5 1.9 0
1 41.4 0 3.6 1.6 2.8 1.2 1 0 2.4 0.4 0.8
2 18.4 0 2 0.9 1.6 0.7 0.6 0 1.6 0.3 0.8
3 32.2 0 3.6 2 3.6 1.6 1.4 0 4 0.8 2.4
4 27.6 0 3.2 1.8 4 1.8 1.6 0 4.8 1 3.2
5 11.5 0 1.4 0.8 1.8 1 0.9 0 2.8 0.6 2
6 0 0 0 0 0 0 0 0 0 0 0
7 20.7 0 3 1.8 4.2 2.4 2.7 0 1 1 2.4 8.4
8 13.8 0 2.4 1.5 3.6 2.1 2.4 0 1 2 2.7 9.6
9 6.9 0 1.8 1.2 3 1.8 2.1 0 1 1 3 10.8
1 0 0 0 1.2 0.9 2.4 1.5 1.8 0 9.6 2.7 1 2
0.639
Table C l6. Frequency table of the weighted agreement expected by chance. 
Kw = (0.836 -0.639)/(l-0.639) = 0.546
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Agreement for the dementia of the Alzheimers type category 
from CBF SPECT Scan and SPM(t) data.
DAT
obs 2
obs 1 0 1 2 3 4 5 6 7 8 9 1 0
0 22 2 2 0 1 1 0 0 1 0 0 29
1 3 0 0 0 0 0 0 0 0 0 0 3
2 0 0 0 1 0 0 0 0 1 0 0 2
3 0 0 0 0 0 0 0 0 0 0 0 0
4 0 0 0 0 0 0 0 0 0 0 0 0
5 0 0 0 0 0 0 0 0 0 0 0 0
6 0 0 0 0 0 0 0 0 0 0 0 0
7 0 0 0 1 0 0 0 0 0 0 0 1
8 0 0 0 0 0 0 0 0 0 0 0 0
9 0 0 0 0 0 0 0 0 0 2 0 2
1 0 0 1 0 0 0 0 0 0 0 0 1 2
25 3 2 2 1 1 0 0 2 2 1 39
Table C17. Frequency table of agreement for the disease category DAT.
obs2
obs 1 0 1 2 3 4 5 6 7 8 9 1 0
0 21 1.8 1.6 0 0.6 0.5 0 0 0.2 0 0
1 2.7 0 0 0 0 0 0 0 0 0 0
2 0 0 0 0.9 0 0 0 0 0.4 0 0
3 0 0 0 0 0 0 0 0 0 0 0
4 0 0 0 0 0 0 0 0 0 0 0
5 0 0 0 0 0 0 0 0 0 0 0
6 0 0 0 0 0 0 0 0 0 0 0
7 0 0 0 0.6 0 0 0 0 0 0 0
8 0 0 0 0 0 0 0 0 0 0 0
9 0 0 0 0 0 0 0 0 0 2 0
1 0 0 0.1 0 0 0 0 0 0 0 0 1
0.856
Table C l8. Frequency table of weighted agreement 
obs 2
obs 1 0 1 2 3 4 5 6 7 8 9 1 0
0 672 75 .6 44.8 39.2 16.8 1 4 0 0 11.2 5.6 0
1 64.8 0 0 0 0 0 0 0 0 0 0
2 38.4 0 4 3.6 1.6 1.4 0 0 1.6 1.2 0.4
3 0 0 0 0 0 0 0 0 0 0 0
4 0 0 0 0 0 0 0 0 0 0 0
5 0 0 0 0 0 0 0 0 0 0 0
6 0 0 0 0 0 0 0 0 0 0 0
7 7.2 0 1 1.2 0.7 0.8 0 0 1.8 1.6 0.7
8 0 0 0 0 0 0 0 0 0 0 0
9 4.8 0 1.2 1.6 1 1.2 0 0 3.6 4 1.8
1 0 0 0 0.8 1.2 0.8 1 0 0 3.2 3.6 2
0.686
Table C19. Frequency table of the weighted agreement expected by chance.
Kw = (0.856 -0.686)7(1-0.686) = 0.541
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Agreement for the dementia of the frontal lobe type category 
from CBF SPECT Scan and SPM(t) data.
DFLT
obs 2
obs 1 fc) 1 2 3 4 5 6 7 8 9 10
0 28 1 4 1 0 0 0 0 0 0 0 34
1 0 0 0 0 0 1 0 0 0 0 0 1
2 0 0 0 0 0 0 0 0 0 0 0 0
3 0 0 0 0 0 0 0 0 0 1 0 1
4 0 0 0 0 0 0 0 0 0 0 0 0
5 0 0 0 0 0 0 0 0 0 0 0 0
6 0 0 0 0 0 1 0 0 0 0 1 2
7 1 0 0 0 0 0 0 0 0 0 0 1
8 0 0 0 0 0 0 0 0 0 0 0 0
9 0 0 0 0 0 0 0 0 0 0 0 0
1 0 0 0 0 0 0 0 0 0 0 0 0 0
29 1 4 1 0 2 0 0 0 1 1 39
Table C20. Frequency table of agreement for the disease category DFLT.
obs 1
obs 1 0 1 2 3 4 5 6 7 8 9 1 0
0 28 0.9 3.2 0.7 0 0 0 0 0 0 0
1 0 0 0 0 0 0.6 0 0 0 0 0
2 0 0 0 0 0 0 0 0 0 0 0
3 0 0 0 0 0 0 0 0 0 0.4 0
4 0 0 0 0 0 0 0 0 0 0 0
5 0 0 0 0 0 0 0 0 0 0 0
6 0 0 0 0 0 0.9 0 0 0 0 0.6
7 0.3 0 0 0 0 0 0 0 0 0 0
8 0 0 0 0 0 0 0 0 0 0 0
9 0 0 0 0 0 0 0 0 0 0 0
1 0 0 0 0 0 0 0 0 0 0 0 0
0.913
Table C21. Frequency table of weighted agreement
obs 1
obs 2 
0 1 2 tj-co 5 6 7 8 9 1 0
0 986 30.6 108.8 23.8 0 34 0 0 0 3.4 0
1 26.1 1 3.6 0.8 0 1.2 0 0 0 0.2 0.1
2 0 0 0 0 0 0 0 0 0 0 0
3 20.3 0.8 3.6 1 0 1.6 0 0 0 0.4 0.3
4 0 0 0 0 0 0 0 0 0 0 0
5 0 0 0 0 0 0 0 0 0 0 0
6 23.2 1 4.8 1.4 0 3.6 0 0 0 1.4 1.2
7 8.7 0.4 2 0.6 0 1.6 0 0 0 0.8 0.7
8 0 0 0 0 0 0 0 0 0 0 0
9 0 0 0 0 0 0 0 0 0 0 0
1 0 0 0 0 0 0 0 0 0 0 0 0
0.854
Table C22. Frequency table of the weighted agreement expected by chance.
Kw = (0.913 -0.854)7(1-0.854) = 0.4
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Agreement for the dementia of the vascular type category from 
CBF SPECT Scan and SPM(t) data.
DVaT
obs 2
obs 1 1 0
1 0
0 79 3 2 1 4 4 4 14
7
4
4
2
3 
0 
1
4 
6 
3
5 
39
Table C23. Frequency table of agreement for the disease category DVaT.
obs 2
obs 1 1 0
0.9 0.5
0.9
0.8
0.7
0.9 0.8
0.5
0.9
0.8 0 . 6
0.9
0.8
0.7
0.4 0.5 0
0 0.4 0.5 0.80.2 0.9
0.8
0.61 0
0.79
Table C24. Frequency table of weighted agreement 
obs 2
0 1 2 3 4 5 6 7 8 9 1 0obs 1 
0 
1 
2
3
4
5
6
7
8 
9
1 0
63 18.9 22.4 9.8 4.2 14 11.2 8.4 1.4 0 0
32.4 12 14.4 6.4 2.8 9.6 8 6.4 1.2 0 2.8
28.8 10.8 1 6 7.2 3.2 11.2 9.6 8 1.6 0 5.6
12.6 4.8 7.2 4 1.8 6.4 5.6 4.8 1 0 4.2
16.2 6.3 9.6 5.4 3 10.8 9.6 8.4 1.8 0 8.4
0 0 0 0 0 0 0 0 0 0 0
3.6 1.5 2.4 1.4 0.8 3.6 4 3.6 0.8 0 4.2
10.8 4.8 8 4.8 2.8 12.8 14.4 1 6 3.6 0 19.6
10.8 5.4 9.6 6 3.6 16.8 19.2 21.6 6 0 33.6
2.7 1.8 3.6 2.4 1.5 7.2 8.4 9.6 2.7 0 18.9
0 1.5 4 3 2 10 12 1 4 4 0 35
0.581
Table C25. Frequency table of the weighted agreement expected by chance. 
Kw = (0.79 -0.581)7(1-0.581) = 0.498
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Agreement for the normal category from CBF SPECT Scan and 
SPM(t) data.
norm
obs 2
obs 1 0 1 2 3 4 5 6 7 8 9 1 0
0 1 6 0 0 0 1 0 0 0 1 0 0 1 8
1 2 0 0 0 0 0 0 0 0 0 0 2
2 2 0 1 0 0 0 0 0 0 0 0 3
3 2 0 0 0 0 0 1 0 0 0 1 4
4 1 0 0 0 0 0 0 0 0 0 0 1
5 0 0 0 0 0 0 0 0 0 0 0 0
6 1 1 0 0 0 0 1 0 0 0 0 3
7 0 0 0 0 0 0 0 0 1 0 1 2
8 1 0 0 0 0 0 0 0 0 0 0 1
9 0 0 0 0 0 1 0 0 1 0 1 3
1 0 0 0 0 0 0 0 0 0 0 1 1 2
25 1 1 0 1 1 2 0 3 1 4 39
Table C26. Frequency table of agreement for the normal category.
obs 2
obs 1 0 1 2 3 4 5 6 7 8 9 1 0
0 1 6 0 0 0 0.6 0 0 0 0.2 0 0
1 1.8 0 0 0 0 0 0 0 0 0 0
2 1.6 0 1 0 0 0 0 0 0 0 0
3 1.4 0 0 0 0 0 0.7 0 0 0 0.3
4 0.6 0 0 0 0 0 0 0 0 0 0
5 0 0 0 0 0 0 0 0 0 0 0
6 0.4 0.5 0 0 0 0 1 0 0 0 0
7 0 0 0 0 0 0 0 0 0.9 0 0.7
8 0.2 0 0 0 0 0 0 0 0 0 0
9 0 0 0 0 0 0.6 0 0 0.9 0 0.9
1 0 0 0 0 0 0 0 0 0 0 0.9 1
0.826
Table C27. Frequency table of weighted agreement
obs 1
obs 2 
0 1 2 3 4 5 6 7 8 9 1 0
0 450 16.2 1 4 0 10.8 9 14.4 0 1 1 1.8 0
1 45 1.8 2 0 1.6 1.4 2.4 0 2.4 0.6 0
2 60 2.4 2.7 0 2.7 2.4 4.2 0 4.5 1.2 0
3 70 2.8 3.2 0 4 3.6 6.4 0 7.2 2 6.4
4 1 5 0.6 0.7 0 0.9 1 1.8 0 2.1 0.6 2
5 0 0 0 0 0 0 0 0 0 0 0
6 30 1.2 1.5 0 2.1 2.4 5.4 0 8.1 2.4 8.4
7 1 5 0.6 0.8 0 1.2 1.4 3.2 0 6 1.8 6.4
8 5 0.2 0.3 0 0.5 0.6 1.4 0 2.7 1 3.6
9 7.5 0.3 0.6 0 1.2 1.5 3.6 0 7.2 2.7 1 2
1 0 0 0 0.2 0 0.6 0.8 2 0 4.2 1.6 7.2
0.632
Table C28. Frequency table of the weighted agreement expected by chance. 
Kw = (0.826 -0.632)7(1-0.632) = 0.53
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Appendix D
The following pages list the the results from an SPM analysis to investigate the impact of 
visual stimulus on CBF, using two groups of subjects. The first group contains five 
patients who were injected with 9 9 m H M P A O  with their eyes shut, the second group 
were injected with their eyes open. The statistical option chosen was ’compare groups; 1 
scan per subject’. The contrast design was (1, -1) and (-1,1). Global normalisation was 
acheived using proportional scaling.
Figure D l. A list of the scan numbers, group number, subject number and the global 
mean voxel intensity scaled to 50 ml/min/lOOg
Figure D2. Design matrix of the SPM analysis described above.
Figure D3. SPM(F) map of the results of an F test on every voxel in the analysis and 
represents any unexplained variance in the data. The contrasts are listed below.
Figure D4. SPM(t) contrast 1 (1 -1) represents the increases in the eyes closed condition 
with respect to the eyes open condition.
pg 5 SPM(t) contrast 2 (-1 1) represents the increases in the eyes open condition with 
respect to the eyes closed condition.
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Statistical analysis
X
0
l i  -g __ Base directory:
c  §" .SB, /homes/abarnes/work_in_progressA/NS/occ_act/nformat
|  |  O Filename Tails
01 : 1 1 52.5178 /snA509B.img
02 : 1 2 46.3219 /snD615B.img
03 : 1 3 46.8641 /snD705B.img
04 : 1 4 50.2058 /snD707B.img
05 : 1 5 51.634 /snD709B.img
06 : 2 1 49.1376/snD699S.img
07 : 2 2 51.7105 /snP157S.img
08 : 2 3 52.3154/snD701S.img
09 : 2 4 47.0633 /snP253S.img
10: 2 5 52.2296/snD719S.img
Images scaled to an overall grand mean of 50 
Gray matter threshold is 80% of the whole brain mean 
Covariates are centered before inclusion in design matrix
SPM96 (abarnes) -  20/04/1999 (15:41)
Design Matrix
I C\JII
Q_
I
CL
D D
O O
O 5
1
2
3
4
co c  o
03 
£Q)
CO 
_Qo
7
5
6
8
9
10
ii 11 ■
0.5 1 1.5 2 2.5 3 3.5
effects 
Design: Compare-groups: 1 scan per subject 
Global normalisation: Proportional scaling 
Parameters:
2 Condition + 0 Covariate + 1 Block + 0 Confound
= 3 parameters, having 2 degrees of freedom, giving 8 residual df (10 scans).
SPM96 (abarnes) -  20/04/1999 (15:41)
SPM{F} p < 0.05, df: 1.0,8.0
Search volume: 110114 voxels 
Image size: 79 95 34 voxels 
Voxel size 2.0 2.0 4.0 mm 
Resolution {FWHM} 17.2 18.8 19.8 mm
Results directory:/homes/abarnes/work_in_progress/VNS/occ_act/selected_!
Contrasts 1 2
Group_1 1 -1
Group_2 -1 1
SPM96 (abarnes) -  20/04/1999 (15:44)
SPM{Z}
contrast
1 2 3
design matrix
P values & statistics: ../VNS/occ_act/all_scans
se t-le ve l {c} c luster-leve l {k,Z} voxe l-leve l {Z} uncorrected k & Z x,y,z {mm}
0.863  (2 ) 0.247  (224 , 3 .95 ) 
0.908  ( 125 , 3 .14 )
0.187  (3 .95 ) 0.116  0.000  26 - 2  -3 6
0.897  (3 . 14 ) 0.233  0.001 -1 4  34 -3 6
Height threshold {u} = 2.33, p = 0.010 
Extent threshold (k) = 94 voxels, p = 0.299 
Expected voxels per cluster, E{n) = 94.3 
Expected number of clusters, E{m} = 3.5
Volume {S} = 110114 voxels or 276.1 Resels 
Degrees of freedom due to error = 8.0 
Smoothness FWHM (mm) = 17.2 18.8 19.8 
(voxels) = 8.6 9.4 4.9
SPM96 (abarnes) -  20/04/1999 (15:44)
SPM{Z}
contrast
1 2 3
design matrix
P values & statistics: ../VNS/occ act/all scans
se t-leve l {c} c luster-leve l {k,Z} voxe l-leve l {Z} uncorrected k & Z x,y,z {mm}
0.273  (5 ) 0.002 (3555 , 3 .83 ) 0.264 (3 .83 ) 0.000 0.000 -6 -8 8 -8
0.349 (3.73) 0.000 14 -9 2 -4
0.619 (3.46) 0.000 10 -7 6 -8
0.646 ( 103 , 3 .48 ) 0.602 (3 .48 ) 0.278 0.000 -2 6 16 36
0.424 (416 , 3 .3 9 ) 0.698 (3 .39 ) 0.039 0.000 4 -8  60
1.000 (2.46) 0.007 10 -2 0 56
0.749 ( 198 , 3 .37 ) 0.716 (3 .37 ) 0.138 0.000 32 -4 0 56
0.972 (94 , 2 .97 ) 0.969 (2 .97 ) 0.299 0.002 -1 8 -2 4 -2 0
1.000 (2.46) 0.007 -1 4 -3 6 -2 4
Height threshold {u} = 2.33, p = 0.010 
Extent threshold {k} = 94 voxels, p = 0.299 
Expected voxels per cluster, E{n} = 94.3 
Expected number of clusters, E{m} = 3.5
Volume {S} = 110114 voxels or 276.1 Resels 
Degrees of freedom due to error = 8.0 
Smoothness FWHM {mm} = 17.2 18.8 19.8 
{voxels} = 8.6 9.4 4.9
SPM96 (abarnes) -  20/04/1999 (15:44)
Appendix E
The following pages contain copies of the personal communications referred to in the text 
and footnotes, available from the spm mailbase facility for a limited time.
SPM-mailbase letter dated Jan/98 at http://www.mailbase.ac.uk/lists/spm/1998- 
01/0078.html
SPM-mailbase letter dated feb/98 at http://www.mailbase.ac.uk/lists/spm/1998- 
02/000 Lhtml
SPM help line letter dated - http://www.mailbase.ac.uk/lists/spm/1998-04/0014.html 
SPM help line letter dated - http://www.mailbase.ac.uk/lists/spm/1998-06/0076 
SPM help-line http://www.mailbase.ac.uk/lists/spm/1997-12/0009.html
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>111) With regards to the basis functions options in SPM, I had reviewed
> your correspondence with Matthew Brett and S. Kapur... but I would
> appreciate some clarification.
>
> /  thought increasing the number o f basis functions in x, y ,  or z
> would usually improve the solution in each respective axis i.e.
> 4 4 4  will not give as close a mathematical solution as 8 8 8.
> However, sometimes the mathematical solution with more parameters
> is vulnerable to local minima and may not result in the best solution.
> So I thought the best empirical use would be to choose the lowest
> number o f basis functions needed fo r  each axis. 1 would increase
> basis functions from the default until the normalized image no longer
> improved. Improvement could be assessed visually and by choosing
> coordinate points.
>
>
> With this in mind I normalized full head MRls that had been coregistered
> to the SPM96 T1 MRI template (the MRIs are degraded to PET voxel size
> o f about 2X2X3).
You don’t need to work on the degraded resliced MRI. The associated ‘.mat’ 
file contains the information required to map the original MRI to the PET 
images. This information is used by the spatial normalization, enabling 
you to work from the full sized MRI. In fact, one main danger of estimating 
Darameters from the resliced MRI is that there may be artificial edges in the 
resliced image (from where you may have data in the PET images, but none in 
the original MRI). Similarly, it is better to estimate spatial normalization 
parameters from the mean of the PET images that can be generated by the 
realignment routine. This image does not have artificial edges that are 
generated by the ‘masking’.
Another similar issue is what to do with the edge of the FOV. The images are 
smoothed before estimating the registration parameters. Because the values 
outside the FOV are unknown, there are inevitably edge artifacts in the smoothed 
images. In SPM96, the whole of the image is used - including the bits near the 
sdge - and this occasionally causes problems. However, in the next release, the 
bits at the edges will be ignored by the parameter estimation part. This should 
improve the results.
>  /  initially used the default 4 5 4 and noticed that
> the cerebellum seemed stretched in the z axis grossly. Thinking that
> an MRI should have more information than a PET image, I would expect
> better normalization. Thus I thought increasing the basis functions
> in the z axis would inprove the situation because a better mathematical
> solution from  more basis functions would result in a better template
> solution. Empirically 4 6 9 seemed better but there was still downward
> displacement in the z axis o f  about 4mm in the inferior frontal and
> occipital cortex as compared to template. In general, coordinates
> located seemed no more than 8mm apart.
> I found that 4 6 11 made unpleasant (some z axis distortions?) in the
> temporal cortex giving a wide appearance in the transverse view.
> Does this seem general approach seem rational to you? Would you approach
> this any differently?
rhis approach is rational for the spatial normalization of SPM96. Fit as 
nany parameters as possible until the registration becomes unstable. See 
he answer to Q (#4).
> #2) My other question is what set o f  basis functions do you find  provides
> the best normalization fo r  a coregistered quality MRI? (Consider the
> MRI coregistered by the SPM96 program  -  which probably gives similar
> quality images to our coregistration)
I don’t know for SPM96. There are so many parameters to think of.
>  #3) T1 MRI template with 12 subjects - Would you concur that this seems
> to be the best template ? Why do you think so ?
>
> 12 MRIs have more entropy than 305 averaged MRIs which may provide better
> coregistration. (The 305 have a homogenous cortex with limited information)
>
> Why 12 is better than 1 ? : Maybe 12 provide a spatial distribution that
> will be more likely to have more mutual information with an average subject
> than a single MRI. Based on this, I would anticipate that a greater
> proportion o f  subjects would normalize well to the 12 averaged. I would
> also anticipate that the single MRI template would be better fo r  spatial
> normalization fo r  some but worse fo r  others (a wider variance o f quality
> o f  normalization in the single template normalized images). Could you
> clarify whether you agree with these thoughts and perhaps suggest some
> other reasons?
[ agree with you.
[ think that the voxel values in the template should be unbiased estimates 
Df what the voxel values in spatially normalized images should be. The best 
anbiased estimate I could think of would be the mean of a number of spatially 
lormalized images. The images should be normalized as well as possible to 
within the limits of the spatial normalization routine that is to be used.
Hie more images the better, but I expect that adding much more than about 12 
images to the template would not improve it greatly.
Possibly a slightly better approach would be to model the intensity distribution 
Df the normalized images. Rather than just the mean of the images, the mean and 
covariance of the normalized images could be modelled (possibly by fitting to a
inear combination of ‘eigenimages’ and their associated variances).
\nother issue relates to the choice of what is matched. With T1 MRI, much of the 
natching information is around the ventricles, brain and scalp. Because the 
leformations are only defined by a few hundred parameters, the overall shape 
)f the head (rather than just the brain) tends to be matched. This leads to 
naccuracies in brain matching that result from variability outside the brain.
This is particularly evident for T1 MRI, but less so for PET blood flow images 
where there is less signal in the scalp.
Hie next SPM release will give you an option for weighting the registration so that 
he parameters are just based on the shape of the brain.
> #4) What is a good normalization?
Hiis is a good question for which different people are likely to give different 
answers. I guess for SPM, it is the spatial normalization that gives you the 
oest Z-scores for multi-subject experiments.
[ believe that Bayesian statistics need to be applied in order to obtain a maximum 
i posteriori (MAP) estimate (the single most probable solution), minimum variance 
estimate (MVE - a weighted average of all possible solutions, where the weights 
ire the probabilities that the solutions are correct), or something in between.
With little or no smoothing before doing the stats, then a MAP estimate may be 
preferable, but with more smoothing then I think a solution closer to the MVE would 
be better. Unfortunately, MVE solutions require a lot of computation.
In order to adopt Bayesian statistics, it is necessary to have a good model describing 
the a priori probability distribution of the parameters. This means that by plugging 
is some data that represents the true variability of brain shape, then a better estimate 
af the spatial normalization parameters can be made. This is comparable to a statistics 
test that was sent around our unit a few months ago:
D -------------------     O
You feel perfectly healthy. However, one in a thousand persons of your age group, I 
gender and life style suffer from a specific cancer without showing any clinical I 
symptoms. Therefore you decide to participate in a screening test. I 
The screening test is very reliable. The probability that the test is positive I 
given that the person has the disease is 99%, i.e. only 1% of false negative I 
results. The probability that the test is negative given that the person does not I 
have the disease is 98%, i.e. only 2% of false positive results. I 
You are informed that in your case the result of the test is positive. I 
What is the probability that you actually suffer from the disease? I
o--------------------------------------------------------------  o
By knowing the a priori distribution of the disease (1 in 1000 sufferers), it is possible 
to obtain a much more accurate estimate of the answer (0.047 if you are interested).
A Bayesian solution also requires an estimate of the error that would be made by using 
only a maximum likelihood solution (ML). This is comparable to knowing the false positive 
and false negative error rate in the above example. A bit more work has been done on this 
for the next SPM release (see Neuroimage 6:344-352 (1997)).
The spatial normalization of SPM96 slightly overestimates the a priori variability
)f the parameters, and the errors on the fits are slightly underestimated, so the 
itting may be a little bit under-regularized (although it seemed to work OK at 
he time with our images). This means that the algorithm can have problems when 
t attempts to fit too many parameters. Any modeller will tell you that you can only 
it  so many parameters to any data, and that occasionally any nonlinear optimization 
ilgorithm will mess up - especially when it tries to converge too rapidly. Only when 
>rou start using constraints and priors can you begin to attempt to fit lots of parameters.
Another issue is what to do with voxels that shrink and grow dramatically. This is 
sasier to conceptialize with PET, where the simple question would be:
’Should concentration, or absolute amount of tracer be preserved in the spatially 
lormalized images?"
With lots of warping, the relative volumes of the voxels will be more variable.
The way it is done now results in concentration being preserved. So, if any particular 
-egion shrinks after spatial normalization, this results in the absolute amount of 
racer in this region also shrinking. This may or may not be a good thing.
> I have been assessing our application o f  your normalization process upon
> summed WA Y ligand images over time. 
b>
> I have been sampling the location o f  points on normalized images (finding
> their mean coordinate fo r  each image) In general, the average distance
> between subjects ranges from  2mm (anterior insula) to 6mm (midline posterior
> occipital cortex). The greatest distance between a pair o f  subjects fo r  a
> given point is 10mm.
p>
> How does this compare to water images and M RI images ?
[ don’t honestly know. I haven’t evaluated the registration this way. Most 
of the evaluations have involved looking at the decrease in the residual squared 
differences between the templates and images, as well as a few purely qualitative 
evaluations.
> I am not aware o f  a paper that states mean distances between normalized
> images -couldyou refer me to one? I am aware o f  1991 JCBF by Friston
> et al. which states mean template and image coordinates fo r  points (but
> not standard deviation or greatest distance).
There isn’t one for the current nonlinear spatial normalization of SPM.
> #5) Will SPM actually change the values within voxels?
It will try not to, but when it has to interpolate between 8 neighbouring voxels, 
changes in voxel values are inevitable.
> #6) With regards to interpolation, I am aware that sine interpolation has
> been demonstrated to be the best fo r  MR images. What evidence ( if  any)
> supports the use o f  sine interpolation fo r  PET images?
I think sine interpolation should be better for all images. However, there 
is so much noise in PET images, they are relatively smooth, PET signals are 
usually much higher than fMRI signals, and the degrees of freedom are so much
ower in PET experiments that sine and bilinear interpolation should not make 
»o much difference. However, it is worth noting that when you use sine 
interpolation with PET, you will find that the estimates of smoothness have 
ower FWHMs. This is because bilinear interpolation takes a weighted average 
)f the 8 nearest neighbours - which is essentially a smoothing step.
> Is there any way to choose one kind o f interpolation fo r  choosing the
> location o f resliced data and a different interpolation i.e. nearest
> neighbour or bilinear to the actual values ?
Die estimation of spatial normalization parameters always uses bilinear 
interpolation, whereas you get a choice about how you resample the data.
Regards,
-John
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Dear Dr Allison,
You suggested that Dr. Makuuchi employ Global Normalization using 
"Scaling". Please comment on the use o f "Scaling" versus "ANCOVA "for  
Global Normalization. When is each appropriate in the realm o f fM RI 
studies? Why did you suggest "Scaling"?
\nCova and proportional scaling imply very different models for the 
jffect of changes in global measurement. There has been much 
lisagreement and much written about the pro’s and con’s of the two 
ipproaches, but to my mind there’s no general answer as to which is 
jest: It’s a simple case of using the model most appropriate for the 
lata at hand. Here are my general thoughts...
AnCova uses a local linear model for a small range of global values, 
vith constant variance, and assummes activations are additive.
^oportional scaling (followed by Anova) implies a proportional model 
he effect of global changes on regional values, assummes activations 
ire proportional to the underlying global, and (crucially) also that 
/ariance increases with global. This last attribute is oft overlooked, 
nakes a formal comparison of AnCova and Prop.Scale/Anova models on a 
lata set non-trivial, but is really what differentiates the two 
nodels.
[n short: If global measurements vary as a result of a gain effect, 
iuch as scanner sensitivity (fMRI) or introduced activity (PET), then 
he noise should increase with the signal and a proportional model 
vould be appropriate. If global measurements truly reflect a normal 
*ange of an underlying physiological process (i.e.CBF), then there is 
little evidence for globally dependent variance, and the non-linear 
relationship global and regional values is best modelled with a local 
iinear model - AnCova.
' Note that global normalisation implies assessing other changes )
' relative to the global, via the chosen model. In general th en ,)
' you’re in trouble if the global measurement and effects of in terest)
' are correlated. See the Ch3 of the SPMcourse notes for further )
' discussion. )
So, for quantified PET with true rCBF measurements, I’d use AnCova
within subjects, with a different parameter for each subject (subject 
ipecific AnCova in SPMspeak). With relative "counts" data obtained from 
i tightly controlled input dose, I’d again use subject specific AnCova,
)ut would consider scaling across subjects (prior to AnCova) if there 
ire obvious subject differences. Such a scaling would involve scaling 
ill a subjects images by the *same* factor, such that the Grand mean 
mean of the global means) for each subject was the same. For PET with 
i very variable input dose, the Poisson nature of radioactive decay 
immediately suggests variance increasing with intensity, and hence 
proportional scaling.
With fMRI it’s a bit trickier, mainly because we’re not sure what BOLD 
is actually measuring. However, we’ve found that many (older) scanners 
recalibrate prior to acquiring every image volume. This is clearly a 
gain effect. Empirically, for a tight range of global values, there 
appears to be little difference in the results from a proportional 
scaling and a subject-specific AnCova. I therefore suggested "Scaling" 
to Dr. Makuuchi on the grounds that it’s safest for fMRI in the absence 
of additional knowledge.
For further comments I suggest the SPM course notes (Ch3), and a review 
of the literature. There’s a plethora of assessments for various data 
published, and I look forward to reading of other groups thoughts and 
experience.
Hope this helps,
-andrew
■I-- Dr Andrew H olm es------------------------------ a.holmes@fil.ion.ucl.ac.uk-+
I -________ Wellcome Department o f Cognitive Neurology - I
I ( _J( )()  Functional Imaging Laboratory, Stats & I
\ ) _) )( )( 12 Queen Square, Systems I
I (_) ( _ ) (___ ) London. WC1N3BG. England, UK I
If- --------------------- ----------- -------- http://w w w .fil.ion .ucl.ac.uk/-+
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[ have been using spm to do single subject analyses and have encountered 
some interesting if vexing problems.
1. A single subject who has hydrocephalus compared to a normal data 
oase shows less activity in the temporal horns of the lateral ventricle 
ireas (interpreted as grey matter, but easily understood). Curiously he 
shows greater activity on the SPM in the atria of the lateral 
ventricles. How can this be?
2. A subject with a large R frontal lobe lesion simply wouldn’t run. We 
tried no affine, our own iterations, etc. The normalization chops off 
the right frontal lobe in a clean line. Our hypothesis is that if a
lesion exceeds the voxel size after smoothing the normalization 
transformation is "funky" but what exactly happens - just curious?
3. Similar to number one. One subject was tested who has a normal 
brain on MR. Unfortunately he was badly positioned during the scan and 
lost large parts of both the basal temporal lobes and the superior 
frontal parietal cortex instead of small parts of both. Tested against
the normal group spm says the normals have greater activity than all of 
the brain that was included in the scan. It says he has greater 
activity at the lower edge of the scan, where it was cut off. Again I 
would like to know how an edge effect can look like too much activity in 
an area that doesn’t really exist and how relatively normal brain can be 
judged as all significantly depressed "between the edges"?
In case it isn’t obvious, we are using a single subjects, 2-conditions,
1 with replications to run the tests, which has worked well in other 
subjects.
Why bother with bad or distorted scans in the first place you ask? Good 
question! Hopefully it will be a learning experience?
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Dear Darren,
This is a recurrent issue. The following was posted some time ago 
but remains, I think, a reasonable answer to your question:
I think it is appropriate to re-iterate a few points about standard 
anatomical spaces.
(i) The ’standard’ space into which data are normalized is defined 
operationally by the template employed (not by any atlas or system)
(ii) The Talairach ’system’ is used by most people in the imaging 
neuroscience community. This system is a coordinate referencing 
system and can be used with any template.
(iii) Any template that is used to implement the Talairach system can 
be said to effect a normalization into ’a’ Talairach space.
(iv) The relationship between the template used and the Talairach 
atlas drawings may, or may not, be a tight one. The closer this 
relationship, the better the atlas will serve as a guide for labelling 
the Talairach x,y,z designation.
Clearly to maximize the face (and construct) validity of anatomical 
labels it would best if we all used the same template (and this 
template was as canonical as possible). To this end SPM has adopted 
templates that conform to those used by the ICBM project (USA) that 
will create a probabilistic atlas and that will, possibly, supervene 
over the Talairach atlas in the years to come. This template is based 
on a single subject that has been matched to the MNI 305 average.
In short all the templates available with SPM conform to the Talairach 
system with varying degrees of ’closeness’ to the atlas drawings. They 
are all variants of ’a’ Talairach space. The most recent templates 
have been designed to make them compatible with the MNI 305 average and 
implicitly the ICBM atlases that will ensue in the future.
This is a difficult issue and other comments would be valued.
I hope this helps - Karl
Specifically:-
> Dear SPM-folks
>
> A series o f questions have come up regarding the relationship between the
> MNI brain (as provided in SPM96) which defines one version o f "Talairach"
> space and the brain space identified in the 1988 Talairach atlas itself It
> appears these are not the same (the 1988 brain is smaller) and comments to
> that effect were made at HBM98 by Dr. Passingham.
>
> Is there any way to map between MNI space (SPM96) and Talairach-88' space?
> Are there any algorithms fo r  that mapping? How can one compare coordinates
> obtained by matching the MNI template (ala SPM96) with coordinates
> published in the literature supposedly in Talairach space.
There is no unique ’Talairach space’ (see above). Clearly the mappings 
from one ’Talairach space’ to another are easily obtained by 
normalizing the underlying template of one to that of the other. Given 
that the drawings in the T&T atlas do not conform to a ’template’ the 
T&T space is operationally less useful than any other (because its 
relationship to other spaces is less easy to define).
> Many functional imaging studies published today compare results by listing
> "Talairach" coordinates fo r  various studies. The possibility exists that
> one can't compare results in this way at all i f  the brain spaces are
> different. Is there a crisis in normalization?
No. There will be a variance component in the stereotactic metrics due 
to different normalization procedures and the use of different 
templates. The exitance of this component is important but does not 
engender a ’crisis’. This component will be minimized with a 
convergence of nonlinear techniques and when we all adopt the same 
template. This is why we switched to a template that conforms to the 
MNI space and implcitly the ICBM space. The priority for us was to 
promote convergence within the community (not to ensure any backward 
compatibility or contruct validity in relation to a particular set of 
atlas drawings).
With best wishes - Karl
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Dear Anna,
> We are about to embark on a study involving the comparison o f
> individual patients to a ’normal ’ database using SPM96. Does anybody
> have any feeling fo r  the number o f scans needed in the normal
> database? I have seen quoted in abstracts from the FIL n but 1 have
> also seen users on the mailing list quoting numbers ofnO. I have
> tried searching the mailing list archives for more info but had no
> luck. I f  anybody could point me in the right direction I would be
> grateful.
I don’t think there is any absolute answer. The more normals you 
include then the more powerful (increased probablity of detecting an 
effect, if it is there, for a given false positive rate) it will be.
There is the ancillary issue of the approximation implicit in 
Gaussianization of the SPM{t} that is special to SPM. This means that 
a SPM analysis is more conservative than the normal t test for very low 
degrees of freedom (e.g. < 16). I like the number n2 but n would 
be acceptable in terms of power. Of course if you detect an effect 
with n=8 then it is perfectly justifiable to report it (as long as you 
don’t try to interpret negative findings and say that the analysis is 
not powerful).
1 hope this helps - Karl
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